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ABSTRACT 
 
PCR is commonly used for detecting contamination of foods by toxigenic bacteria.  
However, it is unknown whether it is suitable for detecting toxins in samples which 
are unlikely to contain bacterial cells, such as purified biological weapons.  
Quantitative real-time PCR assays were developed for amplification of the genes 
encoding Clostridium botulinum neurotoxins A to F, Staphylococcal enteroxin B 
(SEB), ricin, and C. perfringens alpha toxin.  Botulinum neurotoxins, alpha toxin, 
ricin and V antigen from Yersinia pestis were purified at Dstl using methods 
including precipitation, ion exchange, FPLC, affinity chromatography and gel 
filtration.  Additionally, toxin samples of unknown purity were purchased from a 
commercial supplier.  Q-PCR analysis showed that DNA was present in crudely 
prepared toxin samples.  However, the majority of purified or commercially 
produced toxins were not detectable by PCR.  Therefore, it is unlikely that PCR will 
serve as a primary toxin detection method in future. 
 
Immuno-PCR was investigated as an alternative, more direct method of toxin 
detection.  Several iterations of the method were investigated, each using a different 
way of labelling the secondary antibody with DNA.  It was discovered that the way 
in which antibodies are labelled with DNA is crucial to the success of the method, as 
the DNA concentration must be optimised in order to fully take advantage of signal 
amplification without causing excessive background noise.  In general terms 
immuno-PCR was demonstrated to offer increased sensitivity over conventional 
ELISA, once fully optimised, making it particularly useful for biological weapons 
analysis.   
  iii 
 
Finally, genetic methods for the differentiation of toxigenic Ricinus communis strains 
were examined, including SSR, RAPD, RFLP and SNP analysis using next 
generation sequencing.  The results showed that the species has low genetic 
diversity, making genotyping a particularly difficult task, however SSR analysis was 
able to provide a degree of differentiation and 454 Sequencingª identified six SNP 
targets that warrant further investigation in future. 
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1.  INTRODUCTION 
1.1 TOXINS AS BIOLOGICAL WEAPONS 
Bioterrorism is the intentional use of microorganisms or toxins derived from living 
organisms to cause death or disease in humans, animals or plants on which we 
depend (Ashford, 2003).  Biological warfare (BW) specifically refers to the use of 
such weapons in the battlefield (Carter, 2000).  The Biological and Toxin Weapons 
convention (BTWC) prohibits the development, production and testing of biological 
weapons (United Nations report, 1971).  A number of toxins are on the Centers for 
Disease Control and prevention (CDC) category A, B and C biological weapons 
threat list (http://www.bt.cdc.gov/agent/agentlist-category.asp), including 
Clostridium botulinum neurotoxin, ricin, Staphylococcal enterotoxin B (SEB) and C. 
perfringens alpha toxin.  Toxins may be produced as agents either in liquid or 
powdered form (Carter, 2000), with the most potent method of delivery being via the 
aerosol route (Hawley et al., 2001).  Inhalation of the weapon may or may not be 
lethal.  For example, SEB may evoke a quick and transient debilitation lasting less 
than 24 hours (Carter, 2000). Inhalation of botulinum neurotoxin is more likely to 
cause fatality (Madsen, 2001).  Detection of a disease or intoxication outbreak is 
essential to aid the investigation of potential production facilities, environmental or 
clinical samples (Zilinskas, 1998).  Antibody-based detection techniques such as 
ELISA were first described forty years ago (Engvall and Perlmann, 1971).  The 
utility of ELISA for toxin detection has steadily increased since it was first used to 
detect cholera toxin (Holmgren and Svennerholm, 1973).  However, identification of 
a toxin in a BTWC scenario would require confirmation using an orthologous 
technique.  PCR is exquisitely sensitive and is routinely used for detection of trace 
amounts of DNA enabling specific identification of a source in humans (Jeffreys et 
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al.,  1991) and similar methods exist for numerous other species including the BW 
agent anthrax (Hoffmaster et al., 2002).  It is therefore conceivable that PCR may be 
suitable for detecting toxin DNA in samples where the quantity of DNA is limited.  
Currently, it is unknown whether DNA will be present in a toxin sample presented 
for BTWC analysis, since it may be subject to crude or stringent purification.  To 
determine whether or not this is the case is the primary aim of this thesis.  The 
secondary aim is to investigate the potential of alternative nucleic acid methods for 
detecting toxins.   
 
1.2 TOXINS 
Toxins are chemicals or proteins produced by living organisms such as bacteria, 
fungi, plants and animals ranging from dinoflagellates to vertebrates.  Many have a 
deleterious effect on man.  By definition, they have a toxic effect on the cell type 
they target, which in most cases leads to cell death.  The result of this will be 
incapacitation or fatality of an intoxicated patient if untreated (Wassenaar, 2007).    
 
Toxins can be classified depending on their mode of action.  An exotoxin for 
example, is a toxin that is produced by a bacterium as part of its metabolism.  It is 
normally released into the bacteriumÕs surroundings.  Additionally, they are often 
encoded by plasmids or prophages that have infected or integrated into a bacterial 
host (Abedon and LeJeune, 2007).  They are highly immunogenic and stimulate the 
production of neutralising antibodies.  They are usually categorised as neurotoxins, 
cytotoxins or enterotoxins (Wassenaar, 1997) according to their mode of action.  For 
example, enterotoxins are exotoxins that specifically damage intestinal mucosa, 
causing vomiting and diarrhoea (Henkel et al., 2010). Generally, exotoxins conform 
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to an AB model, where the A subunit has enzymatic activity and the B subunit is 
involved in binding to its target (Gill, 1978). 
 
Endotoxins are the heat stable lipopolysaccharides (LPS) in the cell walls of Gram-
negative bacteria that are released when the bacterium lyses or during growth.  The 
toxic part of LPS is the lipid A portion, a complex arrangement of lipid residues 
(Reeves and Wang, 2002).  This thesis is concerned with protein exotoxins 
exclusively, as endotoxins are not on the CDC threat list independently of their 
parent organism. 
 
It is thought that most agents that cause food borne intoxication are unable to survive 
in vivo except in infants.  Consequently, food borne illness is often caused by pre-
formed toxin (Balaban et al., 2001).  Similarly, toxins may be released as biological 
weapons independently of the organism that produced them.  The presence of viable 
cells in a sample is not proof of the presence of toxin and presumably therefore, 
direct detection of toxins should be demonstrated where possible.  Therefore, the 
method used for detecting a toxin should be carefully considered.  For any toxin 
detection method to be successful, the nature of the causative organism must be 
understood. 
 
1.3 GENETICS OF TOXIN PRODUCTION 
1.3.1  Clostridium botulinum 
Clostridium botulinum is an anaerobic, spore-forming rod that is widely distributed 
in soils and sediments of oceans and lakes.  It is also the causative agent of botulism, 
a neuroparalytic disease of humans and other animals.  Food borne botulism is the 
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most common occurrence of the disease, with 263 cases reported in the US in 
between 1990 and 2000 (Sobel et al., 2004).  C. botulinum spores are commonly 
found in canned and vacuum packed foods (Fach et al., 1995). If the spores are 
allowed to germinate, the neurotoxin is produced during vegetative cell growth.  If 
contaminated food is then eaten without being heated thoroughly, the toxin remains 
active and causes botulism.   
 
The classification of Clostridium botulinum is complex.  Primarily, it is based on the 
type of neurotoxin it produces.  There are seven Clostridium botulinum neurotoxin 
serotypes, A to G, each with different functional and antigenic attributes (Adekar et 
al., 2008).  However, several strains are able to produce more than one type of 
neurotoxin (Table 1.1).  Species are also divided into four additional groups, based 
on cultural, biochemical and physiological characteristics.  Furthermore, botulinum 
neurotoxins (BoNTs) are also produced by C. baratii and C. butyricum (BoNT/F and 
BoNT/E respectively; Collins and East, 1998).   
 
BoNTs are synthesised as a single 150 kDa polypeptide chain (pro-toxin), which is 
post-translationally nicked to yield a di-chain composed of a light (50 kDa) and 
heavy (100 kDa) chain linked by a disulphide bridge in proteolytic strains.  The 
Carboxy terminal (C) half of the heavy chain is involved in the binding to a surface 
nerve cell receptor whilst the amino (N) terminal half is implicated in the 
translocation of the toxin across the cell membrane.  The light chain is involved in 
intracellular activity (Popoff and Marvaud, 1999).   
 
Clinically, the most important strains are group I strains although group II strains 
also cause disease in humans.  Generally, strains within groups I or II are closely 
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related to each other regardless of the toxin type they produce.  In contrast, strains 
belonging to different phenotypic groups exhibit low relatedness even though some 
produce the same toxin type (such as type B strains of group I and II), (Minton, 
1995).  The optimum temperature for growth and toxin production of proteolytic 
strains is 35 
o
C, whereas non-proteolytic strains grow at 25 
o
C and can produce toxin 
in refrigeration (Peck, 2006).  With this in mind, strict guidelines are given for the 
production of chilled foods (Peck et al., 2008).  Toxins produced by non-proteolytic 
strains only exert full toxicity once activated by trypsin whereas proteolytic strains 
initially produce fully active toxins.  
 
There are three main types of human botulism, depending on the strain type and 
mode of infection (Brett et al., 2004).  Food borne botulism is caused by type A 
strains in America, type B in Europe and type E in the extreme Northern Hemisphere 
(Popoff and Marvaud, 1999).  It is more rarely caused by types F and C (Brett et al., 
2004).  This effect may be a result of the geographical distribution of strain types, 
although cultural differences in diet may also affect epidemiology.  Strains belonging 
to group I cause a second category of disease, intestinal colonisation, resulting in 
botulism in infants and immunocompromised adults, as do C. botulinum C, C. baratii 
and C. butyricum.  Wound infection by C. botulinum A or B from group I is the third 
cause of botulism (Popoff and Marvaud, 1999). 
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Table 1.1 Classification of Clostridium botulinum based on phenotypic 
characteristics compiled from Collins (1998) and Hill et al., (2010);  
 
Neurotoxin 
type 
Group I 
Human disease 
High heat 
resistant. 
Proteolytic 
 
Group II 
Human Disease 
Low heat 
resistant. 
Non-proteolytic 
Group III 
Animal 
disease 
Non-
proteolytic 
Group IV 
Non toxigenic. 
Not proven to 
cause disease.  
Uncharacterised 
A  A1, A2, A3, 
A4, A5 
   
B  B B   
C   C  
D   D  
E   E   
F F F   
G    G 
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Botulinum neurotoxins inhibit the release of several neurotransmitters, resulting in 
flaccid paralysis (Davis, 2003). The toxin binds to the pre-synaptic receptor at 
neuromuscular junctions, which is followed by endocytosis directed by a domain 
next to the receptor-recognition element on the heavy chain of the toxin. (Figure 1.1).    
This is followed by zinc-dependent protease activity of the light chain culminating in 
prevention of fusion of the synaptic vesicle with the cell membrane and release of 
acetylcholine (Hambleton, 1992).   
 
Figure 1.1 Endocytosis of botulinum neurotoxin to neuronal cells.    The toxin 
binds to the nerve cell at the neuromuscular junction and enters by endocytocis.  
The light chain of botulinum toxin cleaves specific sites on the SNAP receptor 
proteins, preventing assembly of the synaptic fusion  complex, thus blocking 
acetylcholine release (adapted from Shukla and Sharma, 2005). 
 
 
Synaptic Cleft 
Muscle Fibre 
Light Chain 
Heavy Chain 
X 
Nerve Terminus 
Neurotransmitter 
not released 
Synaptic Vesicle 
Muscle Cell 
Paralysed 
Protease activity of light chain 
prevents vesicle fusion with 
membrane 
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There are different presynaptic receptors for each serotype, for example 
synaptobrevin is the SNAP receptor for neurotoxins of serotype B, D, F and G, 
whilst SNAP-25 is the receptor for type A (Shukla and Sharma, 2005).  The 
physiological effects of flaccid paralysis caused by ingestion of the toxin are dry 
mouth, visual difficulty, speech difficulty, nausea, weakness, vomiting, dizziness, 
and progressive paralysis.  Death is ultimately caused by respiratory or cardiac 
failure (Peck et al., 2011).  Documented cases of inhalational botulism are rare, but 
one reported case of accidental exposure in a laboratory in Germany in 1962 lead to 
symptoms similar to those described above (Arnon, 2001). 
 
Terrorists have previously attempted to use botulinum toxin as a bioweapon.  
Aerosols were dispersed at various sites in Tokyo by the Japanese cult Aum 
Shinrikyo (Arnon, 2001).  The toxin is extremely potent; as little as 1-2 µg of toxin 
can prove fatal (Shone et al.,1987). The toxin is unstable in the pure state, which is 
therefore unlikely to be used as a biological weapon (Gill, 1982).  However, it is 
stable when partially purified and spray dried and it is also stable in cold water for 1 
week which may be a more suitable way of disseminating the toxin (Gill, 1982).    
 
BoNT is produced as part of a complex, which ranges in size and content depending 
on serotype, host strain and environmental factors (Peck, 2009). A non-toxin, non-
haemaglutinin (NTNH) protein is common to each complex.  The larger toxin 
complexes are more resistant to the extremes of pH and temperature found in the 
stomach than the purified toxin (Hambleton, 1992). There are several types of 
haemagglutinating (HA) proteins associated with BoNT, ranging in size from 147 to 
625 amino acids, in two transcriptional units (Peck, 2009).  The toxin (bont) and ntnh 
genes comprise one unit and the gene encoding HA proteins are transcribed in the 
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opposite direction.   Between these units is a sigma factor which positively regulates 
gene expression (Dupuy and Matamouros, 2006).  Types A1, A2, A3, A4, 
Proteolytic F, E and non-proteolytic F additionally contain a group of three open 
reading frames of, as yet, unknown function (Peck, 2009). 
 
Until fairly recently, the accepted international standard for detection of C. botulinum 
in food samples involved enrichment for 5 days followed by microbiological tests 
and mouse bioassay which takes two weeks in total (Alsallami and Kotlowski, 2001).  
Immunological methods are quicker, but enrichment for five days may still be 
necessary to enable the production of enough toxin for detection by ELISA (Ferreira 
et al., 1994).  PCR is deemed sensitive enough by the food industry to side-step 
enrichment procedures and can deliver results in a few hours.  Consequently, a lot of 
research has been published on the subject of PCR methods for detection of C. 
botulinum neurotoxin genes using extracted DNA.  For example, traditional assays 
have been developed by Szabo et al.,  (1992), Campbell et al., (1993); Franciosa et 
al., (1996) and Lindstrom et al., (2001) amongst others, each with similar sensitivity 
and specificity.  Real-time PCR assays have also been in existence for a number of 
years, for example an assay able to detect 10
2
 CFU/ml of type E cells was developed 
by Kimura et al., (2001), giving more sensitive detection than the comparative mouse 
lethality test.      
 
Real time multiplex assays have been developed since the onset of this study by 
researchers including Fach et al., (2009), Satterfield et al., (2010), Kirchner et al., 
2010.  Additionally, Macdonald et al., (2008), successfully used VNTR analysis to 
type C. botulinum strains in crude preparations, indicating that PCR analysis of toxin 
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samples is feasible.  However, the use of real time PCR to detect DNA in 
preparations of C. botulinum neurotoxin remains largely unstudied.  
 
1.3.2 Clostridium perfringens 
C. perfringens is a widely occurring spore-forming, non-motile, Gram-positive 
bacterium commonly found in soil, sewerage and the intestines of humans and other 
animals (Tsutsui et al., 1995).  It is one of the most common causative agents of 
gastrointestinal disease such as intoxication and antibiotic related diarrhoea 
(McClane, 2004). It is a fast growing obligate anaerobe whose virulence is largely 
attributed to the production of numerous exotoxins, with α, β, ε and ι being the 
major lethal toxins and θ and κ being implicated in some diseases (Titball, 1998).  
Individuals never produce all seventeen C. perfringens toxins identified (Ma et al., 
2011), allowing strains to be classified as summarised in Table 1.2.   Besides 
producing typing toxins, C. perfringens also produces sialidase, hyauronidase, 
perfringolysin O and an enterotoxin (Ma et al. 2011).  Different toxinotypes produce 
different diseases, for example type A strains cause gas gangrene and type C strains 
cause necrotic enteritis in calves, lambs and pigs (Johnson et al., 1997).  Epsilon 
toxin, produced by type B and D isolates is an extremely potent pore-forming toxin 
which causes vascular endothelial damage (McClane, 2004), causing it to be a CDC 
category B biological weapon.  As the exact nature of the toxin remains to be 
elucidated it was not included in this study.  In contrast, alpha toxin, has been 
extensively studied (Vachieri et al. 2010).   
 
C. perfringens alpha toxin is a 42.5 KDa protein, which can be expressed at levels up 
to 10 mg/l when growth conditions are optimal.  If cloned into E. coli, production is 
three times greater (Popoff and Marvaud, 1999).  It is a membrane-damaging toxin 
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with phospholipase C and sphingomyelinase activities. Phospholipases naturally 
hydrolyse phospholipid molecules, the location of the hydrolysed bond is used to 
characterise the enzyme as types A1, A2, C, or C2. C. perfringens alpha toxin is a 
phospholipase C (PLC) (Figure 1.2).   Traumatic gas gangrene develops after a deep 
penetrating injury that compromises the blood supply, such as a gunshot or knife 
wound, that creates an anaerobic environment ideal for clostridial proliferation.  Gas 
gangrene may also develop after a surgical procedure.  It is caused by opportunistic 
infection of tissues by C. perfringens vegetative cells or spores in about 70% of cases 
with the remaining 30 % being caused by other Clostridial species (Stevens and 
Bryant, 1997).   Anaerobic conditions resulting from vascular damage facilitate the 
germination of spores and the subsequent production of α toxin under the control of 
the VirR/VirS regulon (Ba-Thein et al., 1996).  Onset of the disease occurs 6-8 hours 
after colonisation by C. perfringens.  This leads to gas production, increased vascular 
permeability, intravascular haemolysis, clot formation, necrosis and tissue damage 
which ultimately causes death by shock (Rood, 1998).   
 
The genetic organisation of toxin production in C. perfringens is relatively 
uncomplicated compared to that of C. botulinum.  Toxin types are genetically distinct 
from each other, which means that α and ε toxins, for example, are completely 
unrelated (McClane et al., 2006).  The alpha toxins produced by C. novyi and C. 
bifermentans are also phospholipase Cs and are closely related to C. perfringens 
alpha toxin.  Additionally, PLC from Listeria monocytogenes and Bacillus cereus 
may be closely related to that produced by C. perfringens.   
 
PCR has been previously used for sensitive and specific detection of C. perfringens 
alpha toxin DNA in animals (Kadra et al., 1999), autopsy tissue samples (50-500 
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genome copies per sample; Wu et al., 2009) and faecal samples (30 genome 
equivalents; Rinttila et al., 2011) amongst others.   Whilst PCR is routinely used to 
detect purified DNA from C. perfringens samples, the potential for the assay to 
detect contaminating DNA in toxin preparations is unstudied. 
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Figure 1.2 Site of phospholipid cleavage by Clostridium perfringens 
phospholipases  PLA1, PLA2, or PLC (adapted from Titball, 1999). 
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Table 1.2.  Classification of Clostridium perfringens toxinotypes, according to 
genotype, adapted from Tsutsui et al., (1995) 
 
C. 
perfringens 
toxinotype  
α  β  ε  ι  Strain Genbank 
Accession 
Number 
A + - - - NCTC 8237 M24904 
A + - - - 8-6 X17300 
A + - - - PB6K D32123 
A + - - - 13 D32127 
A + - - - KZ21 D32124 
B + + + - NCIB 10691 D32128 
C + + - - NCIB 10662 D10248 
D + - + - L9 D40068 
D + - + - NCIB 10663 D49969 
E + - - + CL49 D32125 
E + - - + NCIB 10748 D32126 
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1.3.3 Staphylococcus aureus 
 
Staphylococcus aureus is a Gram-positive coccus that is found on the skin and in the 
nasal passages of humans and other mammals worldwide (Masiuk et al., 2010).  It is 
an important human pathogen as it causes several conditions such as boils, wound 
infections and pneumonia.  It can readily enter food as it occurs so commonly and if 
allowed to multiply it will produce a range of exoproteins which enables it to 
colonise and persist within the host (Pinchuk, 2010).  These include haemolysins, 
nucleases, proteases, leucocidins, lipases, collagenases, cell-surface proteins and 
various superantigens.  Staphylococcal enterotoxins (SEs) belong to the pyrogenic 
toxin family because of their biological activities and structural relatedness (Balaban 
and Rasooly, 2001).   
 
Staphylococcal enterotoxins are classified as superantigens that induce polyclonal 
proliferation of certain T cells bearing Vβ receptors (Fleischer et al., 1991).  Unlike 
conventional antigens, superantigens associate with the major histocompatability 
complex (MHC) class II and T cell receptor directly, without being processed by 
antigen presenting cells.  The mechanism by which this occurs involves the 
formation of a tri-molecular complex of the superantigen with the Vβ receptor and 
MHC class II molecules outside the typical binding cleft (Figure 1.3). The 
consequence of such proliferation is a production of a cytokine bolus (Balaban and 
Rasooly, 2001), including interleukin 1 (IL-1), IL-2, Interferon-γ (IFN-γ) and tumour 
necrosis factor-α (TNFα) which ultimately induce symptoms in the host.  The 
presence of these cytokines induces the expression of pro-inflammatory mediators 
IL-6 and IL-8, as well as platelet activating factor, leukotrienes, thromboxane A2 and 
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prostaglandins (Monday, 1999).  TNF α acts on the hypothalamus to produce fever 
and also acts to produce extensive endothelial damage, capillary leakage and 
decrease in peripheral vascular resistance leading to hypotension and shock 
(Chesney, 1997). 
 
 
Figure 1.3 Schematic diagram of the mechanism of T cell activation by 
superantigens such as Staphylococcal enterotoxins.   
 
 
T cell 
Antigen presenting cell 
MHC 
TCR 
Superantigen 
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Twenty types of SE have been identified (A to V; Pinchuk et al., 2010).  Although 
theoretically distinct, SEA, SED and SEE share 70 to 90 % sequence homology 
(Pinchuk et al., 2010) and antibodies to SEA cross react with SEE (Sharma et al. 
2000). As with C. botulinum neurotoxin genes, SE genes are either carried by 
phages, plasmids, or on the chromosome.  Chromosomal genes may be part of a 
pathogenicity island (PI) or in the egc cluster, an operon which contains five 
enterotoxin genes and two pseudogenes (Jarraud, 2001).  Horizontal gene transfer is 
common, resulting in strains carrying between one and six enterotoxin genes 
(Varshney et al., 2009), although the most common types are SEA and SEB 
(Pinchuk et al., 2010).   
 
Staphylococcal enterotoxin B (SEB) is incapacitating to a susceptible host (Hawley, 
2001).  The toxin is a 28 336 Da single chain protein (Jones and Khan 1986).  It is 
heat stable, resistant to inactivation by proteases and is reasonably stable in aerosol 
form (Madsen, 2001).  It is an incapacitating toxin, with an LD50 of 27 µg/kg 
intravenously.  An ingested dose of 20-35 µg of purified protein is enough to cause 
vomiting in human volunteers within 4 hours (Merson, 1973).  Symptoms caused by 
inhalational intoxication include fever, malaise, muscle and chest pains, headache, 
cough, loss of appetite but no vomiting or diarrhoea.  Symptoms are rarely fatal 
(Madsen, 2001). 
 
Detection of SEB has been reported in a variety of sample types including food, 
(Holeckova et al., 2002; Rall et al., 2008; Ertas et al., 2010) biological fluids, 
(Mukhin and Chatterjee 1997), and the battlefield (Ulrich, 2000).  Many research 
groups have developed sophisticated multiplex PCR reactions to enable the detection 
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of more than one staphyloccocal toxin at once, for example (Schmitz et al., (1998); 
Mehrotra et al., (2000); Sharma et al., (2000); Nakayama et al., (2006) and Manfredi 
et al., (2010).  Although SEB can be detected in food by PCR the application of the 
technique for the detection of purified SEB toxin remains to be studied.    
 
1.3.4 Ricinus communis 
The plant toxin ricin is a protein component of Ricinus communis seeds, more 
commonly known as castor beans (Lord et al., 1994).    It is a 66 kDa lectin, a protein 
that binds carbohydrates, that belongs to the A-B family of toxins that are highly 
toxic to eukaryotic cells.  Specifically, ricin is a Ribosome Inactivating Protein (RIP). 
Most RIPs are Type I, consisting of an A chain which on its own is harmless. Type II 
RIPs, such as ricin, are heterodimeric, with the toxin subunit bound to a lectin 
subunit (Sandvig et al., 1996).  
 
Although ricin is the best known type II RIP, several unrelated dicotyledonous plants 
also produce such toxins including abrin from Abrus precatorius, modeccin from 
Adenia digitata, volkensin from Adenia volkensii, ebulin from Sambucus ebulis and 
viscumin from Viscum album (mistletoe) (Olsnes et al., 2001).  Although the plants 
producing these toxins are from unrelated species, the protein sequence, structure and 
mode of action of each toxin is very similar.  As ricin binds to both glycolipids and 
glycoproteins on the cell surface it is presumably transported inside the cell using all 
endocytic mechanisms in a given cell (Sandvig and van Deurs, 1996). One ricin 
molecule is sufficient to kill a cell and is reported to inactivate 1777 ribosomes per 
minute (Olsnes et al., 1975).  The A chain depurinates a universally conserved 
adenosine found in a GAGA tetraloop in eukaryotic 28S rRNA of the 60S ribosomal 
subunit.  The depurinated RNA is susceptible to hydrolysis and unable to bind 
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elongation factor 2, which prevents protein synthesis. As ricin irreversibly inactivates 
ribosomes, its toxicity manifests in widespread cell death (Endo et al., 1987). 
 
Exposure to ricin toxin by inhalation will cause respiratory difficulty and pulmonary 
oedema after several hours.  Ingestion of the toxin will cause nausea, vomiting, 
bloody diarrhoea, drowsiness, stupor, cyanosis, dehydration, myosis, convulsions 
and circulatory collapse within a few hours (Madsen, 2001).  The lethal dose by 
inhalation is 15 µg and 3-7 µg/kg when injected intravenously (Gill, 1982). Ricin has 
previously been used as a biological weapon by terrorists.  In 1972, the Bulgarian 
defector Georgi Markov was stabbed in the thigh with an umbrella impregnated with 
ricin in the tip.  He died on the third day post-exposure (Madsen, 2001).  Ricin is 
easily prepared with minimal knowledge or equipment; therefore, rapid detection and 
medical countermeasures remain priorities (Eitzen, 1998). 
 
There are several isoforms of the toxin including ricin D and E and the closely 
related R. communis agglutinin (RCA) which is a tetramer, consisting of two ricin-
like heterodimers (Olsnes et al., 1974). RCA is only weakly toxic in vivo, but it is so 
structurally similar to ricin that antibodies raised to either ricin A or ricin B chains 
cross react with the corresponding chain of RCA (Lord et al., 1994).  
 
In contrast to the toxins that cause food poisoning described previously, few 
researchers have published research describing PCR detection of the ricin gene, as it 
is less relevant to public health.  Nevertheless, He et al., (2007) described an assay 
that was able to detect DNA in dairy products that equated to 5 ng of toxin per ml of 
sample.  Melchior and Tolleson (2010) estimated their assay to be sensitive enough 
to detect 30 picograms of toxin which is well below the LD50, demonstrating the 
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suitability of the technology to this area of research.   As with the other toxins 
described however, analysis of weaponsÕ grade ricin by PCR is yet to be carried out. 
 
1.4 PROTEIN PURIFICATION 
1.4.1 Biological weapons 
Currently it is unknown whether toxins prepared as biological weapons would be 
crudely prepared or highly purified, since it would depend on the aggressor.  
Similarly, it is unknown whether toxins prepared as BW agents would contain 
residual DNA, as that too would depend on the nature of the threat.  For example, 
botulinum neurotoxin is reported to have been prepared for weaponisation from 
culture supernatant during the Gulf War (Zilinskas, 1997).   It is therefore important 
to understand the protein purification processes that may be used to prepare 
biological weapons. 
 
1.4.2 Purification schemes 
Protein purification strategies vary from simple one step precipitation procedures to 
large scale, validated production processes. The purification process employed is 
dependent on the properties of the protein, such as isoelectric point (pI) and 
hydrophobicity (Skopes, 1993).  Often more than one step is necessary so the most 
appropriate techniques should be used to maximise yield with the least number of 
steps.  By far the easiest method to produce large quantities of a protein is to clone 
the gene and over express the recombinant protein.  The use of recombinant proteins 
also allows subtle changes to the protein to facilitate purification.  A commonly used 
strategy is to capture the protein, follow that stage with an intermediate purification 
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step, followed by purification and, finally, polishing, commonly known as CIPP 
(Amersham Biosciences, 2001).   
 
1.4.3 Precipitation 
The oldest and simplest method for protein purification is precipitation, which alters 
the properties of a solute so that the proteins become insoluble.  Only a limited 
amount of specialist equipment is required to concentrate large amounts of protein 
using this method.  Indeed, UN weapons inspectors found 19 000 litres of acid 
precipitated botulinum neurotoxin in Iraq (Zilinskas, 1997).  The proteins can then be 
concentrated by centrifugation and re-dissolved in the original solvent.  Most 
proteins are soluble in cytoplasm.  Once extracted, these conditions can be varied to 
precipitate the proteins of interest providing that the properties of the protein are 
understood, bearing in mind that most proteins have a minimum solubility around 
their isoelectric point. 
 
1.4.4 Purification using adsorbents 
Adsorbents used in protein chromatography have two essential features, the nature of 
the matrix and the type of functional group that carries out the adsorption (Skopes 
1993).  The purification matrix is normally made from an insoluble polymer which is 
cast into bead form.  The size of the pore dictates the size of protein molecule that 
will be retained by the matrix.  There are several types of material used as 
adsorbents: 
 
1.4.4.1 Ion Exchangers 
Ion exchangers (IEX) are the most widely used of all adsorbents.  They exploit the 
different net charges on proteins at a given pH and interact with proteins by 
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electrostatic attraction.  Anion exchangers such as DEAE, TEAE and QAE are 
positively charged whilst cation exchangers such as carboxymethyl and sulphonates 
are negatively charged.  Cation exchangers may be weak carboxymethyl substituents, 
strong sulphonate groups or phosphates.  The latter have certain affinity actions, in 
that they bind enzymes that interact with phosphorylated substrates such as nucleic 
acids.   
 
1.4.4.2 Hydrophobic and reverse phase adsorbents 
Hydrophobic and reverse phase adsorbents exploit the variability of external amino 
acid residues on different proteins.  They interact with proteins as a result of their 
hydrophobic properties (Skopes, 1993).  The most common type of hydrophobic 
adsorbent used contains short aliphatic chains, composed of four to ten carbons.  
Such hydrophobic interactions are weakened by detergents and strengthened by high 
salts and temperatures.  Only a slight change in buffer condition is necessary to 
preferentially affect the binding properties of the purification matrix.  Hydrophobic 
interation chromatography (HIC) is an ideal first step in a purification strategy 
(Amersham Biosciences 2001).   
 
Reverse phase adsorbents are similar to hydrophobic adsorbents, but contain longer 
aliphatic chains between 8 and 18 carbons.  They are used exclusively in High 
Performance Liquid Chromatography (HPLC).  The operating conditions of the 
method are harsh, requiring the use of acids and organic solvents, which makes the 
method unsuitable for purification of some proteins.  It utilises pumps, mixers, 
detectors and collectors to improve on traditional reverse phase chromatography.  It 
operates under high pressure to increase the flow rate of chromatography columns 
and requires small beads that are strong enough to withstand such pressures.  
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Consequently, HPLC columns and equipment are costly to obtain and maintain and, 
as a result the procedure is usually restricted to specialised laboratories.  
Nevertheless, the high resolving power of this technique makes this a valuable and 
commonly used final step in protein purifications (Skopes, 1993).  Fast Protein 
Liquid Chromatography (FPLC) is a variant of HPLC developed by Amersham 
Biosciences (2001).  Its principles are based on those of ion exchange, but it uses 
highly refined Monobeads™ that are able to produce extremely high resolution.   
 
1.4.4.3 Affinity Chromatography 
Modern affinity chromatography was first used in 1967 (Axn 1967), using 
cyanogen bromide for the immobilisation of ligands on agarose supports.  It is an 
effective method of purification that uses general or specific ligands to capture 
molecules.  Specific ligands include antibodies, enzyme substrates, or cellular 
targets.  General ligands are molecules which bind to certain groups of solutes, such 
as lectins or protein A which bind carbohydrates or various immunoglobulins, 
respectively (Walters, 1985).  Naturally, the suitability of general ligands depends on 
what other components are in the sample. 
 
If a specific ligand is not available, proteins can be cloned into a plasmid that has 
particular properties that allow affinity purification.  For example, pGEX is designed 
for inducible, high level intracellular expression of genes with Schistosoma 
japonicum glutathione S transferase (GST).  Expression is under the control of the 
lac promoter, which is induced using the lactose analogue isopropyl-β−D-
thiogalactopyranoside (IPTG).  Induced cultures are allowed to express GST fusion 
proteins for several hours and then cells are harvested.  Protein purification can then 
be carried out in one step on a glutathione sepharose column.  The protein of interest 
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is easily cleaved from its fusion protein by a site-specific protease and is readily 
eluted from the column to give a protein that is over 90% pure.  Using this method 
80 µg to 400 mg of protein can be purified (Amersham Biosciences, 2010). 
 
His6 tagging of proteins is an alternative to using large fusion tags such as GST.  The 
purification strategy for His-Tag proteins is very similar to that for GST, in that the 
protein of interest is cloned into a vector that encodes a polyhistidine tag.  Affinity 
separations are possible using a Ni
2+
 charged chelating sepharose.  Weakly binding 
contaminants that have an affinity for nickel are washed away using a low 
concentration of imidazole.  The strongly bound His-Tagged proteins are then eluted 
from the column by competitive elution with high concentrations of imidazole. 
 
1.4.5 Gel Filtration 
Gel filtration separates molecules according to differences in their sizes as they pass 
through a gel-packed column (Amersham Biosciences, 2010).  The gel contains 
pores that have a controlled range of sizes which, in turn, allows for the controlled 
separation of molecules.  The method is ideal for the final ÔpolishingÕ steps in a 
purification protocol.  Samples are eluted in a single buffer as opposed to an elution 
gradient as used with ion exchange.  High molecular weight molecules are eluted 
from the column first, followed by intermediate and low molecular weight molecules 
over one column volume.  The type of gel filtration media chosen for an experiment 
depends on the molecule to be purified.  For example, a Superdex 200 column is 
used for separating proteins or DNA fragments (Amersham Biosciences, 2001). 
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1.5 TOXIN DETECTION METHODS 
Toxins can be detected directly using in vivo assays which demonstrate lethality in 
animals, such as the mouse bioassay for botulinum neurotoxins (Dowell et al., 1977) 
or the guinea-pig skin test for SEB (Scheuber et al., 1983).  However, they are used 
less commonly nowadays as they require the use of animals.   In vitro testing has also 
been used for toxins lethal to culturable cells such as LT toxin from Escherichia coli 
(Guerrant, 1974).  More recently, other methods have been used for antigen detection 
including mass spectrometry (Kawano et al., 2000), surface plasmon resonance 
(Homola et al., 2002), antibody microarrays (Panchal et al., 2005), surface enhanced 
resonance scattering (Graham and Faulds, 2010) and nanotechnology using 
antibodies conjugated to gold or silver nanoparticles (Rosi and Mirkin, 2004; 
Schaller et al., 2004; Jain, 2005;).  However, the most commonly used method by far 
is ELISA.   
 
1.5.1 Enzyme-linked immunosorbent assay (ELISA) 
ELISA was first described by Engvall and Perlmann (1971).  The simplest form of 
the assay, termed Direct ELISA, involves adsorbing the antigen to a solid support 
such as a polystyrene 96 well plate.  Non-bound antigen is removed by washing, 
leaving an antigen-coated plate.  An antibody solution is subsequently added to the 
plate and incubated.  Unbound antibody is removed by washing and detection is 
performed using a substrate and chromogen which react with the enzyme label on the 
antibody to produce a colour change (Crowther, 2001).  The colour change can be 
quantified on a spectrophotometer.  An Indirect ELISA avoids the need to perform 
an enzyme labelling reaction with detection antibody.  Instead, the detection antibody 
is in turn detected with a labelled species-specific antibody.  For example, if the 
detection antibody was raised in mice, it would be possible to use labelled anti-
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mouse antibodies to drive the colourimetric change, indirectly detecting the antigen 
of interest.  A sandwich ELISA uses an antibody-coated plate to capture the antigen, 
which is consequently detected using the same direct or indirect method described 
above.  The advantage of the sandwich assay is that it often has lower background 
signal, however it is more labour intensive as it involves an additional incubation 
step.   
 
ELISA has a tendency to be subject to high background, since the polystyrene plate 
will passively adsorb proteins unless a blocking buffer is used.  Numerous agents are 
suitable for use as blocking buffers, including detergents such as Tween-20, or 
proteins such as BSA or milk powder (Crowther, 2001).  In spite of this, a colour 
change will most likely be observed in the negative control, limiting the sensitivity of 
the assay (Crowther, 2001).  The sensitivity may also be limited by the colourimetric 
reaction, with enhanced chemiluminescence (ECL) being more suitable for 
ultrasensitive detection of toxin (Yang et al., 2011).  Nevertheless, ELISA is a 
relatively simple technique that can be used for sensitive and specific detection of an 
antigen, once optimised.  Immunoassay tickets, also known as lateral flow assays, are 
often a good alternative to ELISA.  ELISA is sensitive and specific and can be 
performed in a basic laboratory.  In contrast, immunoassay tickets, as epitomised by 
the home pregnancy test, are intended to be used by non-experts, making them 
suitable for use in countless scenarios (Tomaso et al., 2007).   
 
The disadvantage of using ELISA or Immunoassay tickets for toxin detection is that 
specificity and sensitivity may be poor.  It can be difficult to generate high quality 
antibodies to toxins, since the toxin often kills the animals before an efficient 
immune response is elicited.  Formalin can be used to inactivate a toxin prior to 
 26 
immunisation, to produce a toxoid.  However this may alter the structure of the 
protein, generating antibodies with poor specificity to their target (Smith, 2009).  
PCR primers can be designed without such restrictions.  Therefore, PCR was 
considered to be the most suitable alternative method for toxin detection, although it 
was unknown whether residual DNA would be present in toxins.  Accordingly, 
immuno-PCR was also investigated with the aim of increasing the sensitivity of the 
assay in comparison to ELISA, whilst directly detecting the toxin.   
 
1.5.2 Polymerase Chain Reaction (PCR) 
PCR was the first method of nucleic acid amplification to be developed (Saiki, 
1985).  In those preliminary experiments, the Klenow fragment of DNA polymerase 
I from Escherichia coli was used to replicate DNA molecules in a manual series of 
heating to denature the template strand and cooling to allow primers to anneal to the 
target.  Since then, the method has undergone significant improvements including the 
substitution of the Klenow fragment for a thermostable DNA polymerase and the 
advent of programmable thermocyclers.  Typically, 30 to 40 temperature cycles are 
required to obtain maximum sensitivity of the assay.  Beyond this, the sensitivity of 
the reaction is limited by depletion of reagents and accumulation of pyrophosphatase 
and PCR artefacts (Lee, 2001).   
 
1.5.3 End-point PCR 
End-point PCR reactions are carried out on a solid block thermocycler able to 
complete 40 cycles in approximately two hours.  PCR products produced in this way 
must be stained with a DNA intercalator such as ethidium bromide and visualised by 
size separation on an agarose gel. This method is able to discriminate between 
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genuine products and PCR artefacts accurately based on differences in molecular 
weight.  
 
1.5.4 Real-Time PCR 
More recently, fluorescent probes have been used to detect and monitor in vitro DNA 
amplification, eliminating the need for post amplification handling of PCR products.  
This reduces the risk of carry-over contamination of subsequent reactions with 
amplicon and further automates the PCR process.  Several manufacturers have 
developed thermal cyclers with built-in fluorimeters. Measuring the fluorescence 
generated during the reaction once per cycle enables the progress of the reaction to 
be monitored in real-time (Figure 1.4).  
 
There are several types of fluorescent probe that can be used in real-time PCR. The 
simplest and cheapest type of probe is a non-specific double-stranded DNA 
intercalator such as ethidium bromide, YO-PRO-1 or Sybr Green™ I (Ririe et al., 
1997).  Fluorescence is monitored once per cycle after product extension.  
Amplification of a PCR product results in an increase in fluorescence above 
background level.  DNA intercalating dyes detect all double stranded DNAs 
including primer-dimers and secondary structures.  Verification of product identity 
by melt curve analysis is therefore necessary (Figure 1.5).   
 
At the end of the PCR cycles the reaction is heated at a rate of 0.2¡C per second and 
the fluorescence is measured once per second. A rapid loss of fluorescence is seen 
near the denaturation temperature of the PCR product.  The second derivative of this 
curve allows the melting point of the PCR product to be visualised as a peak, 
allowing differentiation of amplification products separated by less than 1 ¡C 
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(Wittwer et al., 1997).  High resolution melt analysis using a non-standard DNA 
intercalater (Wittwer, 2009) may allow discrimination between single nucleotide 
polymorphisms (SNPs), offering a rapid and simple method of strain typing. 
 
Numerous specific real-time PCR chemistries also exist which overcome the 
disadvantages of DNA intercalaters, including TaqMan¨ (Livak, 1999), Scorpionsª 
(Whitcombe, 1999), Molecular Beaconsª (Tyagi et al., 1996) and dual 
Hybridisation Probes developed by Roche.  TaqMan¨ assays were used exclusively 
in this study.   
 
1.5.4.1 TaqMan¨ 
 
The 5Õ exonuclease reaction (TaqMan
¨
) uses the 5Õ to 3Õ exonuclease activity of Taq 
DNA polymerase.  Holland et al., (1991) created a substrate suitable for exonuclease 
activity in a PCR, an oligonucleotide probe designed to hybridise within the target 
sequence.  The 5Õ end of the probe is labelled with a fluorophore such as fluorescein 
(FAM), which emits fluorescence at a certain wavelength when an excitatory light 
source of a different wavelength is provided by the thermal cycler.  The 3Õ end is 
labelled with a quencher dye, such as tetramethylrhodamine (TAMRA).  When the 
two dyes are in close proximity the fluorescence is quenched by fluorescence 
resonant energy transfer (FRET) (Livak, 1999).  As the reaction proceeds, the 5Õ 
exonuclease activity of Taq polymerase cleaves the probe, separating the two dyes, 
causing an increase in fluorescence from FAM (Livak, 1999).  As the number of 
amplicons increase, the fluorescence increases proportionally.   
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Figure 1.4 Typical real-time PCR fluorescence readings produced using a 10 
fold dilution series of template DNA with Sybr Greenª I intercalator.  An 
increase in fluorescence is observed with each thermal cycle as the quantity of 
PCR product increases exponentially.  The threshold (or crossing point) at 
which the fluorescence exceeds a given value can be used  to quantify DNA in an 
unknown sample, providing standards of a defined concentration are also 
amplified. 
 
 
Figure 1.5 Example melt curve analysis graph.  The apex of the curve represents 
the point at which an amplicon ÔmeltsÕ and becomes single stranded, leading to 
a rapid loss of fluorescence.  This melting temperature (Tm) can be used to 
differentiate between PCR products. 
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1.5.4.2 Quantitative PCR 
Quantitative PCR is a fast, accurate and reliable means of measuring the distribution 
or expression of target nucleic acids.  Real-time PCR can be quantitative if samples 
containing unknown amounts of DNA are analysed against data generated from 
amplification of samples of known concentration.   Many machines have PCR 
capabilities that generate quantitative data based on the PCR at early cycles when the 
fidelity of the reaction is highest.  Data generated outside of the log-linear phase of 
the reaction is disregarded, as the amplification efficiency is poor (Rasmussen et al., 
1998).  For accurate quantification it is necessary to verify that PCR efficiency is 
independent of the initial concentration of target DNA (Ponchel et al., 2003).  
Testing primer pairs against a dilution series of target DNA across several logs 
serves to do this as well as a standard curve. 
 
1.5.4.3 Multiplex PCR 
Multiplex PCR uses more than one primer set in a reaction with the aim of detecting 
two or more genetic targets simultaneously.  Visualisation of multiple products relies 
on differences in fluorescent probe signature, size or melting temperature, depending 
on whether traditional or real-time PCR is used.  Many research groups have 
developed such systems for detection of bacterial virulence markers using traditional 
PCR (Mehtrota et al., 2000; Sharma et al., 2000; Luo, 2002).   Normally four or five 
targets are amplified at once using this method (Mehrotra et al., 2000). For example, 
quadruplex real-time PCR has successfully been used for the differentiation of C. 
botulinum strains A, B, E and F (Satterfield et al., 2009).  However, it is possible to 
amplify as many as twenty different targets simultaneously (Butler, 2002) using 
traditional PCR.   
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Probes such as TaqMan
¨
 or Molecular Beaconsª that fluoresce at different 
wavelengths for each target have successfully been used to identify amplification of 
two bacterial virulence markers in one tube (Belanger, 2002; Palladino, 2003; Ryu, 
2003).  Currently, the degree to which real-time PCR assays can be multiplexed is 
limited to between four and six targets by the range of detection channels available in 
machines such as the I-Cyclerª (Biorad, UK), Smartcyclerª (Cepheid, USA) or the 
Rotorgeneª (Qiagen, UK).  This range may be extended if alternative fluorophores 
can be coupled to oligonucleotides, providing that the instrumentation to detect a 
wider range of wavelengths is available. 
 
1.5.4.4 Internal Controls 
Co-amplified internal positive controls are portions of DNA that are genetically 
modified to contain the same specific PCR primer sequences as the specific gene 
(Cone et al., 1992).   They can be constructed by amplification of a suitable portion 
of stuffer DNA using chimeric primers flanked with the target specific primers.  For 
example, Hoorfar et al., (2000) developed an internal control for a Salmonella 
enterica assay using Drosophilla melanogaster specific primers flanked by 
Salmonella specific sequences to amplify Drosophilla DNA.   
 
Internal controls can be used in both traditional and real-time PCR.  They should be 
constructed to be larger than the target amplicon to ensure that they are not amplified 
preferentially over the target DNA.  This also allows the internal control and the 
target amplicon to be differentiated using gel electrophoresis.  Alternatively, a probe 
that hybridises to the stuffer DNA may be used to report amplification of the internal 
control in real-time PCR.   
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1.5.5 Immuno-PCR 
Immuno-PCR was first described by Sano et al., (1992).  It is based on a standard 
sandwich ELISA format, able to detect antigen directly, combined with the 
sensitivity of PCR.  The secondary or tertiary antibody in a sandwich ELISA is 
labelled with a reporter DNA sequence, which can then be amplified by PCR, as a 
potentially more sensitive alternative to colorimetric detection.  A number of 
strategies have been reported for linking the DNA to the antibodies.  Sano et al., 
(1992) used streptavidin to bind to biotin labelled DNA, an approach which is simple 
and easy to adopt in any laboratory.  Other teams have used covalent linkage of DNA 
to antibodies, which although more difficult to perform than utilising the avidin-
biotin interaction, allows the assay time to be reduced significantly (Niemeyer et al., 
2007).  Other approaches include using phage displayed antibodies (Guo et al., 2006) 
although theoretically any ligand can be labelled with DNA and amplified using any 
nucleic acid detection method (Niemeyer et al., 2007).    
 
The advantages of I-PCR over conventional antibody-based assays are well 
established (Niemeyer et al., 2007).  For example, unlike ELISA, immuno-PCR 
theoretically allows the detection of multiple analytes simultaneously if the reporter 
DNA used to label an antibody is different for each analyte.  If real-time PCR is 
used, a different fluorescent probe is needed for each analyte, therefore up to four 
targets could be detected simultaneously using the most commonly used instruments.   
 
Immuno-PCR has been successfully used to detect bacterial toxins by a number of 
research groups.  Wu et al., (2001) developed an immuno-PCR system for the 
detection of Clostridium botulinum neurotoxin A using a standard immunoassay 
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format with monoclonal antibodies that were covalantly coupled to reporter double 
stranded DNA.  The I-PCR assay was 1000 fold more sensitive than the ELISA, with 
the detection limit of the assay being 50 picograms.  Chao et al., (2004) 
independently developed an I-PCR assay which reduced the detection limit of 
Bont/A to 50 femtograms by optimising streptavidin and reporter DNA 
concentrations in both indirect immuno-PCR and indirect sandwich immuno-PCR 
formats.  Fischer et al., (2007) also observed a 1000 fold increase in sensitivity with 
an assay developed for detection of SEB.  They used real-time immuno-PCR to 
detect antibodies covalently labelled with reporter DNA to detect 600 femtograms of 
SEB.  Yang et al., (2009) used a gold nanoparticle based immuno-PCR assay to 
detect SEB spiked into meat and baby food, detecting 0.01 ng of toxin per ml.  It can 
be seen that immuno-PCR is particularly well suited to toxin detection as it is 
generally more sensitive than ELISA.  It is not used as routinely as PCR, with 
approximately 100 papers being published on the subject in the past twenty years.  
However, it was included in this study to determine whether the increase in 
sensitivity offered by the technique would facilitate detection of the limited 
quantities of toxin that may be present in BTWC samples.   
 
As previously mentioned almost any ligand can be used for immuno-PCR.  For this 
reason, aptamers were also studied as they themselves are nucleic acid molecules 
with the potential to detect toxins. 
 
1.5.5.1 APTAMERS 
An aptamer is a small oligonucleotide with high specificity for their target due to 
their specific three-dimensional conformations (Fan et al., 2008).  They are ÔevolvedÕ 
to detect a specific target by a process known as SELEX (Systematic Evolution of 
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Ligands by EXponential enrichment; Tuerk and Gold, 1990).  It has been used to 
isolate high affinity nucleic acid ligands, known as aptamers, to a variety of protein 
and carbohydrates as well as organic dyes, amino acids and antibiotics (Jayasena, 
1999). They have the potential to replace antibodies in detection assays in general, 
but may be particularly suitable for use with toxins as they can be generated in vitro.  
This is advantageous as it avoids the use of animals in experiments and circumvents 
the requirement for formaldehyde inactivation of the toxin, with the native toxin 
being used instead.  Theoretically, aptamers have the potential to have higher 
specificity for a toxin than an antibody raised in an animal using inactivated toxin 
(Bruno and Kiel, 2002).   
 
Aptamers have many uses both in in vitro and clinical settings, with their therapeutic 
uses being reviewed recently in Ni et al., (2011).  Aptamer based detection of targets 
can be carried out in numerous ways, being as easy to conjugate to reporter 
molecules as antibodies.  Aside from eliminating the use for animals in their 
generation, one of the main advantages of aptamers over antibodies is that they can 
be chemically synthesised with numerous modifications at any oligonucleotide 
synthesis house.  For this reason they make incredibly diverse biosensors utilising 
beacons (Nutiu and Li, 2003) and quantum dots (Ellingham et al., 2000; Fan et al., 
2008) amongst other things (Juskowiak, 2011).   
 
The selection protocol used depends on the target molecule.  For example, aptamers 
to small compounds such as peptides can be obtained by selection on an affinity 
column containing the immobilised ligand (Jayasena, 1999).  SELEX experiments 
that target proteins and utilize RNA pools can be carried out by isolating protein-
aptamer complexes on modified cellulose filters or magnetic beads. To avoid 
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selection of matrix-binding molecules, the pool should be pre-treated with the matrix 
and matrix molecules should subsequently be eliminated from any further rounds of 
selection with the target protein (Vivekanenda and Kiel, 2006).  The specificity of 
aptamers can be increased by using a close relative of the antigen of interest in 
negative selection experiments before (Chen, 2007) or after (Shangguan et al., 2007) 
the SELEX experiment. 
 
SELEX is a versatile process.  The success of an experiment reportedly depends on 
the properties of the target ligand (Jayasena, 1999).  Generally, nucleic acid binding 
proteins will be better aptamer targets than other proteins.  Positively charged ligands 
will be easier to work with than negatively charged ligands owing to the negative 
charge on DNA molecules (Jayasena, 1999).  Controlling the concentration of target 
and magnesium can vary the stringency of selection (Osborne, 1997).  The inclusion 
of molecules that compete with nucleic acids for binding to a target will encourage 
the isolation of high-affinity species from a random sequence population.  Non-
specific competitors such as tRNA can help eliminate most weakly binding species 
from the population. Therefore the stringency of a selection can also be controlled by 
varying the ratio of pool to competitor.   
 
SELEX has previously been used to develop aptamers to toxins including pepocin 
(Hirao et al., 1997), ricin (Hesselberth et al., 2000), SEB (Bruno and Keil, 2002; 
Purschke, 2003), botulinum neurotoxin (Wei et al., 2009; Tok and Fischer, 2008; 
Chang et al., 2010) and Shiga toxin (Fan et al., 2008).   The selection processes used 
by each research group differed depending on whether DNA or RNA was used, 
however the most popular methods involved semi-automation using magnetic bead 
bound targets (Bruno and Keil, 2002; Chang et al., 2010).   
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1.6 NEXT GENERATION SEQUENCING 
The final aim of this study was to investigate the use of DNA sequencing as a strain 
typing tool, a possible requirement following positive identification of a BTWC 
sample.  DNA sequencing was first described in 1977 by Maxam and Gilbert.  The 
method involved cleavage of radioactively tagged oligonucleotides at different points 
followed by size separation by agarose gel electrophoresis.  In the same year an 
alternative method was developed by Sanger et al., (1977).  The method developed 
by Sanger et al., (1977), termed dideoxy sequencing, employed novel nucleoside 
analogues that would act as chain terminators when incorporated by DNA 
polymerase.  It was used extensively to sequence the complete genome from a large 
number of species, including humans (Venter et al., 2001) and the biological agents 
Francisella tularensis (Larsson et al., 2005) and Yersinia pestis (Parkhill et al., 
2001).  The gold standard for molecular strain differentiation is DNA sequencing.  It 
can be used to characterise fragments of genomes (such as amplicons) or entire 
genomes.  Although extremely powerful, ÔSangerÕ sequencing was labour intensive, 
taking years to generate the data to assemble a draft genome.   
 
Ronaghi et al., (1996) developed the concept of detecting the pyrophosphatase 
released during DNA amplification to sequence-by-synthesis, using enzyme-coupled 
reactions and bioluminescence to report nucleotide incorporation.  This allows 
simultaneous sequencing of many fragments of a genome in a very short space of 
time.  Next generation sequencing platforms began to emerge nearly ten years after 
the concept was first reported, including Roche 454ª Sequencing, Illumina GA2 
and the ABI SOLiD, and are reviewed in Hall (2007).  Each utilises a different 
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reaction chemistry, resulting in different read lengths.  454ª Sequencing offers the 
greatest read length (500 basepairs) of any currently used system, capable of 
generating one million random reads which equates to 500 megabases of sequence 
per run (Roche, 2009).  The technology therefore has the potential to rapidly 
sequence prokaryotic genomes and larger eukaryotic species can theoretically be 
sequenced within a few runs.   
 
1.7 PROJECT AIMS 
The aim of this thesis was to determine the utility of nucleic acids for analysis of 
weaponised toxin samples.  Principally PCR was investigated, analysing toxin 
samples of varying purifications thereby mimicking samples that may be 
encountered in a BTWC environment.  To meet the requirements of sensitive and 
unequivocal detection, it was necessary to investigate alternative nucleic acid 
approaches to the problem.  The aim of the final Chapter in this thesis was to 
investigate genetic methods for strain differentiation of toxin-producing organisms, 
with a specific focus on 454 Sequencingª. 
Chapter 2 Materials and Methods. 
 38 
2  MATERIALS AND METHODS 
2.1 BACTERIAL STRAINS 
2.1.1 Clostridium botulinum strains 
Clostridium botulinum strains listed in Table 2.1 were obtained from NCTC 
(National Collection of Type Cultures, HPA Collindale, London, UK) or ATCC 
(American Type Culture Collection, LGC, London, UK).  Proteolytic C. botulinum 
strains were inoculated into 10 ml cooked meat carbohydrate broth (Oxoid) in a Don 
Whitley Mark III Anaerobic cabinet and grown statically at 34 
o
C overnight.  
Saccharolytic strains were inoculated into cooked meat broth supplemented with 1 % 
sucrose (w/v) and grown in the same way.  The number of colony forming units was 
subsequently determined by spreading triplicate 100 µl samples of overnight culture, 
serially diluted in PBS from 10
-1
 to 10
-8
, onto anaerobic blood agar plates (Oxoid).  
Resulting colonies were counted after overnight static incubation at 34 
o
C in the 
anaerobic chamber. The number of colony forming units per ml (CFU/ml) was then 
calculated by multiplying the number of colonies counted by 10 and then by the 
dilution factor.  The mean CFU/ml were calculated as one third of the sum of the 
values obtained. 
 
Chapter 2 Materials and Methods. 
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Table 2.1.  List of Clostridium botulinum strains used.  Cultures were obtained 
from the National Type Culture Collection (NCTC; HPA London) or American 
Type Culture Collection (ATCC, LGC London). Ò ÐÒ  indicates that the culture 
source was unknown.   
Organism Strain Genotype/ designation Origin 
Clostridium 
botulinum A 
NCTC 7272 A1 Unknown 
Clostridium 
botulinum A 
NCTC 887 A1 Crop of chicken with 
botulism, 1920 
Clostridium 
botulinum A 
NCTC 2916 A1 (B) Home made canned corn 
1926 
Clostridium 
botulinum A 
NCTC 3806 A Canned peas, 1932 
Clostridium 
botulinum A 
NCTC 4587 A - 
Clostridium 
botulinum A 
NCTC 9837 A2 Fish from Mauritius, 1955 
Clostridium 
botulinum A 
NCTC 11199 A1 (B) Faeces, 1978 
Clostridium 
botulinum A 
NCTC 2012 A2 Unknown 
Clostridium 
botulinum B 
NCTC 751 B Group I California, 1920 
Clostridium 
botulinum B 
NCTC 3807 B Group I Soil, Blue Ridge Mountains, 
1021 
Clostridium 
botulinum B 
NCTC 3815 B Group I Cheese, 1932 
Clostridium 
botulinum B 
NCTC 7273 B Group I Beans, 1947 
Clostridium 
botulinum B 
NCTC 12265 B Hazelnut yoghurt, 1989 
Clostridium 
botulinum B 
9581 - - 
Clostridium 
botulinum B 
ATCC 17841 B Group I  - 
Clostridium 
botulinum B 
ATCC 17844 B  Group II (2217) N/D 
Clostridium 
botulinum B 
ATCC 17845 B (2254) - 
Clostridium 
botulinum B 
Eklund 17B 
(ATCC 
25765) 
B Group II Marine Sediment, USA 
Chapter 2 Materials and Methods. 
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Clostridium 
botulinum B 
ATCC 17780 B (3137) - 
Clostridium 
botulinum B 
ATCC 
17783? 
B - 
Clostridium 
botulinum B 
ATCC 439 Group I - 
Clostridium 
botulinum B 
ATCC 17843 B (2017) - 
Clostridium 
botulinum E 
NCTC 8266 E Nanaimo Group II MRE Porton 1952 
Clostridium 
botulinum E 
NCTC 8550 E Group II Institut Pasteur 1952, possess 
OS variants. 
Clostridium 
botulinum E 
ATCC 17854 E Group II - 
Clostridium 
botulinum E 
ATCC 8550 E Group II - 
Clostridium 
botulinum E 
ATCC 17854 E Group II - 
Clostridium 
botulinum E 
ATCC 17786 E Group II - 
Clostridium 
botulinum E 
ATCC 11219 E Group II - 
Clostridium 
botulinum E 
ATCC 9564 E Group II (Hazen) Smoked Salmon, Canada 
Clostridium 
botulinum F 
NCTC 10281 Langeland Group I Liver paste, Vancouver 1962. 
Clostridium 
botulinum F 
ATCC 23387 Group II Eklund 
(202F) 
- 
Clostridium 
botulinum F 
ATCC 25764 Group I Crab 
Clostridium 
botulinum F 
ATCC 27321 VPI 2382 - 
Chapter 2 Materials and Methods. 
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Table 2.2.  List of Staphylococcus aureus strains used.  Cultures were obtained 
from the National Type Culture Collection (NCTC; HPA London) or American 
Type Culture Collection (ATCC, LGC London). Ò ÐÒ  indicates that the culture 
source was unknown.   
Organism Strain Genotype/ 
designation 
Origin 
Staphylococcus aureus 
Rosenbach 
ATCC 6538 (Oxoid) FDA 209 Human lesion 
Staphylococcus aureus 
Rosenbach 
ATCC 25923 (Oxoid) Seattle 1945 Clinical isolate 
Staphylococcus aureus 
Rosenbach 
ATCC 33862 (Oxoid) SS697 - 
Staphylococcus aureus 
Rosenbach 
ATCC 9144 (Oxoid) 3R7089 strain 
Oxford 
- 
Staphylococcus aureus ATCC 23144 (held at 
Dstl) 
- - 
Staphylococcus aureus NCTC 10656 (Dstl) - Turkey salad, 
1964 
Staphylococcus aureus NCTC 10657 (Dstl) - - 
Staphylococcus aureus NCTC 10652 (Dstl) - Ham involved in 
food poisoning 
 
2.1.2 Staphylococcus aureus strains 
S. aureus strains detailed in Table 2.2 were cultured from glycerol stocks held at Dstl 
or obtained as Culti-loops¨ from Oxoid.  Culti-loops¨ were inoculated into Nutrient 
broth (Oxoid) and grown in a shaking incubator at 200 rpm (Stuart, Jencons, UK) at 
37 
o
C overnight.  A streak plate was made by plating 10 µl of liquid culture or 
glycerol stock onto a Nutrient agar plate (Oxoid), followed by growth in a static 37 
o
C incubator (Hettich, Jencons, UK).   
Chapter 2 Materials and Methods. 
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2.1.3 Bacillus  cereus strains 
B. cereus spores were produced from glycerol stocks of vegetative cells held at Dstl.  
Sporulation broth (100 ml of SchaefferÕs sporulation medium: 0.8% nutrient broth 
(Difco), 27 mM KCl, 2 mM MgSO4 · 7H2O, 1 mM Ca(NO3)2 · 4H2O, 0.1 mM 
MnCl2 · 4H2O, and 1 µM FeSO4 · 7H2O) was inoculated with a single colony of B. 
cereus NCTC 2566 from a L-agar streak plate made by plating 10 µl of glycerol 
stock onto a L-agar plate.  Broths were incubated with shaking (200 rpm) at 37 ¡C 
for two days. Cells were heat shocked at 65 ¡C for 1 hour, followed by incubation 
with lysozyme (Roche, UK) at a final concentration of 200 µg/ml for 30 minutes at 
37 ¡C. Percentage sporulation was assessed by microscopic examination.  Where 
required, sporulation was continued for a further two days and the culture was re-
examined by microscopy.  Culture broth (100 ml) was transferred to sterile 
centrifuge pots (Sorvall, Thermo Fisher, UK) and centrifuged at 800 x g for 30 
minutes in order to collect spores.   
 
2.1.4 Growth of recombinant E. coli 
Liquid cultures of recombinant E. coli cells were obtained using grid plates, glycerol 
stocks or cryobeads as starter cultures, as detailed in Section 2.2.3, 2.3.3 or 2.7.  
Small or large volumes (5 or 100 ml) of inoculated L-ampicillin broth (containing 
12.5 mg of ampicillin; Roche) were grown at 37 ¡C overnight in a shaking incubator 
at 200 rpm (Stuart, Jencons, UK).   
Chapter 2 Materials and Methods. 
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2.1.5 Ricinus communis strains 
Twenty cultivars of R. communis (Table 2.3) were grown on a large scale by a 
commercial grower in France, (Sandeman Seeds).  
 
Table 2.3  List of cultivars of Ricinus communis used in this study. 
 
R. communis cultivar Origin 
A007, Black Diamond 1, Black Diamond 2, Dwarf 
Australia, Imp A Ethiopia, JanXiang 1, JanXiang 2, 
Noori Jalab Pakistan, Noori Pakistan, TCO 202, Sara 
Hybrid Brazil, VC007/9 Paraguay, VCR Colombia, 
Zanzibar, Zanzibar Kenya, Zibo 1, Zibo 2, Zibo 3, Zibo 
101, Zibo 108, Zibo 305. 
Sandeman seeds, France 
Black Diamond, Jin Castor 2, Kunming 202,  
Sanguinis, Shang Dong 108, Zanzibar, Zibimas. 
Private garden, U.K. 
 
 
2.2 DNA EXTRACTION PROCEDURES 
2.2.1 C. botulinum genomic DNA extraction 
Clostridium botulinum samples were handled in a designated laboratory, with 
particular safety restrictions.  To comply with Dstl safety rules in the toxin laboratory 
a DNA extraction kit that used magnetic particle collection was used. Toxin or 
culture broth samples (200 µl) were centrifuged at 11 000 x g, resuspended in 200 µl 
bead lysis buffer and incubated at 65 ¼C for ten minutes to aid cell lysis, followed by 
DNA binding to silica coated Dynabeads DNA Direct 1 (Dynal, UK).  Magnetic 
particles were then collected and washed in 500 µl wash buffer three times.  Finally, 
DNA was eluted from the beads in 50 µl TE (10 mM Tris HCl, 1 mM EDTA) buffer. 
Chapter 2 Materials and Methods. 
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2.2.2 Plasmid DNA extraction 
Plasmid DNA was extracted using a QIAGEN Plasmid mini kit (Qiagen, UK), 
according to the manufacturersÕ instructions.  Bacterial cells grown as described in 
Section 2.1 were centrifuged at 5000 x g.  The supernatant broth was removed and 
the cell pellet was gently resuspended with 1 ml of a chilled resuspension buffer (P1, 
containing 50 mM TE, 10 mM EDTA and 100 µg/ml RNase A), to release plasmids 
without disrupting genomic DNA.  Proteins were then precipitated gently in 250 µl 
of lysis buffer P2 and 350 µl N3 on ice for 15 minutes and removed by centrifugation 
at 10 000 x g for 1 minute.  DNA was subsequently bound to a silica column by 
centrifugation as above, washed in 500 µl buffer PB and re-centrifuged.  Further 
washes were performed using 750 µl of buffer PE and centrifugation as before.  
Traces of ethanol were removed during a further centrifugation step at 10 000 x g for 
2 minutes and DNA was subsequently eluted in buffer 50 µl EB and stored at Ð 20 
o
C 
until needed. 
 
2.2.3 Genomic DNA extraction 
Genomic DNA was extracted from all other microbial species and sample types 
using a QIAamp DNA mini-prep kit (QIAgen, UK), according to the manufacturersÕ 
instructions, unless stated otherwise.  Bacterial or fungal cells (1 ml of an overnight 
culture) grown as detailed in Section 2.1 were centrifuged at 10 000 x g for 3 
minutes.  The cell pellet was resuspended in 200 µl of lysis buffer AL and 20 µl of 
proteinase K (20 mg/ml).  The cells were lysed further by incubation at 56 ¡C for 10 
minutes in a Thermomixer (Eppendorf, Fisher, UK) at 1400 rpm.  Ethanol (96%; 500 
µl, VWR, UK) was then added to the cell lysate which was spun through a silica spin 
column at 15 700 x g for 1 minute.  DNA bound to the column was washed in wash 
Chapter 2 Materials and Methods. 
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buffers AW1 and AW2 and finally eluted in 50 µl of TE buffer.  DNA concentration 
was determined by using a Nanodrop spectrophotometer (Labtech International, 
UK).  
 
2.2.3.1 Masterpure Plant DNA extraction 
Small volumes of plant leaf samples (35 mg) were processed using the Masterpure 
Plant leaf DNA purification kit
¨
 from Epicentre (Cambio, UK).  The plant leaf was 
ground in 300 µl of extraction buffer using a pestle and mortar and then heated to 70 
¡C for 30 minutes to aid cell lysis.  Samples were then precipitated on ice for 10 
minutes.  Cell debris was collected by centrifugation at 10 000 x g for 5 minutes.  
The supernatant was then re-centrifuged to remove remaining debris and the 
resulting supernatant was precipitated in an equal volume of isopropanol (Sigma, 
UK).  DNA was collected by centrifugation at 10 000 x g for 5 minutes and 
resuspended in 100 µl of Cleanup Solution.  DNA was then precipitated again in 100 
µl isopropanol and collected as previously described.  The pellet was washed in 70 % 
ethanol and the resulting DNA was resuspended in 50 µl TE buffer and stored at Ð 20 
o
C until needed. 
 
2.2.3.2 Powerplant¨ DNA extraction of R. communis DNA 
DNA was extracted for 454ª sequencing from 50 mg of R. communis leaf using the 
MoBio PowerPlant¨ DNA Isolation Kit (Cambio Ltd, UK).  Plant tissue was added 
to a bead tube containing stainless steel balls.  Bead solution (550 µl) was added to 
the tube which was then vortexed.  PB1 lysis buffer (60 µl) was added to the tube 
and then plant tissue was degraded at 65 
o
C for 10 minutes in a waterbath (Grant, 
Fisher, UK).  The tube was allowed to cool briefly and then plant tissue underwent 
mechanical lysis with the stainless steel beads at 2000 rpm for 30 seconds in a 
Chapter 2 Materials and Methods. 
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Fastprep 24 (MPBio, UK ).  Following centrifugation for 30 seconds at 10 000 x g 
the supernatant was transferred to a clean tube.  PB2 buffer was added to the tube 
(250 µl) to precipitate proteins at 4 
o
C for 5 minutes.  Particles were collected by 
centrifugation at 10 000 x g for 1 minute.  The supernatant was transferred to a clean 
tube and 1 ml of PB3 was added.  The tube was inverted 5 times to mix the contents 
and then incubated at room temperature for 10 minutes.  The tube was centrifuged at 
13 000 x g for 15 minutes and the resulting supernant was discarded.  The pellet was 
resuspended in 100 µl PB6 (TE) and 500 µl PB4 (isopropanol).  The entire contents 
were then captured on a silica spin column which was centrifuged at 10 000 x g for 1 
minute.  The flow through was discarded and the filter was washed in 500 µl PB5 
(ethanol).  The tube was centrifuged at 10 000 x g for 30 seconds.  The flow through 
was discarded and the tube re-centrifuged to remove residual alcohol. The purified 
DNA was subsequently eluted from the column in 50 µl PB6 at 10 000 x g for 30 
seconds.    
 
2.2.3.3  Gel purification of amplicon (QIAquick¨) 
 Agarose gels (Type II, Sigma, UK) were made with 1 X TAE buffer (Biorad 
Laboratories Ltd, Herts, UK) and stained with 1.5 mg/ml crystal violet (Sigma).  Gel 
slices were excised from the gel using a scalpel blade whilst the DNA band was 
illuminated by white light on a light box (UVITEC, Cambridge, UK) and transferred 
to a 1.5 ml Eppendorf tube.  The gel slice was weighed then three volumes (w/v) of 
buffer QG (QIAquick¨, Qiagen, UK) were added to the tube, which was 
subsequently incubated at 60 
o
C until the gel had dissolved.  Isopropanol (one 
volume) was then added to the mix to facilitate binding of the DNA to the silica in a 
QIAquick Spin Column.  The DNA was bound to the column following 
centrifugation at 10 000 x g for one minute and then washed in 0.75 ml Buffer PE by 
Chapter 2 Materials and Methods. 
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centrifugation as before.  Residual ethanol contained in buffer PE was removed by a 
further centrifugation step as before.  The DNA was eluted into a clean 1.5 ml 
microcentrifuge tube with 50 µl Buffer EB (10 mM Tris HCl, pH 8.5) by 
centrifugation at 10 000 x g for 1 minute.  
 
2.3 PCR METHODOLOGY 
Simple sequence repeat primers were obtained by searching the castor bean genome 
using the FASTA Simple Sequence Repeat finder software http://abajian.net/sputnik/ 
(Jewell et al., 2006).  All other PCR assays were designed using sequences obtained 
from the public Genbank database  (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) 
or the castor bean EST database (http://plantta.tigr.org).   DNA sequence analysis 
was subsequently performed using DNASTAR (DNASTAR Inc, Madison, 
Wisconsin, USA).  PCR primer and probe sets were designed using Primer Express 
1.0 software (Applied Biosystems, CA, USA).  Oligonucleotide PCR primers were 
synthesised by various companies including Thermo Hybaid (Thermofisher, UK), 
ATDBio (Southampton, UK), Sigma Genosis (UK), and MWG, (Germany).  The 
sequences of the designed primers are included in Chapter 3.   
 
2.3.1 Traditional PCR 
Traditional PCR was carried out on a 9700 thermal cycling machine (Applied 
Biosystems, Warrington, UK).  Reactions contained 1 x reaction buffer (Roche), 
0.04U/ µl Taq polymerase (Roche), 500 nM of each primer, DNA and dH2O in a 
total volume of 20 µl.  Thermal cycling conditions are detailed in chapter 3. 
Chapter 2 Materials and Methods. 
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2.3.2 Real-time PCR 
Real-time PCR was initially carried out on the Roche Lightcycler.   Later work 
was performed on the Cepheid Smartcycler, or the Corbett Rotor-Geneª.  In all 
cases, each 20 µl reaction contained 0.5 µM of each primer, 1x PCR buffer 
composed of 50 mM Tris pH 8.8 (Sigma, UK), 3 or 4 mM MgCl2 (Sigma, UK), 0.2 
mM each dNTP (Roche, UK), 0.04 U/µl Taq polymerase (Roche, UK), 250ng/µl 
BSA (Sigma, UK), and 8% glyercol (w/v) (Sigma), plus either 1 x SYBR
¨
 Green I 
(Sigma) or a specific TaqMan
¨
 probe (Qiagen, UK).  Thermal cycling conditions 
were optimised for each primer set; the results of this are detailed in Chapter 3. 
2.3.3 Internal controls 
Internal PCR controls were constructed for each assay used in this study.  Composite 
primers were designed so that toxin-specific primers flanked primers specific for a 
region of the human β actin gene (Figure 2.1). 
 
Figure 2.1 Construction of internal controls using chimeric primers.  Chimeric 
primers were synthesised to contain the sequence of interest followed at the 3Õ 
end by primers specific for the human β  actin gene.  The forward and reverse 
primer sequences used were AGTACTCCGTGTGGATCGGA and 
GCTGATCCACATCTGCTGGA respectively.   
Human DNA 
template β actin     
Toxin    β actin 
PCR 
Internal control composed of toxin and human DNA 
Composite Reverse Primer 
Composite Forward Primer 
Chapter 2 Materials and Methods. 
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2.4 CLONING 
2.4.1 Microconcentration 
Amplicon or plasmid DNA was purified by microconcentration to remove PCR 
reagents or reduce the volume.  Preservative was removed from a Microcon YM 100 
centrifugation cup (Millipore, Fisher, UK) by washing through with 500 µl of water 
using centrifugation at 6000 x g for 5 minutes.  This was followed by inversion of the 
cup at 4000 x g for 1 minute to remove traces of water.  Plasmid DNA or completed 
PCR reaction mixtures were recovered, pooled and added to the cup and the volume 
made to 500 µl with dH2O.  Waste products were removed by centrifugation at 6000 
x g for 5 minutes.  The retained DNA was washed in a further 500 µl dH2O.  Purified 
DNA was recovered by inverting the centrifuge cup into a clean tube and 
centrifuging at 4000 x g for 8 minutes.   
 
Centricon purification of larger volumes was occasionally carried out, as detailed in 
the Results chapters and described in Section 2.7.5. 
 
2.4.2 Restriction enzyme digestion 
Reactions were composed of 1 X NEB  # 2 reaction buffer (New England Biolabs, 
UK), 10 X BSA, Sfi I (10 units), 1 µg of DNA to be digested and dH2O to make a 
total volume of 50 µl.  Reactions were then incubated at 50 ¼C for 4 - 16 hours on a 
Perkin Elmer 9700 PCR thermocycler.  Digested products were purified by agarose 
gel electrophoresis as described in Section 2.2.3.2. 
 
2.4.3 Ligation 
Internal control PCR amplicons were ligated into a TA cloning vector (pT7 Blue, 
Novagen, Cambridge Bioscience, UK) and single chain antibody amplicons were 
Chapter 2 Materials and Methods. 
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ligated into pAK100 (as detailed in Krebber et al. 1997).  Ligation reactions 
comprised 200 ng of linearised plasmid, 20 ng of purified single chain antibody 
amplicon, 1 unit of T4 DNA ligase (NEB, UK), 1 x ligase buffer and water in a 
volume of 20 µl.  The contents were mixed well and then incubated for 16 hours at 
16 ¼C in a Perkin Elmer 9700 thermal cycler. 
 
2.4.4 Transformation of chemical competent cells (internal control cloning) 
Recombinant plasmid DNA (between 1 and 50 ng) was added to 100 µl of   E. coli 
JM109 competent cells in a 15 ml polypropylene tube (Falcon¨, Fisher, UK).  The 
cells were then shocked at 40 
o
C for 40 seconds and immediately chilled on ice for 
20 minutes.  SOC broth (900 µl, Promega, UK) was added to the cells which were 
then incubated at 37 
o
C with shaking in a Stuart Orbital S150 incubator at 200 rpm 
for 1 hour.  The resulting culture (100 µl) was plated out onto LB agar plates 
supplemented with 100 mg/ml of ampicillin.  Plates were incubated in a static 37 
o
C 
incubator (Hereus, Jencons, UK) overnight.   
 
2.4.5 Transformation by electroporation (single chain antibody production) 
Electrocompetent E. coli cells (100 µl; Stratagene, UK) were thawed slowly on ice.  
Recombinant single chain antibody cDNA (prepared as described in Section 2.8.6.2) 
was then added to the cells at a concentration of 10 pg/µl. The contents of the tube 
were then quickly added to an electroporation cuvette and pulsed at 2500 V, 200 
ohm, 25 µF, with a time constant of ~4.5 - 5.0 milliseconds.  Room temperature 2 X 
YT broth (900 µl; 16g Bacto¨ Tryptone, 10g Bacto¨ yeast, 5g NaCl per litre) was 
added to the cells which were then incubated at 37 
o
C with shaking at 150 rpm for 
one hour.  Transformed cells were subsequently plated onto 10 cm 2 X YT plates 
(made as 2 X YT broth, plus 15g Difco agar) supplemented with 30 µg/ml of 
Chapter 2 Materials and Methods. 
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chloramphenicol and incubated for 16 hours at 37 
o
C.  Cells were then recovered 
from the plates by gently scraping them into a 50 ml tube (Falcon, VWR, UK), 
concentrated by centrifugation at 5000 x g at 4 
o
C for 10 minutes and the 
concentration adjusted to OD600=1.   
 
2.5 ANALYSIS OF DNA BY GEL ELECTROPHORESIS 
2.5.1 Agarose gel electrophoresis 
DNA amplicons were analysed by agarose gel electrophoresis.  Between 10 µl and 
25 µl of each sample, with a final concentration of 1 X tartrazine loading buffer 
(50% v/v glycerol, Sigma, UK, 50 % dH2O, plus 0.1 g tartrazine, Sigma) was loaded 
onto a 2 % (w/v) agarose gel (Type II, Sigma).  Gels were made with 1 X TAE 
buffer (Tris Acetate EDTA; Biorad Labs Inc, UK) and contained a final 
concentration of 0.05 % ethidium bromide (Biorad, UK) or 1.5 mg crystal violet 
(Sigma, UK).  Molecular weight standards XIV (100 bp ladder), or III (both obtained 
from Roche, UK) were loaded into adjacent lanes.  Each gel was run in 1 X TAE 
buffer at 90 volts until the amplicons were separated (30 to 60 minutes).  Agarose 
gels were visualised using a Gel Doc 2000 (Biorad, UK).  E-gels from Invitrogen 
were run using the automatic settings on the iBase powerpack appropriate for the size 
of gel.  Sample was added to the wells in the absense of loading buffer. 
 
2.5.2 Polyacrylamide gel electrophoresis (PAGE) 
PAGE analysis of SSR PCR products was carried out.  Pre-poured Novex¨ Tris 
Borate EDTA (TBE) PAGE gels (10%; Invitrogen) were placed into an XCell 
Surelockª Mini-Cell tank (Invitrogen) which was then filled with 1 X Novex¨ TBE 
running buffer.  The wells were rinsed three times in running buffer by gently 
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running and discharging a 1 ml pipette across the tops of the wells (Invitrogen).  
Samples were prepared in 1 X Novex¨ TBE High-Density sample buffer.  The gels 
were electrophoresed 175 V per gel for 45 minutes. The cassettes were then carefully 
split apart with a palette knife so that the gel remained on one half of the casing. The 
gels were stained in ethidium bromide (0.025 mg/ml in dH2O) for 20 min and de-
stained for 20 min in three changes of dH2O. The gels were carefully peeled from the 
cassette casing onto the transilluminator for visualisation. 
2.6 DNA QUANTIFICATION 
2.6.1 UV densitometry 
Molecular weight markers III or XIV (Roche) were loaded in triplicate.  The DNA 
samples were loaded alongside the markers in two concentrations (undiluted and 
1/10 dilution) in triplicate.  Gels were electrophoresed and visualised as described in 
Section 2.5.  The saturation function was then employed to ensure DNA band 
intensity was proportional to the DNA concentration.  DNA concentrations were 
computed using a comparison of values for known (markers) and unknown samples.   
 
2.6.2 UV spectrophotometery 
DNA samples were analysed on the Nanodrop¨ (Labsystems, UK), which measured 
the absorbance at A260 nm and A280 nm of 1 µl and calculated the DNA 
concentration accurately, provided it was between 1 and 1000 ng/µl.  It also 
compared the ratio of A260/A280.  A value of 1.8 to 2 was indicative of a good 
quality DNA preparation with little or no protein contamination. 
 
2.6.3 Picogreen/Ribogreen quantification of DNA (for 454ª sequencing) 
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Double- and single-stranded DNA quantification was carried out for 454ª 
sequencing using the Qubitª fluorometer.  Picogreen¨ or Ribogreen¨ Quant-iTª 
intercalater was diluted 1:200 in Quant-iTª buffer immediately before use to make a 
working solution.  The Qubit was calibrated before use with 10 µl of lambda phage 
standard provided in the kit diluted with 190 µl of working solution.  DNA samples 
(1-10 µl) were diluted to 200 µl in working solution and incubated at room 
temperature for 2 minutes.  Samples were subsequently analysed on the fluorometer 
which automatically calculated the concentration.     
2.7 PROTEIN PURIFICATION 
2.7.1 GST fusion protein purification of recombinant V antigen. 
2.7.1.1 Preparation of cell lysate 
Recombinant V antigen from Yersinia pestis was prepared as a Glutathione S-
transferase (GST) fusion protein in E. coli by Sarah Hayward (Dstl) using the pGEX 
recombinant expression system from GE Healthcare (UK), as described in Carr et al., 
(1999).  The pGEX 6-P-1 vector containing the lcrV gene from Yersinia pestis was 
grown in E. coli BL21.  Cultures were grown in 4 litres of L broth supplemented 
with 100 mg/ml of ampicillin at 37 
o
C overnight with shaking at 200 rpm in a Stuart 
Orbital Incubator S150.  Cells were harvested by decanting into 400 ml centrifuge 
pots (Beckman Coulter, UK) followed by centrifugation at 8000 x g for 15 minutes.  
The pellets were resuspended in 50 ml PBS supplemented with DNase I and RNase 
A (2 mg of each; Roche, UK).  Cell lysis was carried out in aliquots of 15 ml using 
four bursts of sonication at 20 000 Hz for 30 seconds on ice to prevent excess heat 
build up.  Cell debris was removed by centrifugation at 8000 x g for 15 minutes.  
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2.7.1.2 Purification using glutathione sepharose 4B 
A pre-packed 5 ml glutathione Sepharose-4B column (GE Healthcare, UK) was 
prepared on an ΑKTAª prime automated liquid chromatography system by washing 
in 20 ml of PBS to remove all traces of ethanol then pre-equilibrated in 6 ml PBS 
plus 1% Triton X-100 (Sigma, UK).   On completion of centrifugation, the 
supernatant was injected onto the pre-equilibrated Glutathione Sepharose-4B 
HiTrapª affinity column through a syringe in the presence of protease inhibitor (GE 
Healthcare, 10 µl/ml) at a flow rate of 1 ml per minute.  Proteins were eluted from 
the column by the addition of 10 column volumes of elution buffer (50 mM Tris-
HCl, 10 mM reduced glutathione, pH 8.0) at a rate of 4 ml per minute and 7.5 ml 
fractions were collected, in accordance with the manufacturerÕs instructions.   
 
2.7.1.3 PreScission Protease cleavage of eluted GST-tagged LcrV protein 
To remove low molecular weight contaminants, such as salt, a quick buffer exchange 
step was carried out.  The eluate was loaded onto a 5 ml HiPrepª 26/10 Desalting 
column (GE Healthcare), containing Sephadex G25 gel filtration medium.  The 
eluate was added to the column in 15 ml volumes through a syringe.  Proteins were 
then eluted in PreScission cleavage buffer (GE Healthcare; 50 mM Tris-HCl, 150 
mM NaCl, 1 mM EDTA, 1 mM dithiothreitol (DTT), pH 7.5).  The GST tag was 
subsequently cleaved from the LcrV protein with the addition of 80 µl (160 U) 
PreScission Protease cleavage buffer per ml of eluate followed by incubation for 4 
hours at 4 ¡C.  Following digestion, the GST moiety of the tagged protein was bound 
to a pre-equilibrated GSTrap 4B column (as described in Section 2.7.1.2) during a 30 
minute incubation at room temperature.   The flow-through containing the purified 
LcrV protein was collected in 2 ml fractions.  Fractions containing the most protein, 
as determined by spectrophotometry at A280, nm were pooled.   
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2.7.2 Acid precipitation of Clostridium botulinum neurotoxins 
An overnight culture of Clostridium botulinum (50 ml) was prepared as described in 
Section 2.1.1 and centrifuged at 10 000 x g for 30 minutes.  The supernatant was 
transferred to a clean centrifuge tube (Falcon¨, Beckton Dickinson, UK) and 
neurotoxins were precipitated in house by Dr Beverley Roberts using one of two 
methods, ammonium sulphate precipitation or acid precipitation.  
 
2.7.2.1 Ammonium sulphate precipitation 
Bacterial culture supernatants were precipitated with the addition of ammonium 
sulphate to 60 % (w/v) saturation. The suspension was centrifuged at 10 000 x g for 
20 minutes. The pellet was resuspended in 50 mM Tris buffer, pH 6.5 and transferred 
into a 10 KDa molecular weight cut off Slide-A-Lyzer (Pierce, Fisher, UK) dialysis 
cassette using the syringe and needle supplied with the cassette.  Air was withdrawn 
from the membrane using the syringe and dialysis was carried out overnight in 10 
litres of 50 mM Tris buffer, pH 6.5 at 4 
o
C with constant stirring using a sterile 
magnetic flea, in order to remove traces of ammonium sulphate.  
 
2.7.2.2 Acid Precipitation 
The pH of the culture supernatant was subsequently adjusted to 3.5 with 3M 
sulphuric acid. The acid precipitate was formed during an overnight incubation at 4 
¼C.  Precipitate was concentrated by centrifugation at 10 000 x g for 20 minutes. The 
majority of the supernatant was removed by carefully decanting, and the precipitate 
was resuspended in the 2 ml of the residual supernatant.   
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2.7.3 Anion exchange chromatography purification of alpha toxin using the 
AKTAªPrime  module 
Recombinant C. perfringens alpha toxin was extracted at Dstl by Dr Helen Jones 
using anion exchange chromatography.  Genetically modified E. coli JM109 cells 
containing the cloned plc gene in pBluescript were grown as described in Section 
2.1.5.  The overnight culture was subsequently divided between four 400 ml 
centrifuge pots with O-ring sealed lids (Beckman Coulter, UK) and centrifuged at 10 
000 x g for 10 minutes at 4 ¡C.  Cell pellets were resuspended in 50 ml of ice cold 20 
mM Tris-HCl pH 8, containing 10 µl/ml protease inhibitor (GE Healthcare, UK).  
Aliquots of 15 ml were sonicated for four 30 second bursts on ice with a 30 second 
rest period between each and then centrifuged at 15 000 x g for 20 minutes.  The 
ionic strength of the supernatant was adjusted to 20 mM Tris-HCl (from 16 to 4.5) 
with distilled water and then filtered through a 0.2 µM membrane (Minisartª, 
Sartorius UK).  The clarified extract (150 ml) was loaded onto the Superloopª (GE 
Healthcare), which was then connected to the FPLC valve on an AKTAªPrime (GE 
Healthcare, UK).  The extract was loaded onto a 5 ml HiTrapª Q ion exchange 
column previously equilibrated in 40 ml 40mM Tris-HCl pH 8 (GE Healthcare, UK).  
The column was then washed in 40 ml 40 mM Tris-HCl pH 8 to remove unbound 
proteins. Adsorbed toxin was eluted in a continuous ionic strength NaCl gradient 
ranging from 0 to 100% over 10 column volumes.  Fractions containing the most α 
toxin, as determined by phospholipase activity assay as described in Section 2.7.3.1 
were pooled.  Samples were then dialysed as described in Section 2.7.2.1 against 4 
litres of 20 mM Tris-HCl, pH 8 overnight.  Samples were then filtered through a 0.2 
µM membrane (Minisartª, Sartorius) and then loaded onto a 10 ml Mono Q HR 
anion exchange superloop (GE Healthcare, UK).  The column was washed in a NaCl 
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gradient as described above, eluted and concentrated from 40 to 4 ml in a YM 100 
Centricon column (Millipore UK) as described below in Section 2.4.2.  The sample 
was filtered again and then a 10 ml Superdex 200 prep HiLoad 16/60 gel filtration 
column (GE Healthcare, UK) was loaded at a rate of 1 ml per minute.  Fractions 
were eluted from the column with a continuous flow of PBS.  The eluates were 
filtered as described above one final time and then pooled.   
 
2.7.3.1 Phospholipase activity assay 
Toxin samples (200 µl) were double diluted across a 96 well ELISA plate (Immulon 
2, Corning) in DMG buffer pH 7.2 (0.2 M 3,3 dimethylglutaric acid, 5 mM calcium 
lactate, 0.2 mM zinc sulphate, 1 mg/ml BSA).  Egg yolk emulsion (100 µl; Oxoid) 
diluted 1:10 in PBS was added to each well and incubated at 37 
o
C for one hour.  The 
absorbance at 540 nm was then read on a microtitre plate reader (Ascent scan, 
Thermo Fisher, UK). 
 
2.7.3.2 FPLC purification of ricin 
Ricin was extracted from castor beans at Dstl by Nicki Walker using the following 
procedure.  Beans (100 g in 200 ml 0.5 M NaCl) were disrupted using a Waring 
blender using four bursts at low speed for 15 seconds.  The homogenate was then 
acidified to pH 4.0 using glacial acetic acid and stirred overnight at 4 ¡C.  The 
homogenate was centrifuged at 18 600 x g for 30 minutes to remove large plant seed 
debris and castor oil.  The turbid supernatant was then poured into a bottle (Duran, 
Sigma UK) and clarified using 5 volumes of petroleum ether. The organic and lipid 
phases were discarded and the aqueous phase was drained and filtered through a 
Whatman Number One filter paper.  The clarified supernatant (30 ml) was subjected 
to precipitation with 60 % ammonium sulphate (v/v) overnight. Following 
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centrifugation and dialysis as described in Section 2.7.2.1, the extract was 
centrifuged at 13 000 x g for 30 minutes.  The dialysed extract containing the toxin 
was applied to a 0.2 µM filter (Minisart, Sartorius) through a syringe.  It was then 
loaded via the FPLC superloop onto a sepharose-4B affinity chromatography 
column, using the same method as described in Section 2.7.1.2. The column was then 
washed with 25 ml 0.5 M NaCl to remove unbound proteins, and the toxin (and 
agglutinin) eluted with 25 ml of 0.5 M NaCl with 0.15 M galactose.  Fractions 
containing ricin toxins, as determined by SDS-PAGE (see Section 2.7.5) were pooled 
and concentrated. The ricin and agglutinin in the concentrated pool were then 
separated by gel filtration chromatography again using a Sephadex 200 column.  The 
sample was loaded via the superloop onto the column and eluted in 25 ml with a 
continuous flow of 0.5 M NaCl and 0.2 M galactose.  Fractions containing agglutinin 
were discarded and those containing ricin were pooled. 
  
2.7.4 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
 The inner core of a Mini-PROTEAN 3 Module (Biorad) was filled with 1 X Tris-
Glycine SDS running buffer (Biorad; 25mM Tris, 192 mM Glycine, SDS 0.1%, pH 
8.3).    A pre-made 12% Tris-HCl Ready 15 lane gel was loaded into the tank and 
then loaded with 5 µl of marker (SeeBlue Plus 2; Invitrogen, UK).  Samples were 
diluted in 2 X Laemmli sample buffer (62.5mM Tris-HCl pH6.8, 2% SDS, 25% 
glycerol, 0.01% Bromophenol Blue freshly prepared to contain 5 % β-
mercaptoethanol; Biorad, UK) and denatured by heating to 95 
o
C for 5 minutes.  
Samples were loaded onto the gel and then the outside core was filled with 1 X 
running buffer.  Gels were run for 30 minutes at 200 volts and then stained with 
SimplyBlue SafeStain (Invitrogen, UK).  
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2.7.5 Centriconª concentration of proteins 
Proteins were concentrated using a 50 ml YM-100 Centriconª column from 
Millipore (UK).  Preservative was removed from the centrifugal cup by washing in 
50 ml of water at 5000 x g for 5 minutes.  The sample was then loaded onto the cup 
(50 ml) and centrifuged for 45 minutes at 5000 x g.  The sample was recovered by 
inverting the cup into a clean tube and centrifuging at 3000 x g for 5 minutes.   
2.8 IMMUNO-PCR 
2.8.1 Biotinylation of antibodies 
Rabbit anti-ovalbumin polyclonal antibodies were obtained from Dr Steven Lonsdale 
(Dstl).  A Biotinylation kit was obtained from Sigma and used in accordance with the 
manufacturerÕs instructions.  The antibody was dissolved in phosphate buffer to a 
final concentration of 10 mg/ml.  The biotinylation reagent was dissolved in 
dimethylformamide (DMF) to a concentration of 25 mg/ml and added slowly to the 
antibody solution while agitating, to a molar excess of 15 times.  The solution was 
then mixed for one hour at room temperature.  Following incubation, the biotinylated 
antibody was purified using a Sephadex G25 column, pre-equilibrated with three 
times 10 ml volumes of phosphate buffered saline (PBS).  The biotinylated antibody 
was eluted with 13 ml of PBS and 650 µl fractions collected.  Fractions containing 
protein were pooled, as determined by measuring the absorbance at 280 nm on a 
spectrophotometer (Helios Omega UV/Vis spectrophotometer, Thermo Fisher, UK). 
 
2.8.2 Enzyme-Linked Immunosorbent Assay 
Immulon 2 plates (Corning, UK) were coated in 5 µg of capture antibody in 100 µl 
PBS at 4 ¡C overnight.  Plates were then washed three times in PBS with 0.01 % 
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Tween (PBS-T) using a plate washer (Titertek, UK) and then blocked in 2 % (w/v) 
skimmed milk powder (Marvel) solution in 150 µl PBS (colloquially known as 
Blotto) for 1.5 hours at 37 ¡C.  The plate was washed three times in PBS-T and then 
incubated with a 150 µl of a dilution series of ovalbumin in 2 % Blotto, ranging in 
concentration between 1 µg/ml and 11 pg/ml for 1 hour at 37 ¡C.  Plates were 
washed again and 150 µl of biotin labelled detection antibody, labelled as described 
in Section 2.8.1, was added at a concentration of 2.5 µg/ml in Blotto, unless detailed 
otherwise.  Plates were incubated for 1 hour at 37 ¡C and then washed three times in 
PBS-T. Extravidin-HRP (1:2000 in Blotto) (150 µl; Sigma, UK) was added to each 
well to a final concentration of 1 µg/ml and incubated in the plate for 1 hour at 37 
¡C.  A stock solution of ABTS chromogenic substrate (2,2'-azino-bis(3-
ethylbenzthiazoline-6-sulphonic acid) was prepared  with 5 µl of hydrogen peroxide 
and 2 ABTS tablets (both Sigma UK) in 100 ml of ABTS solution.  The plate was 
washed five times and 100 µl of ABTS was added to each well.  Colorimetric 
changes were read following fifteen minutes incubation at room temperature using an 
Ascent scan plate reader at 414 nm (Thermo Fisher, UK). 
 
2.8.3 Direct Antibody Labelling (Alchemy UK) 
A 72 bp amino-modified oligonuceotide (an Aspergillus flavus ord PCR product) 
was synthesised by Thermo Hybaid (UK).  Antibody labelling was then carried out 
under an extra-mural research contract by Alchemy (BBI, Dundee, UK).  The 5Õ 
terminus was derivatised to incorporate a primary aliphatic amino group (Qiagen 
UK). The antibody modification was then performed 75 minutes after the oligo 
modification to minimise the deactiviation of maleamide groups. 
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2.8.3.1 Preparation of acetylthioacetyl derivatised DNA (from Hendrickson, 
1995) 
Amino modified oligonucleotide (50 to 60 nmol) was added to 667 µl of reaction 
mixture containing 100 mM sodium bicarbonate buffer (pH 9; Sigma), 13.3 mg/ml 
N-succinimidyl-S-acetylthioacetate (SATA; Pierce) and 50% (v/v) 
Dimethylformamide (DMF; Sigma).  After 30 minutes at 25 ¡C, the reaction mixture 
was immediately applied to a 1 x 20 cm Sephadex
¨
 G 25 column (GE Healthcare, 
UK) and eluted at room temperature with 100 mM sodium phosphate buffer, pH 6.5, 
at a flow rate of 1 ml/minute.  The absorbance at 280/260 nm was monitored and 
fractions containing the modified oligonucleotides were pooled.  Fractions were 
concentrated using Centriconª columns (Millipore, UK), centrifuged at 7500 x g for 
45 minutes at room temperature.  The modified oligonucleotides were stored at room 
temperature in the dark until needed. 
 
2.8.3.2 Preparation of maleimide-modified antibodies 
The secondary ovalbumin antibodies were derivatized with maleimide groups using 
sulfo-SMCC.  An aliquot containing 25 nmol of antibody was added to a reaction 
mixture (2.2ml) containing 100mM sodium phosphate buffer (pH7.0), 1.2 mg/ml 
sulfosuccinimidyl 4-[N-maleimidomethyl]cyclohexane-1-carboxylate (sulfo-SMCC, 
Pierce), 1.5% (v/v) DMF.  After the reaction mixture had reacted for 30 minutes at 
25 ¡C, it was immediately applied to a 1 x 20 cm Sephadex
¨
 G 25 column and eluted 
at room temperature with 100 mM sodium phosphate buffer pH 6.5 at a flow rate of 
1 ml/min.  Fractions containing the modified protein were pooled into one tube. 
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2.8.3.3 DNA oligonucleotide-antibody conjugations 
The pooled antibody (4-6 ml) was immediately added to a 15 ml Falcon¨ tube 
(Fisher, UK).  The concentrated modified oligos were added to the same tube and 
mixed well.  The coupling reaction was initiated by adding 75 µl of 1 M 
hydroxylamine hydrochloride (Pierce Chemical Co, UK), pH 7, 50 mM EDTA 
(Sigma) and mixing well.  The reaction mixture was then transferred to an Amicon 
Model 3 mini-ultrafiltration stirred cell fitted with a YM5 membrane filter 
(Millipore, UK).  The cell was connected to a helium source adjusted to 60 psi.  The 
coupling reaction proceeded with stirring at room temperature while the entire vessel 
was covered with foil to reduce exposure to light.  The reaction mixture was 
concentrated to 1 ml, removed from the MiniCell apparatus and transferred to a 4.0 
ml amber vial.  This vial was incubated in the dark at room temperature on a tube 
roller until the reaction time totalled 2 hours.  The reaction was terminated by the 
addition of 10 µl of 10 mM N-ethylmaleimide in DMF (Pierce, UK). 
 
2.8.3.4 Purification of the oligo-antibody conjugates 
The reaction mixture was incubated with 1.5 mg of Protein A beads (Dynabeads, 
Dynal UK) for 1 hour to remove unconjugated DNA.  The antibodies were eluted 
from the beads by the addition of 20 µl elution buffer (Dynal, UK).  Next, ds DNA-
antibody conjugates were bound to an ion exchange column (Qiagen tip-20) and the 
unconjugated antibodies were washed off.  The conjugates were eluted from the resin 
with 50 mM 3-(N-morpholino) propanesulphonic (MOPS, Sigma) acid plus 1.25 M 
NaCl, pH 8.  Conjugate-containing fractions were pooled and dialysed against 100 
mM sodium phosphate plus 1 mM EDTA, pH 7 in a Centricon 100 column 
(Millipore, UK) treated with acetylated BSA (Promega).  The final conjugate 
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solution was stored at 4 ¡C in a solution of 100 mM sodium phosphate, 1 mM EDTA 
and 100 mg/l BSA, pH 7. 
 
2.8.4 Immuno-Phage PCR 
2.8.4.1 Treatment of B. cereus spores 
Bacillus cereus spores were grown as described in Section 2.2.1.  Spores (2 ml of 1 x 
10
10
 spores/ml) were incubated with 5% chloros solution for one hour at room 
temperature to remove extracellular DNA.  Spores were centrifuged at 5000 x g for 
10 minutes.  The supernatant was removed and the spores were resuspended in 2 ml 
dH2O.  This process was repeated until three washes had been carried out and the 
spores were suspended in dH2O at their original concentration of 1 x 10
10
 spores/ml. 
 
2.8.4.2 Single chain antibody production 
Single chain antibodies for the detection of B. cereus were engineered by Dr Carl 
Mayers at Dstl, according to the protocol described in Krebber et al., (1997).   
 
2.8.4.3 Messenger RNA extraction  
Messenger RNA (mRNA) was extracted from the spleens of five mice that had been 
immunised with Bacillus spores using a Qiagen RNeasy mini kit according to the 
manufacturerÕs instructions.   Spleens were ground in a pestle and mortar once they 
had rapidly been frozen in liquid nitrogen (BOC gases, UK).  The tissue powder and 
liquid nitrogen were decanted into an RNase-free, liquid-nitrogenÐcooled, 2 ml 
microcentrifuge tube (Ambion, Fisher, UK). The liquid nitrogen was evaporated and 
600 µl of buffer RLT was added to the tissue whilst still frozen.  The lysate was 
added to a QIAShredder tube and centrifuged at 10 000 x g for two minutes.    The 
supernatant was transferred to a clean RNase-free tube and one volume of 70 % 
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ethanol was added.  The sample was then transferred to an RNeasy spin column and 
centrifuged at 8000 x g for 15 seconds.  RW1 buffer (700 µl) was added to the spin 
column which was then centrifuged at 8000 x g for 15 seconds.  The spin column 
was washed in 500 µl of buffer RPE at 8000 x g for 2 minutes.  The tube was then 
placed in a new collection tube and re-centrifuged at 8000 x g for 1 minute to remove 
residual alcohol.  The spin column was transferred to a new collection tube and the 
RNA was eluted in 50 µl RNase free water by centrifugation at 8000 x g for 1 
minute.  The resulting RNA was used immediately for cDNA synthesis. 
 
2.8.4.4   cDNA synthesis 
Reverse transcription of RNA was carried out using a SuperScriptª II Reverse 
Transcriptase kit (Invitrogen, UK).  Reaction mixes were prepared to contain 5 µg of 
total RNA, 10 mM dNTPs and 50 ng of random hexamers in RNase free water.  
Samples were incubated at 65 
o
C for 5 minutes and then snap cooled on ice for 1 
minute.  Following heat denaturation, reverse transcription reactions were prepared 
using 10 X RT buffer (2 µl), 4 µl 25mM MgCl2, 0.1 M Dithiothreitol (DTT; 2 µl) and 
2 µl of RNase Outª Ribnuclease inhibitor (Invitrogen).  This was then added to 9 µl 
of RNA/primer mixture and incubated at 25 
o
C for 2 minutes.  SuperScriptª II 
Reverse Transcriptase (1 unit; Invitrogen, UK) enzyme was then added to the 
mixture.  Reverse transcription was then carried out at 42 
o
C for 50 minutes.  The 
reaction was terminated at 70 
o
C for 15 minutes and then chilled on ice.  cDNA 
hybrids were removed using 1 µl of RNase H for 20 minutes at 37 
o
C.  
 
2.8.4.5   Amplification of antibody light and heavy chains (VL and VH) 
Heavy and light chain antibody fragments were amplified using the method 
described Krebber et al. 1997.  PCR reactions were performed in 50 µl volumes 
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containing 0.005 units pfx 50 Taq polymerase (Invitrogen), 2-5 µl of cDNA, 2 µM of 
primers (see Table 2.4), 2 mM MgCl2 and 1 x reaction buffer (Invitrogen).   
 
Table 2.4 Primer sequences used for amplification of single chain antibodies 
(Krebber et al., 1997); see Section 2.8.4.6 for amplification conditions. 
 
Primer Sequence (5Õ to 3Õ) 
VHF GAGGAGACGGTGACTGAGGT 
VHR GAGGTGAAGGTCATCGAGTC 
VLF ACGTTTGATTTCCAGCTTGG 
VLR ATCCAGCTGACTCAGCC 
SCFOR GGATTCGGCCCCCGAG 
SCBACK TTACTCGCGGCCCAGCCGGCCATGGCGGACTACAAAG 
 
2.8.4.6   Joining ScFv heavy and light chains by overlap extension PCR 
Primers SCFOR and SCBACK (50 nM each; Table 2.4; Sigma Genosys, UK), as 
detailed in Krebber (1997), were used in 50 µl reactions with 10 ng of purified heavy 
and light chain DNA, 1 mM MgSO4, 0.3 nM dNTPs, 1 x Pfx50 buffer and 1 unit of 
Platinum Pfx 50 Taq polymerase (all reagents from Invitrogen, Fisher, UK).  The 
reactions were thermal cycled for 3 minutes at 94¼C to denature the amplicons, 
followed by seven cycles of: 
15 seconds at 94 ¼C, 30 seconds at 63 ¼C, 30 seconds at 58 ¼C, 60 seconds at 68 ¼C.  
This was immediately followed by 23 cycles of: 
15 seconds at 94 ¼C, 30 seconds at 63 ¼C and 60 seconds at 68 ¼C.  Samples of the 
resulting amplicon were visualised on a 2 % crystal violet stained agarose gel to 
confirm the product size. Amplicon was ligated into pAK100 (Krebber et al. 1997) 
as described in Section 2.4.3 and transformed as described in Section 2.4.5. 
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2.8.5 Panning for single chain antibodies 
2.8.5.1 Production of phage particles 
Broth (50 ml of 2 X YT) supplemented with 1% (V/V) glucose (Sigma, UK) and 30 
µg/ml chloramphenicol (Roche, UK) was inoculated with sufficient volume of 
transformed ScFV library (prepared as described in Section 2.8.4.3) to give a starting 
OD600 of 0.05, in a 250 ml sterile conical flask with vented cap (Corning, VWR, 
UK).  The flask was incubated with shaking at 200 rpm in a Stuart Orbital Incubator 
S150 incubator at 37 ¼C until an OD600 of 0.4-0.5 was reached.  A ten-fold excess 
(10
11
 transforming units) of helper phage (M13KO7; Sigma) was added to the cells 
and the mixture was incubated for a further 30 minutes.  Expression of the single 
chain fragments, under the control of the lac operon, was induced with 1 mM 
Isopropyl β-D-1-thiogalactopyranoside (IPTG; Roche, UK) at 30 ¼C with shaking 
(180 rpm) for 16 hours.   
 
2.8.5.2 Phage purification 
Phage particles were separated from E. coli cells by centrifugation at 4000 x g for 15 
minutes at 4 ¼C.   The supernatant containing phage particles (40 ml) was added to 10 
ml 20 % (v/v) polyethylene glycol (PEG 8000; Sigma, UK) and 2.5 M NaCl in order 
to facilitate precipitation.  Phage particles were collected by centrifugation at 4000 x 
g at 4 ¼C for ten minutes and resuspended in 1 ml PBS.   
 
2.8.5.3 Estimation of phage titre 
A dilution series of phage in 2 X YT broth (225 µl) with 25 µl log phase E. coli 
XL1-Blue was made.  Antibiotic resistance was allowed to occur during growth at 37 
¼C for 15 minutes. The resulting cultures (100 µl) were grown on 2 X YT plates 
supplemented with 1 % (v/v) glucose and 30 µg/ml chloramphenicol at 37 ¡C for 16 
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hours and the phage concentration was estimated by plaque counts, as indicated by 
clear regions on the plate. 
 
2.8.5.4 Panning 
Immunotubes (4 ml; Nunc, Fisher UK) were coated in 2 ml Bacillus spores at a 
concentration of 1 x 10
7
/ml overnight at 4 ¡C.  The tubes were then washed three 
times in 4 ml of PBST, then blocked in 4 ml 1% blotto at room temperature for 2 
hours.  During this time, pre-blocked phage was produced by incubating 100 µl of 
phage particles (prepared as described in Section 2.8.7.2) with 900 µl of blotto.  The 
spore coated tubes were then washed three times in 4 ml of blotto to remove excess 
blocking agent.  Binding of phage particles (1 ml) was then carried out at room 
temperature for one hour with mixing on a Dynal windmill.  The tubes were 
subsequently washed with 5 to 20 washes (depending on the stringency of the 
panning round) of PBS, 0.1% (v/v) Tween 20.  A further 5 washes were carried out 
using PBS without Tween 20, to further increase the panning stringency.   
 
2.8.5.5 Phage recovery  
The antibody-spore bond was broken using 1 ml of freshly made 100 mM 
triethylamine during an 8 minute incubation period at room temperature.  The 
contents of the immunotube were rapidly transferred to a tube containing 500 µl 1M 
Tris HCl pH 7.5 to neutralise the solution.  The phage with an affinity for B. cereus 
spores were then incubated with 10 ml log-phase E. coli XL-1 Blue statically for 30 
minutes, followed by shaking 30 minutes at 37 ¼C.  Infected E. coli cells were then 
spread and grown on 24 cm 2 X YT plates supplemented with 1 % (v/v) glucose and 
30 µg/ml chloramphenicol at 37 ¡C for 16 hours.  Phage titre was estimated by 
plaque counts as described in Section 2.8.5.3.  The panning protocol was repeated 
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until phage particles showed sufficient affinity for B. cereus spores, as demonstrated 
by ELISA, at panning rounds three onwards.  
 
2.8.6 I-φ-PCR 
Bacillus cereus spores (50 µl of a suspension containing 10
7
 to 10
0
 spores/ml) were 
dried onto an Immulon 2 ELISA plate at 37 ¡C overnight.  The plate was then 
washed three times in PBS-T in a Titertek plate washer and blocked in 2% Blotto for 
1.5 hours at 37 ¡C.  The plate was washed a further three times in PBS-T and 50 µl 
of phage suspension diluted in Blotto were added per well.  Following incubation at 
37 ¡C for one hour, the plate was washed three times in PBS-T then three times in 
dH2O to remove unbound phage.   
 
2.9 SYSTEMATIC EVOLUTION OF LIGANDS EXPONENTIALLY 
(SELEX) 
2.9.1 Aptamer Library 
SELEX DNA templates were composed of a single stranded template obtained from 
Cruachem UK, with randomised bases (N) in the midsection, flanked by a 5Õ and 3Õ 
primer site as follows:  CCGGATCCGTTGATATATAAAATTC (N)50 
TTGAATGTGGTGTTGGCTCCC.  AP F and R PCR primers (Table 4.4) were 
obtained from Qiagen UK.  PCR was carried out to form a double stranded SELEX 
library.   
 
A 25 µl or 100 µl PCR master mixture consisting of 1ng of DNA, 1 µM each primer, 
0.2mM each dNTP, 1.5 mM MgCl2, 10 mM Tris-HCl, 50 mM KCl and 50 U Taq 
polymerase was used.  PCR (100 µl) was carried out on an ABI 9700 thermal cycler 
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with 40 cycles of 95 ¡C for 1 minute, 55 ¡C for 1 minute and 72 ¡C for 1 minute.  25 
µl reactions additionally contained Sybr Green ¨ I at a final concentration of 2 X and 
were carried out on the Roche Lightcycler. 
2.9.2 Coating tosyl activated Dynabeads with ovalbumin (Bruno and Kiel 
1999) 
Ovalbumin was captured by Tosyl activated Dynabeads (Dynal, UK) by incubating 1 
ml of 0.1 mg/ml ovalbumin in PBS with 1 ml bead solution (1.3 x 10
8
/ml
 
Tosyl 
activated beads) for 16 hours at 37 ¡C in a Thermomixer (Eppendorf).  The beads 
were collected with a Dynal magnetic particle collector (MPC), then washed in three 
times in 1 x coating buffer (0.5M NaCl, 10 mM Tris HCl pH 7.5, 1 mM MgCl and 
0.1 % Triton ¨ X-100). 
 
2.9.3 Elimination of aptamers with affinity to Tosyl activated Dynabeads 
A negative pre-selection round was performed by incubating 100 µl of the beads 
prepared in Section 2.9.2 with 5 µg of DNA aptamer pool in 1 x binding buffer (20 
mM Tris (pH 7.5), 100 mM NaCl, 5 mM MgCl2) for 1 hour on a rolling platform 
(Spiramixer, VWR).  The beads were isolated using an MPC and unbound species 
were collected, PCR amplified as described in Section 2.9.1 and used in the rest of 
the SELEX experiment.   
 
2.9.4 SELEX Procedure 
In the first round of selection 5 µg of the aptamer pool was added to 40 µl of 
ovalbumin bound Dynabeads in 1 X binding buffer.  The aptamers were allowed to 
bind to the beads during a 1 hour incubation at room temperature on a rolling 
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platform.  Beads were isolated using a magnetic rack then washed three times in 1 ml 
of 2 X binding buffer.  Beads were resuspended in 100 ml of 1 X binding buffer and 
then heated in a boiling waterbath for 30 seconds.  The beads were isolated rapidly 
using the MPC and the supernatant was transferred immediately to a clean 1.5 ml 
tube.  The isolated DNA was then amplified by PCR as described in Section 2.9.1 
and then used directly as the DNA pool for SELEX round 2.   Subsequent rounds of 
SELEX were carried out using the same procedure, as discussed in Chapter 4. 
 
2.9.5 Enzyme-linked oligonucleotide assay (ELONA) 
An ELISA type assay was performed, similar to that reported by Drolet et al. (1998).  
Anti ovalbumin aptamers (100 µl) were diluted 1 in 500 in Reacti-Bind¨ (Pierce, 
UK) and added a 96 well Immulon 2 plate.  DNA was allowed to bind to the plate 
overnight.  DNA was then made single stranded by placing the plate in a boiling 
waterbath for 30 seconds.  Free DNA was decanted and the plate was then manually 
washed three times in 300 µl 1 x binding buffer.  The plate was then coated in a 
blocking solution (2 % skimmed milk powder, 10 ng salmon testes DNA) at 37 ¡C 
for 1 hour.  The plate was washed three times in 1 x binding buffer.  Ovalbumin was 
added to the plate at concentrations ranging from 100ng to 0.1 fg/ml and was 
incubated at 37 ¡C for 1 hour.  The plate was then washed and 100 µl of anti 
ovalbumin biotinylated antibody was added to the plate at a concentration of 2.5 
µg/ml. Following washing, streptavidin peroxidase (1 µg/ml) was added to each 
well.  Colour was developed by the addition of 100 µl 2,2Õ-azino-di(3-ethyl-
benzthiazoline-6-sulphonic acid) (ABTS) plus 50 µl H2O2.  Colourimetric changes 
were measured on a plate reader at 440 nm. 
 
2.9.6 SELEX using biotin labelled aptamers (Bruno and Keil 2002) 
Chapter 2 Materials and Methods. 
 71 
Tosyl activated beads were used as described in Section 2.9.2 to produce ovalbumin 
coated magnetic particles.  SELEX library (23 µg) was amplified by PCR as 
described in Section 2.9.1 using biotin labelled APF and APR primers as described in 
Chapter 4.  A negative pre-selection was carried out to eliminate bioinylated 
aptamers that bind to Tosyl activated magnetic beads as described in Section 2.9.2.  
The unbound species were then heated to 96 ¡C for 5 minutes and then added to 200 
µl of ovalbumin coated beads (12.6 x 10
7
 beads coated with 20 ng ovalbumin).   The 
beads and aptamer pool were incubated together for 1 hour at room temperature on a 
rolling platform, and then washed three times in 1 ml of binding buffer.  The aptamer 
bound beads were then added directly to a 100 µl PCR reaction containing 
quadrupled quantities of reagents detailed in Section 2.9.1.  The supernatant 
containing amplified bioinylated aptamers was recovered by magnetic bead 
separation in a Dynal MPC. A further 100 µl of dH2O was added to the beads which 
were then heated to 96 ¡C in a Perkin Elmer 9700 machine for 5 minutes to release 
any remaining DNA bound to the beads.  Both aptamer solutions were combined 
with 100 µl 2x binding buffer, heated to 96 ¡C as before to denature the DNA and 
then added to 200 µl of fresh ovalbumin coated beads.  This process was repeated 
until 5 rounds of SELEX had been carried out. 
2.10 DIFFERENTIATION OF RICINUS COMMUNIS STRAINS USING 
DNA ANALYSIS 
2.10.1 Random Amplified Polymorphic DNA (RAPD) analysis 
RAPD primer sequences were obtained from Eurofins MWG (Germany; Table 2.5).  
RAPD PCR was carried out on a Perkin Elmer 9700 with 200 µΜ dΝΤP (Roche, 
UK), 10 pmol each primer; approximately 5ng template DNA, 1x Roche PCR buffer, 
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2.5 U Taq polymerase (Roche, UK) and 2.5 mM Mg
2+
, using the thermal cycling 
parameters outlined in Table 2.6). 
Table 2.5  DNA sequences of the six RAPD primers used. 
 
Oligo name  DNA sequence 
Sequence (5Õ Ð 3Õ) 
OPAA1 AGACGGCTCC 
OPAB5 CCCGAAGCGA 
OPT05 GGGTTTGGCA 
OPAB18 CTGGCGTGTC 
OPAA10 TGGTCGGGTG 
OPC20 ACTTCGCCAC 
 
Table 2.6 Thermal cycling profile for RAPD reactions. 
 
Temperature Duration Number of cycles 
94 
o
C 2 min 1 cycle 
94
 o
C 30s  
45 cycles 42
 o
C 45s 
72
 o
C 30s 
72
 o
C 7 min 1 cycle 
 
2.10.2 Restriction Fragment Length Polymorphism (RFLP) analysis 
Amplicon was restriction enzyme digested as described in Section 2.4.2.  The 
enzymes shown in Table 2.7 were used.   
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Table 2.7  Restriction enzymes and their conditions of use. 
 
Enzyme Supplier Buffer Incubation 
temperature 
HaeIII Sigma (U.K.) SM buffer 37 
o
C 
TaqI Sigma (U.K.) SB buffer 37 
o
C 
HaeIII  
TaqI 
 SB Buffer 37 
o
C 
HindIII Sigma (U.K.) SB buffer 37 
o
C 
EcoRI Sigma (U.K.) SH buffer 37 
o
C 
HindIII 
EcoRI 
 SB buffer 37 
o
C 
BstNI New England 
Biolabs 
(U.S.A.) 
Buffer 2 60 
o
C 
2.11 454ª SEQUENCING 
454 sequencing was carried out according to the manufacturers instructions issued in 
October 2008, with updates provided in August 2009 (Issue number April 2009), 
December 2009 (issue October 2009) and January 2010 (October 2009 Jan 2010 
revision).  All components were obtained from Roche unless stated otherwise. 
2.11.1 Shotgun library preparation  
2.11.1.1 Nebulisation 
Library preparation was carried out using 5 µg of DNA from R. communis Jianxiang 
1 or Zibo 1.  Whole genomic DNA was prepared using PowerPlant¨ extraction as 
described in Section 2.2.3.2.  DNA was quantified as described in Section 2.6.3.  
Nebulisation was then carried out to shear the DNA fragments using nitrogen gas at 
30 psi for one minute in 500 µl nebulisation buffer (Roche).  The sheared DNA was 
subsequently purified using a MinElute PCR purification kit (Qiagen, UK).   
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2.11.1.2 MinElute purification 
Buffer QBI (2.5 ml) was added to the nebuliser and the contents were mixed.  The 
DNA was bound to a MinElute column in 750 µl aliquots by centrifugation at 10 000 
x g for 1 minute.  The flow though was discarded and the column was re-centrifuged 
as before.  DNA was then eluted from the column in 10 µl of buffer EB and collected 
following centrifugation at 10 000 x g for 1 minute.   
 
2.11.1.3 AMPure bead removal of small DNA fragments 
The volume of eluate was measured with a pipette.  The volume was then made to 
100 µl with buffer EB (Qiagen).  AMPure size exclusion beads (125 µl) were added 
to the DNA.  DNA was bound to the beads during a 5 minute incubation at room 
temperature.  The beads were washed twice in 500 µl of ethanol.  DNA was eluted 
from the beads in 24 µl buffer EB. 
 
2.11.1.4 DNA quality analysis 
The quality of the resulting DNA (1 µl) was assessed on the Agilent Bioanalyser 
using an HS DNA chip (Agilent, UK).  The gel dye mix was prepared by adding 15 
µl of high sensitivity dye to a vial of gel matrix.  Gel dye matrix (9 µl) was added to 
the chip in well G.  The chip was primed in the priming station by releasing the 
syringe.  Marker (5 µl) was added to each well and 5 µl of sample or water was 
added to each unmarked lane.  DNA ladder (1 µl) was added to the yellow well and 
the chip was vortexed using an adapter at 2400 rpm for 1 minute (Agilent, UK).  The 
chip was then loaded into the Bioanalyser and run for 30 minutes.   
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2.11.1.5 Fragment end polishing 
Sticky ends were removed from the nebulized, size selected DNA (23 µl in total), in 
a reaction containing 5 µl 10 × polishing buffer, 5 µl BSA, 5 µl ATP, 2 µl dNTP 
Mix, 5 µl T4 polynucleotide kinase, 5 µl T4 DNA polymerase in a total volume of 50 
µl.  The reaction was carried out at 12 
o
C for 10 minutes in a 9700 PCR machine, 
followed by 25 
o
C for 15 minutes.  Polished DNA was then purified using a 
MinElute kit (as in Section 2.11.1.2).   
 
2.11.1.6 Sequence capture adapters 
Sequence capture adapters were then ligated to the polished DNA (10 µl) in a 
reaction containing 20 µl 2 × Ligase Buffer, 5 µl Adaptors, and 5 µl Ligase at 25 
o
C 
for 15 minutes in a 9700 PCR machine.  DNA was purified using a MinElute  kit as 
in Section 2.11.1.2, however 200 µl QBI was used and DNA was eluted in 50 µl EB.  
Small DNA fragments were removed using the AMPure purification described in 
Section 2.11.1.3. 
 
2.11.1.7 Library immobilisation (Roche)   
The DNA library (25 µl) was then captured onto 50 µl immobilisation beads 
(prepared by washing twice in 2 x library binding buffer and eluted in 25 µl) at room 
temperature on a rolling platform (Spiramixer; Jencons, UK) for 20 minutes.  The 
beads were washed twice in 100 µl 2 x library wash buffer and eluted in 50 µl of fill 
in reaction, prepared as described below.   
 
2.11.1.8 Fill in reaction (Roche) 
A fill in reaction was prepared to fill in gaps in the immobilised DNA using 40 µl 
dH2O, 5 µl 10× fill-in polymerase buffer, 2 µl dNTP Mix and 3 µl fill-in polymerase.  
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The reaction mix was added to the beads prepared in Section 2.12.1.7 and incubated 
at 37 
o
C for 20 minutes.  The beads were were washed twice in 100 µl 2 x library 
wash buffer and eluted in 50 µl of melt solution (0.1 N NaOH, Sigma, UK) prepared 
as described in Section 2.11.1.9.  A MinElute column was used to purify the 
resulting ssDNA as described in Section 2.11.12.  Quality of the ssDNA was 
assessed using an RNA Pico 6000 chip on the Bioanalyser (as Section 2.11.1.4).  
DNA was quantified using Ribogreen (Invitrogen).  The number of molecules per 
bead was calculated (molecules/µl = (Sample concentration; ng/µl) × (6.022 × 10
23
) / 
(328.3 × 10
9
) × (average fragment length; nt).  Library DNA at a concentration of 
1x10
8
 molecules/bead was then stored in frozen aliquots until needed.  
 
2.11.2 Emulsion PCR 
2.11.2.1 Preparation of emulsion reactions 
Roche emulsion oil was shaken in a Qiagen TissueLyser at 28 Hz for 2 minutes.  
Mock amplification mix (5ml) was then added to the emulsion oil which was shaken 
at 28 Hz for 5 minutes.  Live amplification mix was made with 2400 µl dH2O, 3000 
µl emPCR additive, 5 x amplification mix, 560 µl amplification primer, 400 µl 
enzyme mix and 10 µl PPiase (Roche). DNA capture beads were washed twice in 1 
ml 1 x capture wash buffer (Roche), using centrifugation at 10 000 x g for 10 
seconds to collect the beads each time.  DNA (at 10
7
 molecules/bead), were vortexed 
and then added to the live amplification mix tubes.  The live PCR mix was added to 
the emulsion oil prepared above and was then shaken at 12 Hz for 5 minutes.  The 
reaction mixes (100 µl) were dispensed into four 96 well plates using a 5 ml digital 
Eppendorf multistepper pipette.  The plates were sealed with Epppendorf caps and 
were cycled on a Perkin Elmer 9700 machine for 4 minutes at 94¡C followed by 50 
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cycles of 30 seconds at 94¡C, 4.5 minutes at 58¡C, 30 seconds at 68¡C and then held 
at 10¡C for ten hours. 
 
2.11.2.2 emPCR recovery 
The caps were carefully removed from the PCR plates and emulsions were aspirated 
and collected into two 50 ml Falcon¨ tubes (Fisher, UK) using the LV vacuum 
assisted breaking equipment supplied by Roche.  The plates were washed twice in 
100 µl isopropanol (VWR, UK) and collected using the transpipette. The transpipette 
was rinsed in a further 5 ml of isopropanol.  The volume of the tubes was then 
supplemented with isopropanol to total 40 ml and centrifuged at 930 x g for 5 
minutes.  The supernatant was removed and the pellet was resuspended in 35 ml 
isopropanol.  Following centrifugation as above the pellets were washed in 35 ml 
ethanol (96 %; VWR, UK).  The beads were then washed in 35 ml enhancing fluid 
(Roche, UK).  The majority of the supernatant was discarded and the pellets were 
resuspended in 2ml of residual supernatant.  The concentrated bead solutions were 
transferred to 1.7 ml eppendorfs using centrifugation at 10 000 x g for 30 seconds to 
reduce the volume.  The 50 ml tubes were washed in 600 µl enhancing fluid to 
collect any remaining beads which were then transferred to the 1.7 ml tubes.  The 
tubes were centrifuged for 30 seconds as before and the supernatant discarded.  The 
beads were washed three times in 1 ml enhancing fluid (Roche, UK) and then 
resuspended in 1 ml of 0.1 N NaOH.  The beads were incubated at room temperature 
for 2 minutes.  The tubes were centrifuged and a futher 1 ml of NaOH was added.  
The beads were washed twice in 1 ml of annealing fluid and resuspended in 45 µl 
annealing buffer and 25 µl enrichment primer (Roche, UK).  The tubes were 
incubated at 65 
o
C for 5 minutes and then snap cooled on ice for 2 minutes.   The 
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beads were resuspended in 800 µl enhancing fluid, centrifuged and washed twice 
more in a further 1000 and then finally resuspended in 800 µl. 
 
The magnetic enrichment beads were prepared by washing three times in 1 ml 
enhancing fluid, using a magnetic particle collector (Dynal, UK) to concentrate the 
beads each time.  The beads were resuspended in 320 µl enhancing fluid.  The beads 
were then divided between the four dolphin nosed tubes and incubated on a 
Labquake roller for 5 minutes at room temperature.  The beads were then washed at 
least ten times in 1 ml enhancing fluid, or until no beads were visible in the discarded 
supernatant.  Clonally amplified DNA-bead complexes were eluted from the 
magnetic beads twice in 1 ml 1N NaOH.  The DNA-beads were collected by 
centrifugation and washed three times in 1 ml annealing fluid and resuspended in 200 
µl.  The sequencing primer (50 µl; Roche, UK) was added to each tube which were 
then incubated at 65 
o
C for 5 minutes and then cooled on ice.  The beads were 
resuspended in 800 µl of annealing buffer and washed twice in 1 ml.  The beads were 
finally resuspended in 1 ml and stored at 4 
o
C until sequenced (within two weeks).    
 
2.11.3 Sequencing and data analysis (Roche) 
The reagents were taken from the foil packaging and defrosted in the refrigerator 
overnight.  Bead buffer 2 (BB2) was made by adding 34 µl apyrase and 1.2 ml of 
titanium supplement CB  to a 200 ml bottle of titanium bead buffer.  The 
PicoTiterPlateª (PTP) was submerged in BB2 for 10 minutes.  The packing beads 
were washed three times in 1 ml BB2 by centrifuging at 10 000 x g for 5 minutes.  
The packing beads were resuspended in 550 µl BB2.  The entire contents of both 
DNA (sample) beads were vortexed, centrifuged to remove supernatant and 
transferred to a new 1.7 ml tube.   The control beads (10 µl) were added to each tube 
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and the volume in the tube adjusted to 30 µl by removing supernatant.  DNA bead 
incubation mix (DBIM) was prepared by adding 150 µl DNA polymerase cofactor to 
1570 µl BB2 and 300 µl DNA polymerase.  DBIM (320 µl) was added to each tube 
of DNA beads and these were incubated on the Spiramixer (Jencons, UK) for 15 
minutes.  The enzyme and PPiase beads were washed three times in 1 ml BB2, 
resuspended in 1ml or 500 µl BB2 respectively then diluted as shown in Table 2.8. 
Table 2.8: Dilution of the Enzyme and PPiase Beads for bead layers 1, 3, and 4. 
Bead 
Layer  
 
BB2 
(µl) 
 
Enzyme Beads 
(µl) 
 
PPiase Beads 
(µl) 
 
Total Volume 
(µl) 
 
1 3250  550   3800 
2 2500  1300   3800 
3 3340   460 3800 
 
The DNA beads (350 µl) were combined with 100 µl packing beads and 210 µl BB2 
to form the final bead layer (layer 2).  The bead layers were deposited into the PTP in 
turn by pipetting 660 µl into the bead deposition device and centrifuging at 1620 x g 
for 5 minutes.  The enzyme beads prelayer was loaded first, followed by the DNA 
and packing beads, then the enzyme beads post layer, followed by the PPiase layer.  
The sequencing reagents tray was then prepared by adding 6.6 ml CB supplement 
and 1 ml Dithiothreitol (DTT) to each bottle of Titanium buffer CB.  PPiase (5 µl) 
was diluted in 45 µl Inhibitor TW.  A sodium chlorite tablet was added to tube 1, 
13.5 µl diluted PPiase was added to tube 9, 260 µl apyrase was added to tube 11 and 
3 ml of ATP was added to tube 10.  The tube tray was inverted 20 times to mix the 
contents and was then transferred to the sequencer.  The Genome Sequencer FLX 
instrument monitored each well simultaneously overnight.  Data analysis was 
subsequently carried out on an 8 node IT cluster. The Roche GS reference mapper 
software was used to identify high confidence differences between the reference Hale 
strain and either Jianxiang or Zibo 1.   
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3  PCR DETECTION OF PROTEIN TOXINS 
 
3.1   INTRODUCTION 
3.1.1 PCR as a tool for toxin detection 
PCR is an exquisitely sensitive DNA analysis technique, used frequently to identify 
genes for many purposes including genetic fingerprinting (Jeffreys et al., 1991), 
diagnosis of infectious disease (Arthur et al., 1989), phylogenetics (Littlewood, 
1994), diagnosis of hereditary disease (Wong, 1987) and cloning.  However analysis 
of proteins lacks an analogous technique.  Instead, proteins are detected using 
antibody based methods, most commonly ELISA and its derivatives.  Detection of 
proteins using PCR is not intuitive; however it may be possible for the presence or 
absence of a protein toxin to be confirmed by PCR amplification of residual or 
contaminating DNA in a sample.  PCR is commonly used successfully to infer the 
presence of toxin in food samples (for example De Medici et al., 2009; Rall et al., 
2008) as it is rapid, sensitive and is able to detect non-viable organisms (Masters et 
al., 1994).  However, it is unknown whether PCR is capable of detecting toxins that 
have been purified, as may be the case with a toxin used as a biological weapon. 
 
3.1.2 Toxin purification  
Protein purification methods vary greatly depending on the properties of the protein 
and its intended end use.  The simplest form of purification is to precipitate the 
protein by altering the solvent so that the protein becomes insoluble, often by adding 
acid or alcohol.  Other methods of purification may be more labour intensive and 
require more equipment and expertise.  Affinity chromatography simplifies a 
purification strategy to an extent as the properties of the protein need not be 
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determined in fine detail (Axen, 1967), however the protein is often cloned into a 
plasmid vector bearing a tag and then transformed into an organism such as E. coli or 
Pichia pastoris (Skopes, 1993).  The recombinant protein is subsequently expressed 
and purified using a column with affinity for the cloned tag, for example a 
(histidine)6 tag binding to a nickel column.  Ion exchange requires numerous stages 
for capture, intermediate purification and polishing (CIPP) and therefore must be 
optimised using a protocol adapted to the properties of the protein (Skopes, 1993).   
 
3.1.3 Aims 
The aims of this section were firstly to develop real time quantitative PCR assays for 
detection of the toxin genes shown in Table 3.1 and secondly, to use the resulting 
PCR assays to detect toxin samples taken during the purification.  Several toxins 
were purified at Dstl for this research using protocols that have been previously 
optimised by the protein biochemistry team, as summarised in Table 3.1.   
 
Table 3.1 Toxins and purification strategies used in this study. 
Organism Toxin/protein Purification method 
Clostridium botulinum Botulinum neurotoxin Acid precipitation 
Yersinia pestis V antigen Affinity chromatography 
(Carr et al. 1999) (GST 
fusion protein) 
Ricinus communis Ricin Affinity chromatography 
(sepharose) 
Clostridium perfringens Phospholipase C Ion exchange (CIPP) 
 
Chapter 3 PCR Detection of Toxins. 
 82 
3.2 ASSAY DESIGN AND OPTIMISATION 
3.2.1 Design 
The DNA sequences of each toxin gene were obtained from the Genbank database.  
Sequences were also obtained from homologues where available.  The genes were 
aligned using SeqMan software (DNAstar) and PCR primers were designed in 
regions of DNA sequence identity.  The details, including accession numbers, are 
summarised in Table 3.2. 
 
3.2.2 PCR thermal cycler settings 
Each toxin assay was designed using Primer Express software (Applied Biosystems) 
using the default thermal cycling parameters.  This would allow a number of 
different assays to be run simultaneously on the same machine.  PCRs were 
optimised using a 2 step reaction, with a denaturation time of less than one second at 
95 
o
C and a combined annealing and extension phase at 60 
o
C for 30 seconds.  
However a three step PCR was more suited to a number of assays as discussed 
further in the following sections and summarised in Table 3.12.   
 
3.2.3 Reagents 
PCR was carried out with the minimum concentration of reagents required for 
amplification to increase the specificity of the PCR (as detailed in Table 3.12).  
Primers were used at a concentration of 500 nM to limit the formation of primer 
dimer.  Assays were initially tested using Sybr¨ Green I, a double stranded DNA 
intercalator, to report PCR amplification on the Roche Lightcyclerª.  Once a primer 
set was demonstrated to be suitable in terms of specificity and sensitivity, the assay 
was converted to a TaqMan
¨
 assay.  This was performed by replacing Sybr¨ Green I 
with a specific probe labelled with Fluorescein (FAM) at the five prime end and 
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either Tetramethylrhodamine (TAMRA) or Black Hole Quencher at the three prime 
end.  The concentration of TaqMan¨ probe was commonly optimised at 0.3 or 0.4 
µM.  The final magnesium concentration was also optimised for each assay with 3 or 
4 mM being used for the majority.  The results are discussed in detail in the 
following sections and are summarised in Table 3.12.
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Table 3.2.  Accession numbers of the target genes used in this study. 
 
Gene  Locus 
Name 
GenBank  
Accession 
# 
Gene  Locus 
name 
Accession 
# 
bont/a  (C. 
baratii) 
CB43256  Y12091  bont/f; 
ntnh/f 
(nonprot) 
CLOBON
T 
L35496 
bont/a  CBANB  X92973  bont/b  CLOBOT
B 
M81186 
bont/b  CBB2129  X70814  bont/a 
(62A) 
CLONEU
R 
M30196 
bont/b  CBBEKLUN
D 
X70819  bont/f 
(202F) 
CLONEU
TOXF 
M92906 
C.butyricum 
bont/e 
CBBNTTE  X62088  bont/c 
and d 
CLOTNC
O 
D38442 
bont/b  CBBONTB  X71343  bont/c  CSTC1TO
X 
D90210 
bont/f  CBBONTF
G 
X81714  bont/f 
(202F) 
S73676  S73676 
bont/g  CBBONTG  X74162  bont/f; 
ntnh/f 
(nonprot) 
CLOBON
T 
L35496 
bont/a  CBBOTAG  X52066  bont/b  CLOBOT
B 
M81186 
bont/b  CBBOTNTB
G 
Z11934  bont/e  (C. 
butyricum) 
CBTOXE  X53180 
bont/b  CBBPROT  X70817  ntnh/b  CBU6380
8 
U63808 
bont/c  CBCBONT  X72793  bont/b 
ntnh 
CBY1363
0 
Y13630 
bont/c  CBCNIS  X68204  bont/f  CBY1363
1 
Y13631 
bont/c  CBCPHGC1  X53751  bont/a  CBY1423
8 
Y14238 
bont/c  CBCTLE  X68205  bont/b  CBY1423
9 
Y14239 
bont/c  CBCTOX  X62389  bont/c  CLOBN  D49440 
  CBDNABN
G 
X87974  plc  CLOCPA  L43545 
  CBDNAPTC
G 
X87972    CLOCPAA  L43546 
bont/d  CBDTLE  X68206    CLOCPAB  L43547 
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bont/e  CBEDOLM
AN 
X70818    CLOCPAC  L43548 
bont/e  CBEHAZEN  X70815    CLOOLC1  D32123 
bont/f  CBFCRAIG  X70816    CLOPLC  M24904 
bont/f  CBFHOBBS  X70820    CLOPLC0
5 
D32127 
bont/f  CBFLANGE  X70821    CLOPLC2  D32124 
bont/b  CBHA3317  X79103  novyi  CLOPLC3  D32125 
bont/a 
(7272) 
CBHA3372  X79104  subtype e  CLOPLC5  D32126 
bont/a  CBHA3373  X79102    CLOPLC6  D32128 
bont/e  CBNEUTO
XE 
X62089    CLOPLC7  D49968 
ntnh/f  CBNTNH  X99064    CLOPLC8  D49969 
ntnh/f  CBNTNHF  X71086    CLOPLCA  D10248 
ntnh/f  CBNTNHG
EN 
X87850    CPA  X13608 
bont/a 
ntnh/a 
CBNTNHN
TA 
X87848    CPPLCG  X17300 
bont/b 
ntnh/b 
CBNTNHN
TB 
X87849      D63911 
bont/a  CBNTOXA  X73423      AF204209 
bont/d  CBNTTD  X54254  C. 
biferment
ans plc 
  AF072123 
bont/e  CBNTTE  X62683 
ntnh  CBP47NTN
H 
Y10770 
seg    AB01648
7 
seg    AF05314
0 
seg    AF06477
3 
sei    AF06477
4 
sed  M94872  IB4ENTT
OXD 
sec  SAENTC1  X05815 
sec  SAENTC3A  X51661 
seh  SAU11702  U11702 
sea  STATOXAA  M18970 
sec  SAENTC1  X05815 
sec  SAENTC3A  X51661 
see  STAENTE  M21319 
seg  AB016487  AB01648
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7 
seh    AB06053
7 
seg    AB06053
5 
S. 
intermedius 
C entrotoxin  
  SIU9152
6 
sea  STAENTAA  L22565 
sea  STAENTAB  L22566 
seb  STAENTB  M11118 
sed  STAENTD  M28521 
sea  STAENTE  M21319 
sec  STAENTER
OA 
L13374 
sec  STAENTER
OB 
L13375 
sec  STAENTER
OC 
L13376 
sec  STAENTER
OD 
L13377 
sec  STAENTER
OE 
L13378 
sec  STAENTER
OF 
L13379 
sec3  STAENTTX
C 
M28364 
seb  STASEB  M33833 
sea  STATOXAA  M18970 
abrin  APRICA72  X54872 
abrin a chain  APRICA73  X54873 
ricin  E  A 
chain 
  E01355 
ricin D    E01356 
agglutinin  RCCAGG  M12089 
ricin  E  beta 
chain 
RCCRICA  M17631 
ricin cDNA  RCPPRICR  X02388 
ricin  RCRICIN2  X52908 
ricin  RCRICIN  X03179 
ricin    S40366 
agglutinin    S40368 
Aflatoxin ord  AFU81807  U81807 
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3.3 CLOSTRIDIUM BOTULINUM NEUROTOXIN DETECTION 
3.3.1 Generic detection 
There are seven antigenically distinct botulinum neurotoxins, serotypes A to G.  
Thirty six C. botulinum sequences were obtained from Genbank and imported to 
SeqMan (Table 3.2). As expected the homology between serotypes was calculated by 
the software to be as little as 40 %.   SeqMan was unable to align sequences with 
such low homology, so an alignment was performed in MegAlign using the Clustal 
V algorithm (Higgins and Sharp 1989), which examines sequence distances between 
all the pairs.  The consensus sequence produced by the software was not 
representative of all seven strains.  Several regions appeared to share enough 
sequence homology to permit binding of generic primers; however none was 
identified by Primer Express as suitable.  This was attributed to the low GC content 
of the C. botulinum genome resulting in the software discarding potential primers 
with a low melting temperature.  Additionally, distance between the putative primer 
sites was too great to facilitate rapid real time PCR.  Therefore it was not possible to 
design a generic bont PCR assay that was suitable for adding to the suite of real time 
gene probe assays available to Dstl.  The ntnh gene was investigated as an alternative 
target. 
 
3.3.1.1 ntnh PCR assay  
The ntnh gene, also part of the neurotoxin gene complex, is more conserved between 
strains than the bont gene.  All available sequences were entered into an alignment 
but distinct groups were formed.  One alignment comprised the A and B genes, one 
of type F, one D and one type G (Figure 3.1).  The contigs were forced to align by 
increasing the number of mismatches allowed and removing some of the longer 
sequences, resulting in a consensus sequence representative of ntnh/A, ntnh/B, ntnh/F 
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and ntnh/G.  This permitted the design of a primer and probe set in Primer Express 
that was predicted to amplify a region of the consensus sequence.   
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Figure 3.1 Alignment data used to design PCR primers for the detection of Clostridium botulinum ntnh gene.  DNA sequences from the 
ntnh gene of various strains were obtained from Genbank and aligned in SeqMan (DNAstar, Lasergene 6).  The resulting 
consensus sequence was exported into Primer Express v 1.0 (Applied Biosystems) for primer design.  The ntnh amplicon 
designed for this study is  shown. The ntnh F primer used was CTCCTGGACCAAAAATAAC (position 253-232 of the top 
alignment).  The reverse primer sequence was  ATCTTTCATTCTACAGCTATTC (position 1-24). 
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Several DNA samples were tested with the ntnh assay, as shown in Figures 3.2 and 
3.3.  Melt curve analysis of the amplicons highlighted in Figure 3.2 showed that 
ampification had failed, as there was no difference in melting temperature between 
the samples and the no template control (NTC).  In contrast, the data presented in 
Figure 3.2 demonstrates that the assay was suitable for detection of the ntnh gene in 
certain samples, as products with a different melting temperature from the NTC were 
obtained.    These results are summarised in Table 3.3. 
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Figure 3.2 Melt curve analysis of C. botulinum amplification products obtained with DNA extracted from 
strains B to F using the ntnh PCR primer set (refer to Table 3.3 for details of ATCC/NCTC strain 
numbers).  A non specific product with a Tm of 75 ¡C was obtained with the no template control.  All other 
amplification products shown above also had a Tm of 75 ¡C.     
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Figure 3.3.  Melt curve analysis of C. botulinum amplification products obtained with DNA extracted 
from strains A to F using the ntnh PCR primer set (refer to Table 3.3 for details of ATCC/NCTC 
strain numbers).  A non specific product with a Tm of 75 ¡C was obtained with the no template 
control.  All other amplification products shown above had a Tm of between 77 and 83 ¡C.     
 
Chapter 3 PCR Detection of Toxins. 
 93 
 
Table 3.3 Summary of ntnh PCR results with C. botulinum DNA obtained from 
strains A to F (+ indicated amplification of the ntnh gene).   
Strain ntnh result 
A NCTC 9837 + 
A NCTC 7272 + 
A NCTC 3807 + 
A NCTC 887 + 
A NCTC 11199 + 
A NCTC 2012 + 
B 9587 + 
B ATCC 17841 inconclusive 
B ATCC 17844 - 
B ATCC 17782 - 
B ATCC 17845 - 
B NCTC 3815 - 
D NCTC 8265 - 
E unknown + 
E NCTC 8266 - 
E ATCC 11219 + 
F NCTC 10281 + 
F ATCC25764 - 
F ATCC 23387 - 
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3.3.2 C. botulinum A PCR assay 
3.3.2.1 Assay development 
Eight sequences described as encoding C. botulinum neurotoxin A were obtained 
from Genbank.  Of these, three encoded the entire toxin gene, with the rest encoding 
a partial gene or a region upstream of the toxin gene encoding the ntnh gene.  The 
sequences overlapped sufficiently to allow each one to be aligned into a bont/A 
contig in SeqMan.  Overall homology was high between strains, at 94 to 98 %, 
facilitating the design of primer and probe sequences using a representative 
consensus sequence. 
 
Detection of Clostridium botulinum type A strains was achieved using the primer and 
probe set described in Table 3.12, designed using Primer Express 1.0 software 
(Applied Biosystems) without having to alter the pre-set parameters.  PCR reactions 
were optimised using 0.2 ng of DNA from strain NCTC 2916.  The PCR assay was 
demonstrated to be robust and efficient in comparison to the other C. botulinum PCR 
assays developed for this study.  For example, amplification occurred equally well 
with either a two or three stage PCR.  Similarly between 0.2 and 0.4 µM of Taqman 
probe allowed efficient amplification.  Consequently each C. botulinum A DNA 
tested was amplified successfully as summarised in Table 3.4.  The assay was 
demonstrated to be specific for the bont/A gene, with no cross reactivity being 
observed with other C. botulinum strains.  All available strains of C. botulinum A 
were detectable using the primer set designed for this study.  
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Table 3.4 Detection of C. botulinum A strains using the bont A PCR primer and 
probe set.  A Ô+Õ symbol refers to a positive PCR signal.  Type A strains are 
either of type M, L or LL complex. 
 
Strain Genotype Origin/Alternative 
collection name 
PCR type 
NCTC 7272 A1 Unknown + 
NCTC 887 A1 Crop of chicken 
with botulism, 
1920 
+ 
NCTC 2916 A1 (B) Home made 
canned corn 1926 
(2447) 
+ 
NCTC 3806 A Canned peas, 1932 
(97) 
+ 
NCTC 4587 A   
NCTC 9837 A2 Fish from 
Mauritius, 1955 
+ 
NCTC 11199 A1 (B) Faeces, 1978 
(F199-200/78) 
+ 
NCTC 2012 A3 Loch Maree + 
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3.3.3 Detection of BoNT/A by PCR 
Clostridium botulinum neurotoxin samples were prepared by acid precipitation, with 
sulphuric acid or ammonium sulphate as outlined in Sections 2.4.2.1 and 2.4.2.2.  
Briefly, C. botulinum neurotoxin was prepared from a 50 ml overnight culture.  The 
toxin is exported into the culture supernatant when grown in vitro and therefore the 
first stage in the purification was to centrifuge the culture.  The cell debris was 
discarded and the toxin within the culture supernatant was precipitated by Ôsalting 
outÕ with 60 % ammonium sulphate or sulphuric acid during an overnight incubation 
at 4 
o
C.   The toxin was then concentrated by centrifugation, resuspended and 
dialysed in 50 mM Tris buffer, pH 6.5 overnight.   
 
DNA was extracted from the purified toxin using a silica-coated magnetic bead kit 
(Nuclyxª), in order to eliminate the toxin prior to import into the PCR analysis 
laboratory.  Analysis of the extracted DNA showed that a low concentration was 
present in the toxin sample.  It was not possible to quantitate the amount of DNA in 
the toxin sample as the control DNA obtained for this project was not of sufficient 
concentration to facilitate real time PCR amplification in the log-linear phase.  It was 
therefore not possible to generate a standard curve.  The real time PCR graph in 
Figure 3.5 shows that acid precipitated toxins contained DNA.  Although not 
quantitative, different crossing point values were obtained from amplification of the 
two toxin samples (NCTC 2916 and NCTC 2012).  The difference in DNA 
concentration obtained from the two samples is not explained, but may be attributed 
to differences in DNA binding to the protein through electrostatic forces or 
differences in DNA extraction efficiency or quality. However, it seems most likely 
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that the initial cell culture concentrations simply differed as it was not possible to 
measure the OD600 of the cultures grown in the toxin lab due to safety restrictions. 
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Figure 3.4.  Analysis of C. botulinum A acid precipitated neurotoxin samples using the bont/A 
primer set.  Toxin samples were extracted from NCTC strains 2916 and 2012 by acid precipitation.  
DNA was extracted from toxin samples using a Nuclyxª DNA extraction kit and eluted into 50 µl of 
dH2O.  Analysis was carried out using 2 µl per PCR.  An increase in fluorescence was observed in all 
samples apart from the no template control (NTC). 
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3.3.4 Clostridium botulinum B PCR assay development 
Six C. botulinum B gene sequences were obtained from Genbank, from both 
proteolytic and non-proteolytic phenotypic groups.  The primary sequence used was 
3875 bp (accession number M81186, Table 3.2).  When aligned in SeqMan they 
exhibited homology of 95 to 99 %.  A primer and probe set was identified using 
Primer Express, although it was necessary to increase the permitted amplicon length 
from 150 bp to 220 bp and lower the annealing temperature by 5 ¡C to compensate 
for the low GC content of the gene.   
 
C. botulinum B DNA was initially obtained from the test panel described in 
Appendix 1 rather than from known cultures so, strain typing information was 
unavailable.  The assay was shown to require a lower annealing temperature than 
normally used for TaqMan
¨
 assays designed using Primer Express.  Amplification of 
0.1 ng  DNA occurred at a cycle threshold of 20 with an annealing temperaure of 55 
o
C.  This was reduced to a cycle threshold value of 18 when the annealing 
temperature was reduced 50 
o
C; data not shown). Therefore, reducing the annealing 
temperature allowed the DNA to be amplified earlier, thereby increasing the 
sensitivity of the assay but reducing its compatability with other assays used in this 
study.   The specificity of the assay was investigated using a Sybr¨ Green I assay 
with DNA from the C. botulinum A to F, C. perfringens and C. novyi.  As expected, 
the assay was specific for C. botulinum B (Figures 3.5 and 3.6).  The assay was then 
optimised using the specific TaqMan
¨ 
probe (data not shown), again monitoring the 
cycle threshold value for each different concentration of probe.  An optimal probe 
concentration of 0.3 µM was established, as summarised in Table 3.12. 
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Figure 3.5 Dependence of relative fluorescence on PCR cycle number for C. botulinum B sybr Green I 
PCR assay containing the bont B1 primers, in the presence of various Clostridial DNAs.    
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C.botulinum B  
Negative controls and 
other Clostridial samples  
Figure 3.6  First derivative of the fluorescence curves shown in Figure 3.5, obtained from 
amplification of various Clostridial DNA with the bont /b primer set.  A product with a melting 
temperature of 75 
o
C was obtained with C. botulinum B DNA.  Non specific products with a 
melting temperature of 78 
o
C were obtained with the no template controls (samples 23 and 24) 
and other clostridial DNA samples.  
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Fourteen type B strains (see Table 3.5) had been stored in refrigeration at Dstl for a 
number of years.  Cultures were grown and DNA extracted as described previously.  
However, PCR results using the extracted DNA were variable.  ATCC strains 17780, 
17783, 17841 and 25765 were detectable using primers targeting the type B toxin 
gene (Figures 3.7 to 3.9).  Other strains were not detectable using this assay, as 
summarised in Table 3.6.   
 
To determine whether false negative results were being obtained using the original 
primer set DNA was analysed with primers obtained from the open literature 
(Campbell et al., 1993; Szabo et al., 1994).  These results confirmed those obtained 
using the primers designed for this study, indicating that the gene was not present in 
the DNA extracts tested.   
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Figure 3.7 Real-timeTaqMan
¨
 PCR detection of Clostridium botulinum type B gene in 9 
different strains using the bont B primer set.  An increase in fluorescence was seen with 
strains 17841, 17780, 17783 and 25765 
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Figure 3.8 Analysis of C. botulinum B DNA using the bont B PCR primer and probe set.  An increase in 
fluorescence was seen with DNA obtained from strain 751 (positive template control).  A weak increase in 
fluorescence was also seen with strains 3807, 3815 and 17844.  No increase in fluorescence was observed 
with strains 17845 and 17782,   
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Figure 3.9  Analysis of C. botulinum B DNA using the bont B PCR primer and probe set.  An increase in 
fluorescence was seen with DNA obtained from strain 751 (positive template control).  A very weak increase 
in fluorescence was also seen with strain 17845 (in contrast to the results shown in Figure 3.11).   
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Table 3.5  Summary of C. botulinum B PCR results using four different assays.  
Positive amplification" is indicated by a Ô+Õ symbol.  DNA samples marked with 
a Ô*Õ were negative initially.  DNA was then extracted from stock cultures and 
analysed as positive by PCR.  Ô-Ô samples were not amplified.   Results marked 
N/D were not determined, those marked Ô?Õ were unclear.   
Strain Genotype Origin  BoNT PCR Ntnh 
PCR Set1 Cambpell   Szabo 
NCTC 
751 
B GpI California, 
1920 
+ N/D N/D  
NCTC 
3807 
B Gp I Soil, Blue 
Ridge 
Mountains
, 1021 
* N/D N/D + ? 
NCTC 
3815 
B Gp I Cheese, 
1932 
* N/D N/D  
NCTC 
7273 
B Gp I Beans, 
1947 
+ N/D N/D  
NCTC 
12265 
B Hazelnut 
yoghurt, 
1989 
* N/D N/D  
9581    N/D N/D + 
ATCC 
17841 
B Gp I   + + + + 
Chapter 3 PCR Detection of Toxins. 
 107 
ATCC 
17844 
B  Group 
II (2217) 
N/D * - - - 
ATCC 
17845 
B (2254)  * - - - 
Eklund 
17B 
(ATCC 
25765) 
B Gp II Marine 
Sediment, 
USA 
+ + +  
ATCC 
17780 
B (3137)  + + +  
ATCC 
17783? 
B  + + + + 
ATCC 
439 
Gp I  +  - +? 
ATCC 
17843 
B (2017)  + N/D + + 
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3.3.5 Purification of Botulinum Neurotoxins B by acid precipitation 
 
Neurotoxin samples were produced from the culture supernatant of strain ATCC 
17841, known to be detectable using the PCR assay designed for this study.  Toxins 
were expressed during an overnight culture step and then precipitated using 
ammonium sulphate or sulphuric acid according to the method described in Section 
2.4.2.1 and 2.4.2.2.  DNA was then extracted from the toxin samples using a 
Nuclyxª magnetic bead kit. 
 
All toxin samples produced from ATCC 17841, a group I strain, were detectable 
using the bont/b PCR (Figure 3.10).   The PCR was not quantitative, however the 
crossing point (Cp) of the amplification curve (not shown in Figure 3.10 as it is not 
depicted in the primary fluorescence graph) from ammonium sulphate and acid 
precipitated samples indicated that a low concentration of DNA was present in the 
toxin samples.  A sample of the culture supernatant was also extracted using the 
Nuclyx kit.  The crossing point value obtained with this sample (Cp 24) was slightly 
higher than the ammonium sulphate precipitated toxin sample (Cp 25) and lower 
than the acid precipitate (Cp 20).  This again indicates that DNA was co-precipitated 
and concentrated with the toxins. 
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Figure 3.10 Detection of C. botulinum neurotoxin B gene in toxin preparations.  Toxin samples were 
purified from C. botulinum B strain ATCC 17841 culture supernatants using ammonium sulphate or 
sulphuric acid.  DNA within the toxin sample was extracted using a Nuclyx extraction kit and then tested 
for the presence of the toxin gene using the bont B primer and probe set.   
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3.3.6 Clostridium botulinum E PCR assay devlopment 
BoNT/E is produced by C. botulinum, C. butyricum and C. baratii.  Six bont/e 
sequences were available at the start of this study, four C. botulinum and two C. 
butyricum (Table 3.2).  The sequences from both species aligned with 98 % 
homology, indicating that the assay would be generic for the type E neurotoxin rather 
than specific for C. botulinum.  Type E DNA was initially obtained from the DNA 
test panel described in Appendix 1.  The bont/e assay amplified DNA from the 
unknown type E strain successfully.  The assay was then optimised, using this DNA, 
for annealing temperature and magnesium concentration (Table 3.12) and tested for 
cross reaction with near-neighbour strains of Clostridia using the process previously 
described in Section 3.3.3.  The primers were demonstrated to cross react with C. 
botulinum type F DNA (Figures 3.12 and 3.13).  Sequence analysis had not 
previously indicated the type E assay should cross react with type F DNA, but the 
assay was redesigned to target more differences between the two strains (Figure 
3.11). 
The re-designed primers and probe did not cross react with DNA from the Clostridia 
test panel (data not shown) therefore the specificity of the assay against the three 
type F DNA samples available was determined.  The type E primers did not produce 
an amplicon with DNA from C. botulinum F (Figure 3.14).  The new assay was 
tested with DNA extracted from eight subcultured type E strains as summarised in 
Table 3.6.  The assay was verified to work well with all but one, NCTC 8550.  PCR 
analysis of the original stock culture was successful, again demonstrating the 
deleterious effect of subculture on genetic integrity.   
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3.11a bont/E Forward sequence alignment  
 
 
3.11b bont/E Reverse sequence alignment  
 
 
 
3.11c bont/E2 Forward sequence alignment  
5Õ AACTTTTGGAGGTACTGAAT 3Õ  
 
 
3.11d bont/E2 Reverse sequence alignment  
5Õ TATAAGGATTAAGTAGTGGATTAGATAC 3Õ 
 
 
Figure 3.11.  Sequence alignment data for bont/E and bont/E2 primers.   Primer 
bont/E1 F and R was demonstrated to cross react with bont/F DNA, therefore it 
was disregarded.  A second set (bont/E2) was designed targeting more 
mismatches between the type E and F sequences. 
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C. botulinum F product 
C. botulinum E product 
Non-specific products 
Figure 3.12 Analysis of the specificity of the C. botulinum type E PCR assay.  Sybr Green I real time PCR was carried 
out using the bont/e primer set with DNA extracted from type E and F strains.  A large increase in fluorescence was 
observed with type E DNA.  A smaller increase in fluorescence was observed resulting from amplification of type F 
DNA.  A weak increase in fluorescence was also observed after cycle 36 in the negative control (water) and other 
clostridial DNAs.  This weak increase in fluorescence was caused by incorporation of Sybr Green I into artefacts of the 
PCR (primer-dimer). 
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C. botulinum E and F 
Figure 3.13 Melt curve analysis of products obtained with bont E assay and near-neighbour 
strains.  A product with a melting temperature of 76 ¡C was obtained from C. botulinum E 
DNA.  A product with a melting temperature of 77 ¡C was obtained with C. botulinum F 
DNA.  PCR artefacts were also observed with a melting temperature of 76.5 
o
C.   
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C. botulinum E DNA 
C. botulinum F DNA 
Figure 3.14 Analysis of the specificity of the C. botulinum E TaqMan
¨
 PCR assay.  DNA was extracted 
from type F strains NCTC 10281, ATCC 25764 and ATCC 35415 using a Qiagen DNA mini prep kit 
and analysed using the bont E primer set.  An increase in fluorescence was observed with the positive 
control C. botulinum E DNA.   
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Table 3.6 Detection of C. botulinum E species using the bont/E assay designed 
for this study.  Positive amplification is indicated by a Ô+Õ symbol.  DNA samples 
marked with a Ô*Õ were negative initially.  DNA was then extracted from stock 
cultures and analysed as positive by PCR.   
 
Strain Genotype Origin PCR 
result 
NCTC 8266 E Nanaimo Gp 
II 
MRE Porton 1952 * 
NCTC 8550 E Gp II Institut Pasteur 
1952, possess OS 
variants. 
* 
ATCC 17854 E Gp II  + 
ATCC 8550 E Gp II  + 
ATCC 17854 E Gp II  + 
ATCC 17786 E Gp II  + 
ATCC 11219 E Gp II  + 
ATCC 9564 E Gp II 
(Hazen) 
Smoked Salmon, 
Canada 
+ 
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3.3.7 Detection of acid precipitated toxins from C. botulinum type E. 
 
Acid precipitated toxin samples were obtained from several type E neurotoxin 
producing strains grown in cooked meat broth in the presence of sucrose.  DNA was 
extracted from the four samples using the same acid precipitation method described 
for BoNT/A and BoNT/B.  The concentration of DNA carried over into the toxin 
preparation differed between samples as observed with the extractions taken from 
BoNT/A and BoNT/B. One sample was estimated to contain 1000 times more DNA 
than the other positive samples and one sample did not contain detectable DNA 
(Figure 3.15).   A negative mouse lethality or ELISA test performed with fresh 
culture supernatant would determine whether the PCR negative sample contained 
toxin.  However, it was not possible to test this theory during this study as funding 
for antibody or animal work was unavailable.  Although the results were variable, 
overall BoNT/E was successfully detected by PCR. 
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Figure 3.15 Detection of C. botulinum E DNA in acid precipitated neurotoxin samples from strains ATCC 
17854, ATCC 9564, ATCC 11219 and ATCC 17786.  An increase in fluorescence was observed in all 
samples apart from the no template control and the toxin sample prepared from strain ATCC 11219.   
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3.3.8 Clostridium botulinum F PCR assay development 
 
Alignment of the seven C. botulinum type F bont gene sequences obtained from 
NCBI showed homology was lower than with the other neurotoxin genes at 89 to 99 
%.  This may be a result of the species falling into two distinct physiological and 
genetic groups (I and II). Although data relating to the physiological group of the 
Genbank sequences was unavailable, assumptions have been made based on the 
sequence name (Table 3.7).  In spite of low homology, a representative consensus 
sequence was obtained and used to design TaqMan¨ primer and probes with no 
changes to the parameters within Primer Express.  The assay was therefore predicted 
to work well. 
Table 3.7.  Homology of C. botulinum neurotoxin F genes obtained from 
Genbank. 
 
Accession name Assumed physiological  
group 
Percentage match to 
CBY13161.seq 
CLONEUTOXF ? 95 
CBBONTFG ? 89 
CBFCRAIG II 98 
CBFHOBBS II 99 
CBFLANGE I 90 
CBNTNH ? 92 
 
The primer set chosen was tested using a range of magnesium concentrations.  Once 
optimised at 3 mM it was challenged with the DNA test panel described in Appendix 
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1, as well as the clostridial test panel.  The results showed that the assay was specific 
for C. botulinum F DNA (Figure 3.16).   
 
The primer set was then tested with DNA extracted from the four strains that had 
been subcultured and stored in refrigeration.  Only two out of four strains were 
detectable initially (Figure 3.17). Further PCR analysis using DNA extracted from 
stock cultures using a Qiagen protocol was performed, however ATCC strains 23387 
and 27231 were not detected (Table 3.8).  The reason for this is postulated to be due 
to poor culture maintenance as with the type B strains.  However it was not possible 
to rule out the possibility of poor assay design as reliable DNA samples were 
unavailable.   
 
No toxin samples were available from C. botulinum type F strains, however it is 
assumed that detection would have been possible using PCR, in line with results 
obtained with types A, B and E.  In general terms, PCR detection of botulinum 
neurotoxins prepared by acid precipitation was possible.  This finding is significant 
as it is likely that this would be the method of choice for toxin production by 
terrorists (Zilinskas 1997).  Therefore, PCR was useful for detecting residual DNA 
contained in Clostridium botulinum neurotoxin samples. 
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Non-
specific 
products 
C. botulinum F product 
Figure 3.16 Melt curve analysis of PCR products obtained using a clostridial test panel of DNAs with C. 
botulinum  F specific primers.  A PCR product with a Tm of 79 ¡C was obtained with C. botulinum F DNA 
(samples 21 and 22).  Products with a Tm of 72 ¡C were obtained with all other clostridial DNA samples and 
the no template control (water, sample 23). 
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Figure 3.17.  Real-time TaqMan¨ PCR detection of Clostridium botulinum F DNA samples extracted from in 
house culture stocks using the bont F primer and probe set.  An increase in fluorescence was observed in 
reactions containing DNA extracted from ATCC 35415 (black line), ATCC 25764 (green line) and the 
positive template control (PTC; pink line).  No increase in fluorescence was observed in reactions containing 
ATCC 23387 (blue line), ATCC 27231 (red line) or the no template control (teal line).   
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Table 3.8 C. botulinum F PCR assay results using the bont F real-time PCR 
assay designed for this study.  Positive amplification is indicated by a Ô+Õ 
symbol.  DNA was then extracted from stock cultures and analysed as positive 
by PCR.  Ô-Ô samples were not amplified.  N/K denotes Not Known. 
 
Strain Name Alternative 
designation 
Origin PCR result 
NCTC 10281 Langeland Gp 
I 
Liver paste, 
Vancouver 1962. 
+ 
ATCC 23387 Gp II Eklund 
(202F) 
N/K - 
ATCC 25764 Gp I Crab + 
ATCC 27321 VPI 2382 N/K - 
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3.4 RECOMBINANT V ANTIGEN PCR ASSAY  
The Yersinia pestis lcrV gene sequence, encoding V antigen, was obtained from 
GenBank (detailed in Price et al., 1989) and then imported into Primer Express.  
Primer and probe sites were identified for amplification of a 68 bp portion of the 
gene.  The assay was optimised with DNA obtained from Y. pestis strain C092, and 
was shown to work well using standard real-time PCR conditions.  Although 
designed to work as a TaqMan
¨
 assay, the probe was not deemed a requirement of 
the project and was therefore not purchased.  Similarly, the specificity was not 
determined as part of this research.   
 
An in house preparation of the 37 K Da recombinant V antigen (rV) from Yersinia 
pestis was available for PCR analysis. The protein has been studied extensively as a 
potential vaccine target during research carried out at Dstl (Carr et al., 1999). The 
concentration of DNA present in protein vaccines is regulated by the Medicines and 
Healthcare products Regulatory Agency (MHRA) in the UK and the Food and Drug 
Administration (FDA) in the US and should be low or negligible (Ng and Mitra 
1994).  Therefore PCR analysis of highly purified rV protein, as a model for a highly 
purified toxin, was considered a interesting digression.  
 
3.4.1 Purification of Recombinant V Antigen by Affinity Chromatography 
Recombinant V antigen was prepared as a glutathione S transferase (GST) fusion 
protein and was purified by Sarah Hayward at Dstl, described in detail in Section 
2.7.1.  Several samples were taken during the process as summarised in Table 3.9.  
Briefly, a four litre recombinant E. coli culture was grown overnight and then 
centrifuged to harvest cells.  The pellets were resuspended in PBS supplemented with 
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DNase I and RNase to reduce the viscosity of the sample prior to further treatments.  
The cells were then lysed by sonication (sample A), releasing both proteins and 
DNA.  Cell debris was removed by centrifugation and the lysate was loaded onto a 
glutathione sepharose 4 B affinity purification column.  Protein was eluted from the 
column in buffer containing glutathione (samples B to D), along with picogram 
levels of DNA.  Low molecular weight contaminants were removed from the toxin 
solution by gel filtration using a sephadex G25 size exclusion column and the high 
molecular weight proteins and DNA were eluted.  The GST tag was removed by 
protease cleavage which was retained on a GS 4B column and the flow through 
containing the protein and DNA was collected in 2 ml fractions (E to K).  The 
fractions containing the most LcrV were pooled (L).  DNA was then extracted from 
sample L using a Qiagen miniprep kit.    Figure 3.18 shows the real time PCR results 
obtained from amplification of samples taken during the purification of recombinant 
V antigen by affinity chromatography.  Most of the samples tested contained small 
but detectable amounts of DNA.  More importantly the purified protein sample (L) 
contained a mean concentration of 18.25 ng/µl (n=2), as determined by quantitative 
PCR.  In this instance DNA was co-purified with a protein purified by affinity 
chromatography as a GST fusion protein.  Therefore PCR was suitable for detecting 
recombinant V protein prepared by affinity chromatography. 
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Table 3.9 Recombinant V Q-PCR data. 
 
Sample Type/method 
N.B.  4 l overnight culture pelleted, 
sonicated and treated with DNase and 
RNase prior to first sample being taken. 
Lightcycler calculated conc 
(pg/µl) (mean of duplicate 
samples) 
Preparation 1 Preparation 
2 
A Ð sonicated cells run on GST affinity 
column 
90 150 
B 7.5 ml GST fraction Inhibited Inhibited 
C 7.5 ml GST fraction 10 10 
D 30 ml GST fraction 70 75 
E Ð protease cleaved fraction 1 Inhibited Inhibited 
F Ð protease cleaved fraction 2 121 130 
G protease cleaved fraction 3 50 40 
H protease cleaved fraction 4 17 18 
I protease cleaved fraction 5 13 10 
J protease cleaved fraction 29 8 
K protease cleaved fraction 10 4 
L pooled protein sample Inhibited Inhibited 
L DNA extracted sample 4.7 ng/µl  32 ng/µl  
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Figure 3.18.  Analysis of samples taken throughout the 12 stage recombinant V antigen purification process 
using the Y. pestis rV PCR assay designed for this study.  An increase in fluorescence was observed in all of 
the above samples apart from the no template control (NTC, samples 31 and 32).  rV antigen was extracted 
by sonication and purified using a GST affinity column (A-D), protease cleaved (1-5, samples E-K 
respectively) and  pooled.  The pooled product was processed using a QIAamp DNA mini kit.  
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3.5 RICINUS COMMUNIS RICIN DETECTION 
3.5.1 R. communis assay development 
Sixteen Ricinus communis ricin gene sequences were obtained from GenBank.  
Sequence identity was high between those deposited into the database at the onset of 
this study (prior to the R. communis genome being sequenced at JCVI), at 96 Ð 100 
%.  Ribosome inactivating proteins (RIP) have a similar mode of action but are 
produced by several unrelated plant species.  Sequence analysis of RIP gene 
sequences from species such as Abrus precatoris (abrin) and Viscum album 
(viscumin) did not align with the ricin gene.   Furthermore, BLAST analysis of 
primer and probe sequences identified by Primer Express did not identify cross 
reactions with non target species.  Therefore, the assay was predicted to be specific 
for ricin.  The complete sequence of the gene was reported as between 2362 and 
1695 bp and a consensus of 2344 bp was obtained.  The sequence alignment included 
ricin isoforms D and E as well as the agglutinin gene which aligned with 93 % 
homology.  The resulting consensus sequence was exported to Primer Express which 
identified an optimal primer and probe set and was calculated to have very little 
secondary structure or primer dimer formation.     
 
The assay amplified target DNA with high efficiency using standard TaqMan¨ PCR 
conditions (Table 3.12) as predicted by the software.  Cross reactivity tests were 
performed with plant DNAs obtained from two alternative type II RIP producing 
species (Figure 3.19).  The results confirm that although the plant toxins have similar 
mode of action, the gene sequences are completely unrelated.  However, DNA was 
unavailable from other type II RIP producing plants so confirmatory analysis of a 
positive result would be desirable.  
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R. communis DNA 
V. album and A. 
precatoris 
DNA 
Figure 3.19  Real-time PCR analysis of DNA extracted from the ribosome inactivating protein 
producing plants R. communis, V. album and A. precatoris, using ricin specific PCR primers and 
probes.  An increase in fluorescence was observed with the R. communis sample. 
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3.5.2 Purification of Ricin by solvent extraction and Gel Filtration 
Ricin was extracted from castor beans by a colleague at Dstl using solvent extraction 
and gel filtration.  Briefly, castor beans soaked in buffer were homogenised in a 
Waring blender and then acidified using glacial acetic acid.  Plant seed debris and 
castor oil were removed by centrifugation and the supernatant was clarified using 
petroleum ether. The aqueous phase was drained, filtered and then acid precipitated 
overnight.  The precipitate was collected by centrifugation and residual ammonium 
sulphate was removed by dialysis.  The dialysed extract containing the toxin was 
filtered and purified on a sepharose-4B affinity chromatography column. Unbound 
proteins were washed from the column in a salt solution and the toxin (and 
agglutinin) were eluted with salt and galactose.  The ricin and agglutinin in the 
concentrated pool were then separated by gel filtration chromatography again using a 
Sephadex 200 column.   
 
A standard curve was constructed for Q-PCR analysis using preproricin cDNA 
kindly donated by a colleague at Dstl, as genomic DNA was not available at the start 
of the project.  The amount of DNA present in each sample is therefore better 
presented in this instance as copies/µl.  The gene is approximately 2362 basepairs in 
length (RCRICIN2 locus, Genbank accession number X52908) therefore the quantity 
of DNA calculated to be present in sample 1 (Table 3.10) is equivalent to 11.5 copies 
[(0.00000003 ng * 10
-9
)/2362 bp x 650) * 6.022 x 10
23
]. Accordingly, 1.15 copies/µl 
would weigh 3 attograms.  The results in Figure 3.20 show that a low concentration 
of DNA was present in the initial stages of the purification process.  Quantitative-
PCR results are given in Table 3.10.  The bean soak (sample 1) contained only 11.5 
copies of the gene per microlitre of sample.  The bean homogenate pellet (sample 3) 
that was discarded was calculated to contain 61 copies per microlitre, indicating that 
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homogenisation released DNA.  The majority of the DNA within the acidified 
homogenate was removed with the pellet (sample 5) and DNA was detected in the 
solvent (sample 6) but not aqueous phase (sample 7) of the petroleum ether extracts.  
DNA was not detected in further samples of the purification process.    
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 Table 3.10 Mean DNA concentrations observed in samples taken during the 13 
step ricin prurification process, as determined by quantitative PCR analysis of 
duplicate samples. 
 
Sample Sample Type Buffer Q-PCR estimated 
DNA 
concentration 
1 Bean soak Bean Soak 0.5 M NaCl 0.03 fg/µl 
2 Bean 
homogenate 
Supernatant 0.5 M NaCl 0.175 fg/µl 
3 Bean 
homogenate 
Pellet 0.5 M NaCl + 
acetic acid pH 
4 
0.185 fg/µl 
4 Acidified 
bean 
homogenate 
Post incubation 
supernatant 
0.5 M NaCl+ 
acetic acid pH 
4 
0.0002 fg/µl 
5 Acidified 
bean 
homogenate 
after 
incubation 
Post incubation 
supernatant 
pellet 
0.5 M NaCl+ 
acetic acid pH 
4 
0.4 fg/µl 
6 Lipid extract  Solvent phase Petroleum ether 0.375 fg/µl 
7 Lipid 
extraction 
Aqueous phase  0.5 M NaCl + 
acetic acid pH 
4 
Not detectable 
8 Post dialysis  0.5 M NaCl Not detectable 
9 Affinity 
sepharose 
column 
Flow  0.5 M NaCl Not detectable 
10 Affinity 
sepharose 
column 
Wash 0.5 M NaCl + 0.2 
M galactose 
Not detectable 
11 Affinity 
sepharose 
column 
Eluate 0.5 M NaCl + 0.2 
M galactose 
Not detectable 
12 Gel 
filtration 
 Ricin peak  0.5 M NaCl + 0.2 
M galactose 
Not detectable 
13 Gel 
filtration 
Agglutinin 
peak. 
0.5 M NaCl Not detectable 
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Figure 3.20 Amplification of the ricin gene from samples taken during the ricin purification process.  Samples 1 to 6 taken 
throughout the ricin purification process were amplified.    Sample 7 and onwards, purified by dialysis, affinity separation and 
gel purification were not amplified 
Samples 2 and 3 
Samples 4 and 7 
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3.6  CLOSTRIDIUM PERFRINGENS PHOSPHOLIPASE C 
3.6.1 plc assay design 
Eighteen Clostridium perfringens alpha toxin gene sequences were obtained from 
Genbank and aligned using SeqMan software.  Sequence identity was high (98 - 99 
%) between the sequences indicating that the gene is highly conserved between 
strains of the same species.  Several other bacteria produce phospholipases C, 
including other clostridial species and L. monocytogenes (Titball, 1993), 
consequently, the potential for cross-reaction with non-target species was high.  
Therefore, sequences of C. bifermentans and C. novyi plc homologues were also 
obtained from Genbank. The inclusion of homologous plc genes introduced a 
number of gaps into the consensus sequence, with the overall homology reduced to 
40% and the highest number of mismatches found towards the 3Õ end.   The 
consensus sequence was exported to Primer Express, however it was not possible to 
identify suitable primer sequences in the region of divergence due to the low GC 
content of the Clostridium genome.  Increasing the desirable amplicon length from 
100 to 250 bp permitted the software to identify regions of the gene suitable for use 
as primer and probe sites.      
 
The PCR assay was tested and optimised using DNA from NCTC 8237 extracted at 
Dstl prior to the onset of this study.  The reaction did not proceed well using a 
standard two-stage real time PCR thermal cycling profile (40 cycles of 95 
o
C for 1 
second and 60 
o
C 30 seconds) and required a long extension phase, possibly due to 
the assay requiring further optimisation due to low GC content, although this 
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possibility was not investigated at the time of study.  The optimal thermal cycling 
profile and reaction components are summarised in Table 3.12.   
 
Cross reactivity analysis was carried out using the plc primers and DNA from near 
neighbours of C. perfringens (Figure 3.21).  In spite of the PCR primers and probe 
targeting a region of poor homology to C. novyi and C. bifermentans the assay was 
demonstrated to cross react with C. novyi and C. histolyticum, with low levels of 
amplification being observed (Figure 3.21).  At the time of primer design, the 
sequence of the phospholipase C gene from C. histolyticum was unavailable, 
therefore it was not possible to redesign the assay to a region of lower homology.  
Additionally, the cross reaction with the C. novyi plc gene was undesirable.  It was 
not possible to eliminate the cross reaction, however amplification of C. novyi DNA 
was not efficient.  Consequently, the assay could be redesigned to amplify the C. 
novyi and C. histolyticum  plc gene with higher efficiency, intentionally making the 
assay more generic in future work.   
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C. perfringens A and 
D 
C. novyi and     
histolyticum  
Figure 3.21.  Real time PCR analysis of Clostridial DNA samples using primers specific for the plc gene.  The 
increase in fluorescence is indicative of amplification of the plc gene product in C. perfringens A and D, plus C. novyi 
and C. histolyticum. 
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3.6.2 Purification of Alpha Toxin using Ion Exchange Chromatography and 
gel filtration 
Alpha toxin was purified as a recombinant protein from E. coli cell lysates during the 
22-step process outlined in Table 3.11 by Dr Helen Jones at Dstl.  Q-PCR analysis 
was carried out on samples taken at each stage in the process, also detailed in Table 
3.11.  Briefly, cells were harvested by centrifugation and resuspended in Tris buffer 
containing a protease.  The cells were lysed by sonication and removed by 
centrifugation.  The supernatant was filtered through a 0.2 µM membrane to remove 
particulates; alpha toxin was bound to a HiTrapª Q ion exchange exchange column 
(sample 1).  Adsorbed toxin and DNA were eluted in a continuous ionic strength 
NaCl gradient ranging from 0 to 100% (samples 2 to 5).  Sample 2 was discarded and 
samples 3 to 5 were pooled.   Sample 2 contained 1 µg of DNA whilst samples 3 to 5 
contained picogram levels.  Therefore a high concentration of DNA was removed 
from the toxin preparation at an early stage in the purification process.  The toxin 
was subsequently loaded onto a Mono Q HR anion exchange column and eluted 
using a NaCl gradient (samples 9 to 20).  Each of these samples contained picogram 
or negligible quantities of DNA. The toxin was then concentrated using a YM 100 
centricon column, filtered again and further purified by gel filtration (samples 21 and 
22).  Neither of the gel filtered samples contained detectable toxin DNA, therefore 
they were subjected to a Qiagen DNA extraction procedure (samples 23 and 24).  Q-
PCR analysis was carried out on sample 23 using DNA standards of defined 
concentrations (Figure 3.22).  The software calculated 23 pg/µl of DNA was present 
in the Qiagen extracted DNA from the first toxin sample, however the second gel 
filtration eluate did not contain amplifiable DNA.   
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Table 3.11 Mean DNA concentrations present in duplicate samples taken during 
the alpha toxin purification process, as determined by quantitative PCR using a 
standard curve (Figure 3.22). 
 
Sample  Sample Type DNA concentration 
1 Ion Exchange (IEX); 
strong anion 
Sonicated 
supernatant 
loaded on Mono 
Q column 
1.008 ng/µl 
2 IEX Hi trap Q fraction 32 1000 ng/µl 
3 IEX Hi trap Q fraction 33 167 pg/µl 
4 IEX Hi trap Q fraction34 172 pg/µl 
5 IEX Hi trap Q fraction 35 162 pg/µl 
6 IEX Hi trap Q fraction 33, 34,35 
pooled before 
dialysis 
- 
7 Fraction 32 
dialysed in 20 
mM Tris 
140 pg/µl 
8 Pooled fractions 
dialysed 
130 pg/µl 
9 IEX Mono Q IEX run 1, 13 0 
10 IEX Mono Q IEX run 2, 21 0.6 pg/µl 
11 IEX Mono Q IEX run 3, 18 0.45 pg/µl  
12 IEX Mono Q IEX run 4, 12 0.5 pg/µl 
13 IEX Mono Q IEX run 4, 11 0 
14 IEX Mono Q IEX run 2, 20 0 
15 IEX Mono Q IEX run 2, 19 0 
16 IEX Mono Q IEX run 3, 15 0 
17 IEX Mono Q IEX run 1, 14 0 
18 IEX Mono Q IEX run 3, 17 0.45 pg/µl 
19 IEX Mono Q IEX pool 1 0.8pg/µl 
20 IEX Mono Q IEX pool 2 0 
21: Gel filtration 
Superdex 200 
column 
fraction 1 (Pure α 
toxin 2.8 mg/ml) 
0 
22: Gel filtration 
Superdex 200 
column 
fraction 2 (Pure α 
toxin 1.1 mg/ml) 
0 
23:Qiagen DNA 
extraction kit 
Extracted α toxin 
1.1 mg/ml 
23 pg/µl (10 µl 
sample) 
24:Qiagen DNA 
extraction kit 
Extracted α toxin 
2.8 mg/ml 
0 
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Figure 3.22. Quantitative PCR analysis of purified alpha toxin with the plc primer and probe set.  DNA 
standards are shown in unbroken lines, the alpha toxin sample is shown in the hatched line.  Samples were run in 
duplicate, however only single samples are shown for illustrative purposes. 
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3.7 DETECTION OF SIGMA TOXINS 
It was not possible to produce and purify Staphylococcal enterotoxin B for analysis 
at Dstl during this study.  However, commercially produced toxins were available.  
Therefore, SEB, ricin and four types of phospholipase C were obtained from Sigma 
and analysed by Q-PCR.   
 
3.7.1 Staphylococcus aureus assay development 
Numerous Staphylococcus aureus enterotoxin gene sequences were obtained from 
NCBI of which two encoded SEB.  Distinct contigs were successfully formed for 
each toxin type with homology between toxin types reportedly 57 % or less.  
Consequently, the PCR primer and probe set designed using the derived SEB 
consensus sequence was predicted to be specific for SEB. 
 
The SEB assay was demonstrated to work with standard TaqMan¨ thermal cycling 
conditions once optimised for magnesium ion concentration (Table 3.12).  The 
results in Figure 3.23 show that the seb PCR assay was specific and did not detect the 
non-toxigenic strains obtained from Oxoid (ATCC strains 6538, 25923, 33862, 9144 
and 23144).  More importantly, it did not detect strains that produce other 
staphylococcal enterotoxins (NCTC 10652 and 10656 producing SEA and SED 
respectively), although the test panel used in this study was limited. 
 
3.7.2 Detection of Sigma SEB 
 SEB was obtained from Sigma as a lyophilysed powder, purified using a proprietory 
process.  The toxin was reconstituted to a concentration of 3.5 mg/ml.  The 
purification process used to extract SEB was proprietory to Sigma.  A small sample 
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(2 µl) was analysed by PCR but no amplification was observed (Figure 3.23), 
indicating that the concentration of DNA in the preparation was low.  A 200 µl 
sample of toxin was subjected to a Qiagen DNA extraction to concentrate and purify 
the sample.  Again, no amplification was observed.   
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Positive 
template 
control 
Sigma SEB 
toxin 
samples 
Figure 3.23 Real-time PCR analysis of SEB toxin obtained from Sigma using the seb Taqman¨ primer and probe 
set.  DNA was extracted from an SEB sample at a concentration of 3.5mg/ml using a QIAamp kit 2 µ l of DNA 
was then tested by PCR.  An increase in fluorescence was seen with the positive template control sample 
containing S. aureus NCTC 14458 DNA.   
  
S. aureus ATCC 
strain 14458 and 
NCTC 10657 
(SEB positive) 
SEA (NCTC 
10652) and SED 
(NCTC 10656) 
producing strains 
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3.7.3 Detection of Sigma Ricinus communis aggutinin (RCA60) 
Ricin toxin, bought commercially in 2001 from Sigma, was available in two formats, 
either with or without the agglutinin subunit (RCA120 and RCA60 respectively).  The 
exact process used to purify the toxin at Sigma was not known although it was stated 
to be Ôaffinity purified, electrophoretically pure RCA60Õ.  It was therefore assumed 
that affinity chromatography was used in the same way as at Dstl, exploiting the 
lectin property of the toxin to bind it to sepharose media.  Only a small amount of 
toxin was sampled, in accordance with Dstl safety regulations.  A 7.8 µg sample was 
reconstituted in 200 µl dH2O and 2 µl analysed by PCR.  No DNA was detectable in 
the untreated sample, as was the case with the toxin purified at Dstl.  The rest of the 
sample was then subjected to a Qiagen DNA extraction procedure and eluted in the 
smallest volume permissible by the manufacturer, 50 µl.  However, no DNA was 
detected in the treated sample.    
 
3.7.4 Detection of Sigma phospholipase C (alpha toxin) 
Four types of phospholipase C from C. perfringens were obtained from Sigma, UK.  
The crudest preparation, type I, was supplied without additional information but was 
presumably extracted and lyophilised.  The toxin was reconstituted at a concentration 
of 3.5 mg/ml and analysed by plc PCR.  DNA was not detectable from the neat 
sample due to inhibition of the reaction, but the 1/10 dilution was estimated to 
contain 3.24 pg/µl, a relatively high DNA concentration compared to other toxins 
sampled previously.  Thus, it was not necessary to extract DNA from the toxin 
sample in order to obtain a positive PCR signal.   
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The second toxin sample studied was an aseptically filtered derivative of type I, type 
I-S.  This was processed and sampled in the same way as type I and found to contain 
significant amounts of DNA, 3 ng/µl.   
 
Type IX was partially purified before lyophilisation and as a result DNA was not 
detectable, either in the initial preparation or the DNA extracted sample.  Several 
PCR reactions were carried out with this sample in an attempt to determine whether 
it contained any DNA.  However, abnormal fluorescence readings were obtained on 
the Lightcycler, masking the real-time PCR results (not shown).  Agarose gel 
electrophoresis confirmed that weak amplification had occurred, therefore a small 
amount of DNA was present in the toxin.  However, Q-PCR analysis was not 
possible as a result of the spurious fluorescence readings.  It is thought that the high 
fluorescence readings were due to the presence of a fluorescent amino acid such as 
tryptophan (348 nm), tyrosine (303 nm) or phenylalanine (282 nm), however the 
cause is unknown and has not been observed with other samples.   
 
Phospholipase C type XIV was chromatographically purified using an undefined 
method and DNA was not detectable by PCR either in its native or DNA extracted 
state.   
  
In summary, the commercially available toxins purified chromatographically or or 
electrophoretically were not detectable by PCR.  Toxins that were less pure were 
detectable.   
 
In order for PCR to be used as a toxin screening method a large number of assays 
must be run.  One way of reducing this logistic burden would be to combine assays 
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and perform multiplex analysis.  With this in mind, multiplex PCR was carried out 
using C. botulinum A and B DNA. 
 
3.8 MULTIPLEX PCR 
 
Most of the singleplex assays developed in this study can be run using the same 
thermal cycling parameters.  A sample can therefore be tested rapidly for the 
presence of SEB, ricin and possibly botulinum neurotoxins A and F at once by using 
all four singleplex assays on one machine.  However, some of the Clostridiae assays 
have a lower annealing temperature and longer amplicon than most assays due to 
their low GC content.  Therefore, botulinum neurotoxins B and F require another 
protocol utilising a lower annealing temperature.  C. perfringens α toxin requires a 
third protocol which makes use of a low annealing temperature combined with a low 
extension temperature.  Although inconvenient, this should not present a problem 
providing the real-time PCR machine used is able to provide the necessary 
flexibility.  However, differences in thermal cycling parameters between assays may 
prevent multiplexing of certain assays.  Nevertheless, multiplex assays would reduce 
the assay costs and setup time, making PCR more suitable for routine use. 
 
The C. botulinum A and B assays were chosen for use in a multiplex PCR 
experiment.  It was postulated that achieving sensitive detection of both toxin genes 
would be challenging, since their thermal cycling profiles differ.  Experiments were 
carried out on the Cepheid Smartcycler
¨
 and Corbett Rotorgene machines as it was 
not possible to perform multiplex PCR on the Roche Lightcycler using TaqMan¨ 
chemistry.  The C. botulinum B TaqMan 
¨
 probe was labelled with 5Õ FAM and 3Õ 
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BHQ.  The C. botulinum A assay was also quenched with BHQ but labelled with 
ROX at the 5Õ end.  Internal controls for types A and B were labelled with CY5 and 
CY3 respectively. 
 
Initially the sensitivity and efficiency of the C. botulinum A assay (Figure 3.24) 
prevented amplification of low copy numbers of the C. botulinum B gene (Figure 
3.25), with the detection limit being increased from 1 fg/µl to 0.1 ng/µl.  However, 
when optimal ratios of primers and PCR reaction components were used, the 
detection limit for both assays was 1fg/µl (Figures 3.26 and 3.27).  Taq polymerase 
(5U) was added to the multiplex reaction, compared to 0.8U per singleplex assay.  
The concentrations of dNTPs and magnesium chloride were also increased, from 200 
to 600 nM and 3 to 8 mM, respectively.  The concentration of each bont/A primer 
was reduced from 500 nM to 50 nM without affecting the sensitivity of the assay.  
The concentration of bont/B primers remained unchanged, at 500 nM. 
 
Quadruplex PCR was then used to amplify both bont genes with their respective 
internal controls, a composite DNA comprising a portion of the human β actin 
flanked by the bont primers.  Using the dye regimes described previously, there was 
no cross-talk between channels and all four targets were amplified simultaneously 
(data not shown).   
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Figure 3.24 Detection limit of un-optimised C. botulinum A DNA in a multiplexed A/B PCR assay.  
DNA standards were prepared from C. botulinum A NCTC 2916 and amplified with the bont A/B 
multiplex using 500nm of each type A primer.  An increase in fluorescence was observed with DNA 
concentrations between 0.1 ng/µ l and 10fg/µ l 
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Figure 3.25 Detection limit of un-optimised C. botulinum B DNA in a multiplexed A/B PCR assay.  
DNA standards were prepared from C. botulinum A NCTC 2916 and amplified with the bont A/B 
multiplex using 500nm of each type B primer.  An increase in fluorescence was observed with DNA 
concentrations between 0.1 ng/µ l and 10fg/µ l 
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Figure 3.26 Detection limit of C. botulinum A DNA in an optimised multiplexed A/B PCR assay.   
DNA standards were prepared from C. botulinum A NCTC 2916 and amplified with the bont A/B multiplex 
using 50nm of each type A primer, with increased amounts of Taq polymerase, dNTPs and MgCl2.  An 
increase in fluorescence was observed with DNA concentrations between 0.1 ng/µ l and 10fg/µ l. 
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Figure 3.27. Detection lit of C. botulinum B DNA in an optimised multiplexed A/B PCR assay.  DNA standards were 
prepared from C. botulinum B ATCC 17841 and amplified with the bont A/B multiplex using 500nm of each type B primer 
with 50 nM of type A primer.  Extra Taq polymerase, dNTPs and MgCl2 were also added to the multiplex assay.  An increase 
in fluorescence was observed with DNA concentrations between 0.1 ng/µ l and 1fg/µ l.   
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3.9 CHAPTER SUMMARY 
The PCR primer and probe sequences and assay run conditions used in this chapter 
are detailed in Table 3.12.  A summary of PCR toxin detection results are given in 
Table 3.13.  In general terms toxins prepared crudely using basic precipitation 
protocols were detectable by PCR. Only four toxins were detectable following DNA 
extraction treatment of the purified toxin, eight samples did not contain sufficient 
DNA to allow PCR detection.  
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Table 3.12.  Summary of the polymerase chain reaction assays used in this 
study.   
*perf1 demonstrated cross reactivity with C. histolyticum, C. novyi and C. 
bifermentans.  perf2 cross reacted with C. histolyticum. 
 
Primer 
set and 
target 
gene 
Primer sequences 
(F and R) 
TaqMan¨ probe 
sequence and 
concentration 
Mg 
2+ 
PCR Conditions 
Bot A 
bont/A 
F:TTTGAGGAGTC
ACTTGAAG CCTCTTTTAGGTGC
AGGCAAA 
0.3 µM 
3 
95 ¡C 0 sec 
55 ¡C 30 sec, 
72 ¡C 30 sec 
 
R:TTACTGCTGGA
TCTGTAGC 
Bot B 
bont/B 
F: 
CGTTTCTACGAA
TCTGG 
TTGGGATGTAATT
GGCAGTTT 
0.3 µM 
3 
95 ¡C 0 sec 
50 ¡C 30 sec 
72 ¡C 30 sec 
R: 
TTCAGTCCACCCT
TCAT 
Bot E2 
bont/E 
F: 
TTAACTTTTGGA
GGTACTGATT 
ACTAGTGCTCAGT
CCAATGATATCTA
TACTAATCTTCTAG 
0.3 µM 
4 
95 ¡C 0 sec 
50¡C 30 sec 
72¡C 30 sec 
R: 
TATAAGGATTAA
GTAGTGGATTAG
ATAC 
Bot F 
bont/F 
F:TGGATAATTCC
TGAGAGAA TTTTGAT
CCACCG
GCTTC 
0.4 µM 3 
95 ¡C 0 sec 
55 ¡C 30 sec 
72 ¡C 30 sec 
R: 
GCACTGCTTCCG
TTC 
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Perf1 
plc* 
F: 
AGTGCAAGTGTT
AATCGTTATCA CATCAACTAAAGT
CTACGCTTGGG 
0.3 µM 
4 
95 ¡C 0 sec 
55 ¡C 30 secs, 
65 ¡C 60s 
R: 
ACCAAGTAAAAA
CCTGTCTA 
Perf2* 
plc 
F: 
AGTGCAAGTGTT
AATCGTTATCA 
AATGAAAAGAAAG
ATTTGTAAGGCGC
T 
0.3 µM 
4 
95 ¡C 0 sec 
55 ¡C 30 secs, 
65 ¡C 60s 
R: 
TGGACAGATCAT
TTTCTAAGAT 
Ord 
ord 
F: 
CAGTCGGTTCGG
CAGTTTTC 
CACATCTTCTCGCC
AGGAGAGTGGAGT
G 
0.3 µM 
4 
95 ¡C 0 sec 
60¡C 30 sec R: 
GGTCTTCTCACAT
ATCGGGAAGA 
Ricin 
rta 
F: 
GACTGTAGCAGT
GAAAAGGCTGAA 
AACAGTGGGCTCT
TATGCAGATGGTT
CAA 
0.3 µM 
3 
95 ¡C 0 sec 
60¡C 30 sec 
 
R: 
CTCGGTTTGCTG
AGGACGT 
SEB 
seb 
F: 
TGAATTTAACAA
CTCGCCTTATGA
A 
AAATGAGAATAGC
TTTTGGTATGACAT
GATGCCTG 
0.2 µM 
5 
95 ¡C 0 sec 
60¡C 30 sec 
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R: 
AATCAACCATTT
TATTGTCATTGT
ACATC 
Ntnh 
ntnh 
F: 
CTCCTGGACCAA
AAATAAC 
AATTCAATTTTTTA
TTAGATTTTGGTGC
T 
N/A 
R:ATCTTTGATTT
CTACAGCTATTC 
rV 
lcrV 
F: 
CGCCGAATACAC
AATGGGA 
TGCGGGCGTTCAT
GGCAGTAATG 
3 
95 ¡C 0 sec 
60¡C 30 sec R: 
TACGATCGGCGG
TTAAAGAGA 
Bot 
E1(cros
s 
reacted 
with F) 
F: 
AATATTGTTTCT
GTAAAAGGCATA
AGGAA 
Not used 
ND 
ND R: 
AAGTTACTGTAT
CGTCAATTTCTTT
AGGAG 
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Table 3.13 General Summary of Q-PCR Toxin Detection Results 
 
Protein Protein Conc Purification  
method 
PCR result 
Protein 
 sample 
PCR result: DNA 
extracted from 
protein sample 
Clostridium 
botulinum 
neurotoxin A 
Not determined Acid Precipitation N/A Positive 
Clostridium 
botulinum 
neurotoxin B 
Not determined Acid Precipitation N/A  Positive 
Clostridium 
botulinum 
neurotoxin E 
Not determined Acid Precipitation N/A  Positive 
Recombinant V 
antigen 
Not determined 11 stage affinity 
chromatography 
method 
Negative Positive 
(15.2ng/µl) 
Alpha toxin in 
house 
fraction 1 
2.8 mg/ml 18 step ion 
exchange/gel 
filtration 
protocol 
Negative Negative 
Alpha toxin 
fraction 2 
1.1 mg/ml Negative 23 pg/µl 
 
Ricin Not determined Affinity 
chromatography 
Negative Negative 
Sigma Alpha 
toxin Type I 
Ð crude prep 
 3.5 mg/ml Not known Positive 
(32.4 
pg/µl) 
Negative 
Sigma Alpha 
toxin Type I-S Ð 
purified from 
type I 
 
3.5 mg/ml Not known Positive 
(3ng/µl) 
 
Negative  
Sigma Alpha 
toxin Type IX Ð 
partially purified 
 
3.5 mg/ml Not known Negative  Very low, not 
quantifiable using 
Q-PCR 
 
Sigma Alpha 
toxin Type XIV 
highly purified 
 
 Chromatography Negative Negative 
Sigma Ricin 7.8 µg Affinity 
chromatography
. 
Negative Negative 
Sigma SEB 3.5 mg/ml Unknown Negative Negative 
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3.10  DISCUSSION 
 
PCR was used successfully to detect toxin genes from residual DNA in toxin 
preparations, with high sensitivity and specificity, with the exception of the 
Clostridium botulinum DNA samples.  A number of the C. botulinum B DNA 
extractions may have failed or were of poor quality, although this was unlikely since 
favourable spectrophotometry results at A260/280 were obtained.  C. botulinum 
characteristically produces high levels of DNases, which could cause the DNA to 
degrade quickly, although this is not generally thought to cause a problem with PCR 
amplification of short products (Keto-Timonen et al., 2005).  The neurotoxin gene is 
carried chromosomally on an integrated prophage which may be susceptible to 
instability.  However, the most likely theory was that the bacteria had mutated and 
lost their virulence through years of subculturing. To corroborate this theory, further 
analysis of DNA obtained from the original type B stock cultures was obtained.  PCR 
was successful with all but one strain, strongly suggesting that a lack of selective 
pressure caused the toxin genes to be lost or mutated within the bacterial population.  
It should also be noted that the bont/b PCR results were inconsistent and it was not 
possible to reproduce many of the results (hence the need for individual results in 
Figures).  Although it is assumed that toxins can be produced with similar ease from 
group I and II strains, it would have been desirable to test toxins from both types of 
B strain, however it was not possible using the culture stocks held in house.  A 
negative mouse lethality or ELISA test performed with fresh culture supernatant 
would confirm the lack of toxin.  However, it was not possible to test this theory 
during this study as funding for antibody or animal work was unavailable.  
Furthermore, as the utility of toxin detection by PCR was in question following the 
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results obtained in this study, the Clostridium botulinum PCR assays were not 
investigated further.   
 
In order to complement the majority of gene probe assays used in this study, a 
generic bont assay would have been highly desirable.  It was not possible to design 
such an assay using the parameters used in this study, however it should be noted 
that several research groups have more recently designed generic bont real time PCR 
assays, including De Medici et al., (2009), Satterfield et al., (2010), Hill et al., 
(2010), and Kirchner et al., (2010).  These researchers have encountered problems 
similar to those identified in this study, such as poor homology between strains and 
low GC content.  However, they have used elegant solutions to the problem.  
Kirchner et al., (2010) used MGB probes which are similar to TaqMan¨ probes but 
use a unique minor groove binding (MGB) chemistry supplied by Applied 
Biosystems that allows short probes (that would have a low melting temperature if 
used with standard TaqMan¨ chemistry) to be used in place of the usual 20 bp 
probe.  Hill et al., (2010) used degenerate primers targeting a highly conserved 
region of the ntnh gene to facilitate detection of toxin in types A to G.    Both 
approaches were successful, proving that generic detection is possible. 
 
In the current study BoNTs were prepared using a simple acid precipitation method.    
PCR analysis showed that DNA was present in the purified toxin samples, indicating 
that genomic DNA was co-precipitated.  Further protein purification such as affinity 
chromatography or gel filtration was not carried out, limiting the amount of DNA 
that was removed.  The fate of DNA during protein purification processes is not 
known.  It is conceivable that DNA was also precipitated using ammonium sulphate 
but it seems likely that a number of factors allowed the presence of DNA in the 
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BoNT samples.  Ammonium sulphate may have sufficient ionic strength to 
precipitate DNA to a degree, however DNA is more commonly precipitated with a 
combination of acid and alcohol, such as sodium acetate and ethanol.  Therefore, it 
seems most likely that DNA was present in the toxin sample because it was bound 
electrostatically to the protein.  It may also have been free in solution as it would 
have a high molecular weight if the extraction process had not caused degradation or 
shearing.  Therefore some may have been retained and recovered by the dialysis 
process.  Acid precipitation of C. botulinum neurotoxins is thought to have been used 
as a method of preparing biological weapons for use in the Iraq war (Zilinskas 1997).  
Therefore, the fact that the toxin was detectable by PCR is of significant importance. 
 
Affinity chromatography was used to purify recombinant V antigen and ricin.  
Although DNA was removed during each stage of the LcrV purification process, the 
final protein contained a high concentration of DNA in spite of its intended use as a 
vaccine candidate.  Nanograms of DNA were detected in the pure lcrV protein 
sample.  In contrast no DNA was amplified in the ricin sample.  It was interesting to 
note that one of the first steps in clarifying the LcrV protein preparation was to use 
enzymatic degradation of nucleic acids, although the aim of this step was to reduce 
viscosity rather than completely remove DNA.  Consequently, complete removal of 
DNA was not achieved and the nuclease-treated sonicated samples contained 90 to 
150 pg/µl of DNA. Ricin samples were not nuclease-treated and yet contained less 
DNA, with no trace being detectable after the initial petroleum ether extraction.  In 
other words, although ricin was affinity purified, it was not the sepharose purification 
that eliminated DNA from the toxin, but the solvent and salt extraction used initially.  
This was surprising given the effect of acid precipitation on the DNA concentration 
of BoNT.  The use of petroleum ether was governed by the fact that a major 
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component of R. communis seeds is castor oil which must be removed from a 
preparation of ricin if it is to be used in vitro.  Castor oil is insoluble in petroleum 
ether, hence the formation of a lipid and aqueous phase.  The DNA analysis results 
indicate that all R. communis DNA was removed to the lipid layer.  If an alternative 
solvent was used this may not be the case.  Affinity purified ricin from Sigma was 
also not detectable by PCR. Therefore, the results presented for this study show the 
ease with which it is possible to prepare ricin toxin that is undetectable by PCR, 
although expertise is required to produce pure toxin.   
 
Alpha toxin was purified using a capture, intermediate, purification and polishing 
(CIPP) ion exchange chromatography protocol.  DNA was detected in a number of 
samples taken during the process.  The first elution from the HiTrap Q column 
contained a high DNA and low toxin concentration whilst subsequent elutions 
contained less DNA and more toxin.  This is due to the nature of the ion exchange 
medium used.  HiTrap Q is a quarternary ammonium anion exchanger often used at 
the capture stage of the purification process.  As DNA carries a negative charge it is 
likely to bind to an anion exchange column and be eluted at a different ionic strength 
and higher pH than the toxin.  Another anion exchange column was used for 
intermediate purification with similar effects on the protein and DNA concentrations.  
Gel purification was used to ÔpolishÕ the toxin.  Interestingly, no DNA was detectable 
by PCR in the major protein eluate from the gel filtration column; only the second 
eluate had DNA associated with it.  This may be because molecules are eluted from a 
gel filtration column according to size, with the largest molecules being eluted first.  
Alpha toxin is a 42.5 kDa protein whereas contaminating DNA is expected to be 
smaller due to severe degradation by DNase I and sonication.  Consequently, DNA 
would be eluted from a gel filtration column after the major protein eluate had been 
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obtained.  Although a significant amount of DNA was lost during each purification 
step and some of the samples from the final stage of the process did not amplify, 
contaminating DNA within the pure protein was detectable after sample processing.  
This was in contrast to the highly pure samples of SEB and alpha toxin obtained 
from Sigma.  Unless the commercially produced toxin were cloned it seems likely 
that they were purified by a type of ion exchange chromatograpy as the properties of 
the proteins do not immediately suggest an alternative method (Johansson et al., 
2007).  In spite of this, the Sigma alpha toxin was not detectable in its purest form, 
again suggesting that the suitability of PCR as a toxin detection method is entirely 
dependent on the method used to process the toxin.   
 
A sensitive multiplex PCR assay for the detection of Clostridium botulinum A and B 
was developed from the corresponding singleplex assays.   The sensitivity of the 
multiplex assay was unexpected as there was a 5 degree difference in annealing 
temperature of the C. botulinum A and B primers and probes.  Furthermore, this 
success has not been observed with multiplex assays developed subsequently at Dstl 
(Mitchell et al. 2010).  It was a useful technique as it doubled the number of genetic 
tests that were performed per reaction.  This is particularly useful in situations where 
generic assays are unavailable for a target, as is the case with botulinum neurotoxin.  
Although real-time multiplex PCR is currently limited by the reporting chemistry and 
instrumentation, it is expected that this field of science will advance in future.  This 
may permit the detection of all seven bont genes in one reaction 
 
In conclusion, many research groups have successfully used PCR to detect toxin 
genes in food.  It is widely accepted as indicative of the presence of toxin.  However, 
previously it was unknown whether PCR would be a useful method for the detection 
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of toxins on the CDC threat list prepared as biological warfare agents.  The results 
obtained in this study show that expertise is required to remove DNA from samples 
containing toxin.  A number of protein preparations contained enough contaminating 
DNA to allow detection by PCR unless highly purified by a specialised laboratory.  
However, the majority of commercially produced toxins sampled were not detected 
by PCR.  The DNA extraction protocol could be further optimised for low copy 
number detection by the addition of carrier DNA.  Additionally, it woud be 
advantageous to take larger toxin samples for analysis.  The use of PCR for detection 
of toxins needs to be considered carefully, depending on the scenario.  The user 
needs to make an educated guess as to whether a toxin sample is likely to contain 
DNA.  For example, aggressors may not have the laboratory equipment necessary to 
purify toxins sufficiently to evade PCR detection.  Theoretically however, a well-
equipped aggressor may have the capability to produce toxins to such a high purity 
that PCR detection is prevented.  Although it is unlikely that an aggressor will 
remove DNA from a toxin preparation, the prospect exists.  For this reason, PCR is 
not considered a useful approach to toxin detection unless used with an orthogonal 
technology. 
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4  IMMUNO-PCR 
4.1   INTRODUCTION 
The results presented in Chapter Three showed that PCR was not a reliable method 
of toxin detection if contaminating DNA was present in low quantities.  Therefore an 
alternative nucleic acid approach was required.  Immuno-PCR (I-PCR) was 
investigated as the alternative method as it offers advantages over conventional PCR 
and ELISA technologies.  It was first described by Sano et al., (1992) who used PCR 
to detect DNA labelled antibody binding in an immunoassay format.  The way in 
which the antibody is labelled with DNA can vary, as described in more detail in 
Section 4.4.  Although the technique is less widely used than PCR or ELISA it offers 
distinct advantages over both.  Unlike PCR, I-PCR is able to detect antigen directly, 
so results obtained using this method lead to conclusions rather than inferences.  In 
contrast with ELISA, I-PCR offers exponential signal amplification, potentially 
increasing the sensitivity of the assay (Sano et al., 1992).   
 
4.2 AIMS 
The aim of this part of the study was to develop and evaluate I-PCR systems as an 
alternative to PCR detection of toxins.  Firstly, an existing ELISA for the detection 
of the toxin simulant ovalbumin was converted to an I-PCR format using antibodies 
labelled with DNA.  Secondly, a more novel approach using an anti-Bacillus cereus 
single chain antibody (scFv) in place of a conventional antibody, termed immuno-
phage-PCR, was also investigated, since scFv carry intrinsic genetic material that 
avoids the need for a DNA labelling step.  Finally, DNA aptamers were developed 
for detection of ovalbumin using various methods, as summarised in Table 4.1. 
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Table 4.1 Summary of immuno-PCR assays developed for this study. 
 
Antigen/Assay Primary ligand Secondary ligand DNA element 
Ovalbumin I-PCR Anti-ovalbumin 
rabbit polyclonal 
antibody 
Anti-ovalbumin 
rabbit polyclonal 
antibody 
Biotin labelled 
amplicon 
Ovalbumin I-PCR Anti-ovalbumin 
rabbit polyclonal 
antibody 
Anti-ovalbumin 
rabbit polyclonal 
antibody 
Neutravidin 
labelled amplicon 
Ovalbumin I-PCR Anti-ovalbumin 
rabbit polyclonal 
antibody 
Anti-ovalbumin 
rabbit polyclonal 
antibody 
Covalently 
labelled 
secondary 
antibody 
B. cereus spores 
 I-φ-PCR 
Anti B. cereus 
ScFv antibody  
N/A scFv/M13 phage 
DNA 
Ovalbumin Aptamer Anti-ovalbumin 
rabbit polyclonal 
antibody 
Colourimetric 
detection of 
ovalbumin 
Ovalbumin Anti-ovalbumin 
rabbit polyclonal 
antibody 
Aptamer 
(Biotinylated) 
Colourimetric 
detection of biotin 
labelled aptamer 
Ovalbumin Anti-ovalbumin 
rabbit polyclonal 
antibody 
Aptamer Aptamer PCR 
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4.3 IMMUNO-PCR ASSAYS 
A number of PCR assays were used with the immuno-PCR work described in this 
chapter.  Each was designed using Primer Express v1.0 as described previously, with 
the exception of the pgi assay which had been designed at Dstl prior to the onset of 
this study.  An internal control was constructed for each assay using composite 
primers, as detailed in Table 4.2, targeting a region of the human β actin gene.  The 
internal control was designed to be larger than the target amplicon, at 120 basepairs, 
so as not to be preferentially amplified over the target sequence.  The internal control 
was amplified using the composite primers and then cloned into a pT7 plasmid 
vector containing a TA overhang in order to facilitate large scale production of DNA.  
The optimal concentration of internal control DNA for use with the immuno-phage 
PCR assays used in this study, determined empirically, was 10 fg (Figure 4.1).  The 
thermal cycling conditions and sequences are summarised in Table 4.3.  Quadruplex 
PCR was developed for simultaneous detection of the bce and scFv8 gene and 
internal control targets.  To ensure sensitive detection of all four amplicons, the 60 
¡C annealing and extension phase was extended from 30 seconds to 1 minute. 
 
Table 4.2 Composite primer sequences used to construct internal PCR controls 
(where X(n) represents the toxin simulant specific region of the primer). 
 
Forward primer sequence (5Õ to 3Õ) Reverse primer sequence (5Õ to 3Õ) 
X(n)AGTACTCCGTGTGGATCGGA X(n)GCTGATCCACATCTGCTGGA 
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Figure 4.1  Serial dilution of internal control DNA for the immuno-phage-PCR 
assay.  A synthetic DNA construct was made by PCR using a region of the b 
actin gene, flanked by scFv8 specific primers.  Internal control DNA was added 
to the PCR reaction at various concentrations, from 1 pg to 10 fg.  
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Table 4.3 Summary of the thermal cycling conditions used with the immuno-
PCR assays designed for this study. 
Target 
organism/gene 
Gene 
name 
[Probe] [Mg] Thermal 
cycling  
conditions 
Forward 
 primer  
 
Reverse 
primer 
 
Taqman
¨ probe  
 
B. cereus 
entero-toxin 
bce 0.3 µM 4 95 ¡C 1 sec 
60¡C 30 sec 
 
AAGA
GTTAG
TTTCA
ACAGC
GCGT 
 
CACTCGG
TTTTTGC
GTAGCTA
AT 
 
TCGGT
CGTTC
ACTCG
GGATC
CATT 
P.agglomerans 
phosphoglucse 
isomerase
1
 
pgi 0.3 µM 3 95 ¡C 1 sec 
60¡C 30 sec 
GTTTT
GCCGC
CTATT
TCC 
CACGAT
ATGGGCT
ACAGAC
TC 
 
 
Aspergillus 
flavus 
oxidoreductase 
gene 
ord 0.3 µM 3 95 ¡C 1 sec 
60¡C 30 sec 
CAGTC
GGTTC
GGCA
GTTTT
C 
GGTCTTC
TCACATA
TCGGGA
AGA 
 
CACAT
CTTCT
CGCCA
GGAG
AGTGG
AGTG 
 
B. cereus 
specific single 
chain antibody 
CMAN 8. 
ScFv
8 
0.3 µM 3 95 ¡C 1 sec 
60¡C 30 sec 
CCTAT
TGCCT
ACGGC
AGCC 
 
TCTTTGT
AGTCCGC
CATGGC 
 
 
 
Aptamer F and 
R primers 
AP N/A 3 95 ¡C 1 sec 
60¡C 30 sec 
CCGGA
TCCGT
TGATA
TATAA
AATTC 
GGGAGC
CAACAC
CACATTC
AA 
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4.4 DETECTION OF OVALBUMIN USING IMMUNO-PCR  
4.4.1 Anti-ovalbumin ELISA 
An existing, well characterised ELISA for detection of ovalbumin was converted to 
an immuno-PCR (I-PCR) format as described in detail in Section 2.5.2.1.  Briefly, an 
ELISA plate was coated in a rabbit polyclonal capture antibody and non specific 
binding to the plate was prevented by filling each well with 2 % (w/v) milk powder 
in PBS.  Ovalbumin was then diluted three-fold across the plate.  A biotin-labelled 
detection antibody specific for ovalbumin was subsequently bound, followed by the 
addition of a streptavidin-horse radish peroxidase (HRP) conjugate.  Positive 
detection of ovalbumin was determined following the addition of a colorimetric HRP 
substrate and an absorbance reading of three times above background level at A414 
nm.  The approach used is depicted in Figure 4.2a.  The detection limit of the ELISA 
for ovalbumin used in this study was routinely 1.3ng/ml (Figure 4.2b).  This assay 
had been well studied previously at Dstl and was deemed suitable for conversion to 
an immuno-PCR format as it performed reliably and had low non-specific 
background signal.  
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Figure 4.2a Schematic diagram of ELISA.   
Figure 4.2b.  Example ELISA A414 nm results for ovalbumin concentrations diluted 3-
fold, starting at 1000 ng/ml.  The primary antibody was bound to the surface of the 
ELISA plate.  Ovalbumin was subsequently allowed to bind to the antibody.  A 
secondary biotin-labelled antibody was bound to the immobilised ovalbumin.   
Streptavidin labelled with horseradish peroxidase (HRP) was bound to the sandwich.  
This was followed by the addition of the HRP substrate hydrogen peroxide plus ABTS 
resulting in a colorimetric change which can be measured at A414 nm and plotted on a 
graph.  The background fluorescence was 0.062. 
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4.4.2 Immuno-PCR using biotin labelled DNA 
 
Immuno-PCR was initially carried out using the same format as the ELISA, except a 
biotinylated PCR amplicon was added to the ELISA after the Streptavidin-HRP 
conjugate had been added to the sandwich (Figure 4.3).  Although the background 
using colorimetric detection on a control row was low (0.067 OD), the background 
crossing point of the I-PCR was cycle 26, as observed with sample seven and 
onwards (Figure 4.5), limiting the sensitivity of the assay to 1.3 ng/ml.  Therefore, in 
this format, immuno-PCR did not have any advantage over ELISA.  It was thought 
that the lack of sensitivity may have been caused by the biotinylated antibodies 
sequestering any available streptavidin in the penultimate stage of the immunoassay, 
thus preventing binding between streptavidin and biotin labelled DNA in the final 
stage of the process.  This method was therefore disregarded. 
 
 
Figure 4.3 Schematic diagram of immuno-PCR using biotin labelled DNA.  The 
primary antibody was bound to the plate.  Ovalbumin was captured by the primary 
antibody and then detected using a biotin labelled antibody.  Streptavidin was then 
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added to the plate, followed by biotin labelled DNA.  PCR was used as the end-point 
detection method. 
4.4.3 Immuno-PCR using pre-conjugated biotinylated DNA-streptavidin. 
To overcome this problem, biotinylated DNA was directly bound to Streptavidin-
HRP by incubating the two together for one hour at 37 ¡C.  The pre-formed 
conjugate was then added to the ELISA plate following the removal of unbound 
biotinylated secondary antibody (Figure 4.4).  The amount of DNA used in the 
method was optimised at 70 pg/well by performing a series of negative control 
reactions and determining the maximum concentration at which the DNA could be 
used without giving non specific signal (Table 4.4).  DNA concentrations between 
0.7 and 70 pg per well gave the same crossing point value as the no amplicon 
control, however the end point fluorescence value was low with 0.7 and 7 pg.  
Therefore 70 pg of biotin-streptavidin conjugated DNA per well were used in further 
I-PCR experiments.  The number of final plate washes in dH2O was also determined 
and the most reliable results were obtained when 70 pg DNA were used per well with 
2 final dH2O washes.  It was necessary to stop the PCR at cycle 33 rather than 
allowing it to proceed for 40 cycles owing to the signal obtained from non-specific 
binding of the proteins to the ELISA plate.    Using only 30 PCR signals was not 
sufficient to increase the sensitivity with 1.3ng/µl being the detection limit.  The 
results obtained using the optimised method are summarised in Figure 4.4.  In 
general terms the detection limit obtained using immuno-PCR was 50 pg/µl, a 9-fold 
increase in sensitivity compared to ELISA.  When a ten fold dilution series of 
ovalbumin was used in immuno-PCR the detection limit of the assay was 10 pg/µl.  
Therefore the crude and simple method used here was successful.  It should be noted, 
however, that the repeated PCR amplification of amplicon-labelled antibodies caused 
the background of the immuno-PCR became indistinguishable from the positive 
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signal with each successive experiment (data not shown).  Steps to prevent this re-
occuring would be necessary if the method were to be used in future.   
   
 
 
 
Figure 4.4 Schematic diagram illustrating immuno-PCR for the detection of 
ovalbumin using pre-formed conjugates of biotin labelled DNA and 
streptavidin. Ovalbumin was captured by the primary antibody and then 
detected using a biotin labelled antibody.  Streptavidin and biotin labelled DNA 
we pre-conjugated prior to addition to the plate.  PCR was used as the end-point 
detection method. 
 
Key: 
Antibody 
 Biotin 
Ovalbumin 
Biotinylated DNA 
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DNA concentration (ng 
per well) 
Mean crossing point value 
(n=12) 
Standard deviation 
7000 
26.36944 
 
0.298651 
 
700 
28.40833 
 
0.742135 
 
70 
33.41667 
 
0.759203 
 
0.7 
34.65 
 
0.617117 
 
0.07 
35.03333 
 
0.174801 
 
0.007 
34.96667 
 
0.334996 
 
0.0007 
35.11667 
 
0.276385 
 
0 
35.1 
 
0.742135 
 
Table 4.4.  Optimisation of the DNA concentration to be used in Immuno-PCR 
experiments.  Biotin laballed pgi amplicon conjugated to streptavidin was added 
to a 96-well plate at concentrations ranging from 7000 ng to 0.7 pg, in replicates 
of 12.  The DNA was bound to the plate at 37 
o
C for 1 hour.  Following 5 washes 
the plate was analysed by PCR on the Roche Lightcycler.  The average crossing 
point values were obtained, with standard deviation.  Background signal was 
high and the no amplicon control amplified with a crossing point value of 35 due 
to non-specific binding of streptavidin to the plate.    
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Figure 4.5 Immuno-PCR using biotin labelled DNA and a biotinylated DNA-
streptavidin complex. Plates were coated in 5 µg/ml of anti-ovalbumin 
polyclonal capture antibody and blocked in 2 % milk powder solution.  
Ovalbumin was added to columns 1 to 12 at the concentrations stated in the 
graph. 2.5 µg/ml of biotinylated anti-ovalbumin antibody was then was added to 
each well.   Streptavidin was added to each well at a dilution of 1:2000.    Biotin 
labelled was added to the plate.  Following the final incubation period, the plate 
was washed 5 times in PBST and 3 times in dH2O.  DNA was eluted from the 
plate by heating it to 100 
o
C for 30 secs; this was immediately amplified by real-
time PCR on the Roche Lightcycler. 
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4.4.4 Immuno-PCR using neutravidin labelled DNA 
The addition of the biotin-labelled amplicon to the immunoassay described in 
Section 4.4.2 required an extra hour-long incubation step compared to ELISA.  The 
approach in Section 4.4.3, using preconjugated bioton labelled DNA and streptavidin 
was quicker but was inelegant.  An alternative approach was investigated for 
conversion of the ovalbumin ELISA to an I-PCR format.  Neutravidin has the same 
affinity for biotin as streptavidin and is commonly available as an oligonuceotide 
modification.  The use of neutravidin labelled DNA would reduce the assay time in 
comparison to the approach used in Section 4.4.2, since it would bind directly to the 
biotin labelled secondary antibody.  Consequently, although the approach involved 
the use of PCR amplicon, it was deemed worthy of investigation.  The immuno-PCR 
scheme is summarised in Figure 4.6.   
 
 
 
Figure 4.6.  Summary of the I-PCR scheme using neutravidin labelled DNA.  
Key: 
Antibody 
 Biotin 
Ovalbumin 
Neutravidin DNA 
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Neutravidin labelled pgi PCR primers were synthesised by Thermo Hybaid (UK), 
with 1.5 mg being delivered to the thiol modified oligonucleotides, followed by 
HPLC purification.  The neutravidin labelled pgi oligonucleotides, at a concentration 
of 100 µΜ, were used to produce a labelled amplicon by PCR.  Amplification using 
these primers was inefficient compared to that obtained using unlabelled primers, 
however amplicon was collected, purified by microconcentration and used in further 
work.  Initial pilot experiments showed that the neutravidin labelled amplicon was 
able to bind to the biotinylated secondary antibody sufficiently to give a good PCR 
signal (data not shown).   
 
The neutravidin amplicon was tested in I-PCR by using a final concentration 
estimated from Q-PCR data at 10
8
 and 10
7
 copies per µl.  The initial results using 
this approach showed no discrimination between positive and negative samples 
(Figure 4.7), although in general terms the crossing point values increased in relation 
to the ovalbumin concentration.  The crossing point values in Table 4.4 are difficult 
to interpret, demonstrating the lack of reproducibility of the method.  However, the 
negative control samples had high background signals (12.54 or 11.43). Therefore, 
only samples with a value above these thresholds could be considered positive. 
Accordingly, the limit of detection of the assay was between 4.1 and 1.3 ng/ml, 
which was the same as the original colorimetric ovalbumin ELISA.   It was therefore 
necessary to carry out further optimisation experiments in an attempt to exploit the 
sensitivity of PCR whilst reducing the level of background signal.   
 
The primary capture antibody concentration was varied from 5µg/ml to 0.039µg/ml 
in a two-fold dilution series.  The concentration of secondary detection antibody 
remained constant at 2.5 µg/ml.  Ovalbumin was diluted across the plate as with the 
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standard protocol.  The results showed that reducing the concentration of capture 
antibody had no effect on the amount of non-specific binding occurring with the 
neutravidin labelled oligonucleotides (Figure 4.8).  Furthermore, reducing the 
amount of capture antibody used on the plate had an adverse effect on the immuno-
PCR and such results were less consistent than those obtained originally.     
 
The detection antibody concentration was then varied between 2.5 µg/ml and 0.0195 
µg/ml, with all other reagent concentrations unchanged.  The ovalbumin 
concentration was diluted threefold across the plate as in other experiments.  The 
results in Figure 4.9 demonstrate again the inconsistency of the approach, however 
an overall trend can be seen, with an increase in crossing point value being observed 
in relation to a decrease to ovalbumin.  However background was excessively high, 
therefore samples containing less than 0.45 µg/ml of ovalbumin were not analysed 
by PCR. 
 
A third immunoassay was carried out using lowered concentrations of both capture 
and detection antibody, with the ovalbumin concentration remaining the same as 
used previously.  The background signal obtained with this plate was lower than 
observed previously, but was still excessive, preventing the full sensitivity of the 
technique being exploited (Figure 4.10).   
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Figure 4.7 Crossing point values obtained using I-PCR with neutravidin 
labelled DNA.    Plates were coated in 5 µg/ml of anti-ovalbumin polyclonal 
capture antibody and blocked in 2 % milk powder solution.  Ovalbumin was 
added to columns 1 to 12 at the concentrations stated in the graph. 2.5 µg/ml of 
biotinylated anti-ovalbumin antibody was then was added to each well.   
Neutravidin labelled DNA was added to each well at a concentration of 40 ng/µl 
or 4ng/µl.  Following the final incubation period, the plate was washed 5 times 
in PBST and 3 times in dH2O.  DNA was eluted from the plate by heating it to 
100 
o
C for 30 secs; this was immediately amplified by real-time PCR on the 
Roche Lightcycler. 
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Figure 4.8.  Crossing point values obtained using 10
7
 copies/µl neutravidin 
labelled pgi amplicon in I-PCR. Plates were coated in anti-ovalbumin polyclonal 
capture antibody at the concentrations described in the graph and blocked in 2 
% milk powder solution.  Ovalbumin was diluted across the plate. 2.5 µg/ml of 
biotinylated anti-ovalbumin antibody was then was added to each well.   
Neutravidin labelled DNA was added to each well at a final concentration of 10
7
 
copies/ul.  Following the final incubation period, the plate was washed 5 times in 
PBST and 3 times in dH2O.  DNA was eluted from the plate by heating it to 
100¡C for 30 secs; this was immediately amplified by real-time PCR on the 
Roche Lightcycler. 
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Further experiments used a dilution series of neutravidin down the plate with 
standard concentrations of primary and secondary antibodies.  The crossing point 
values are summarised in Figure 4.11.  The 10 and 1 copies/µl dilutions of 
neutravidin labelled amplicon did not amplify as the concentration of DNA template 
was too low.  Therefore, the detection limit of the PCR assay was 100 copies of 
neutravidin labelled pgi.  Despite using the neutravidin label at the minimum 
concentration detectable by PCR the immuno-PCR was still subject to inconsistent 
Ct values.  In spite of this, all samples containing ovalbumin amplified with a Ct 
value above the background level using 100 or 1000 copies of amplicon.  Although 
the Ct values obtained using high concentrations of ovalbumin and amplicon were 
distinguishable from the background, the detection limit of the I-PCR assays were no 
lower than using the colourimetric immunoassay.   
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Figure 4.9 Crossing point values obtained using 10
7
 copies/µ l of neutravidin 
labelled pgi amplicon in I-PCR. Plates were coated in 5 µg/ml of anti-ovalbumin 
polyclonal capture antibody and blocked in 2 % milk powder solution.  
Ovalbumin was added to columns 1 to 12 at the concentrations stated in the 
table. Biotinylated anti-ovalbumin antibody was then was added to each well at 
the concentrations described in the graph.   Neutravidin labelled DNA was 
added to each well at a concentration of 10
7
 copies/µl.  Following the final 
incubation period, the plate was washed 5 times in PBST and 3 times in dH2O.  
DNA was eluted from the plate by heating it to 100¡C for 30 secs; this was 
immediately amplified by real-time PCR on the Roche Lightcycler or Corbett 
Rotorgene¨. 
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Figure 4.10.  Crossing point values obtained using 10
7
 copies/µ l of neutravidin 
labelled pgi amplicon in I-PCR and a ten fold dilution series of capture and 
detection antibody. Plates were coated in 5 µg/ml of anti-ovalbumin polyclonal 
capture antibody and blocked in 2 % milk powder solution.  Ovalbumin was 
added to columns 1 to 12 at the concentrations stated in the graph. Biotinylated 
anti-ovalbumin antibody was then was added to each well at the concentrations 
described in the table.   Neutravidin labelled DNA was added to each well at a 
concentration of 10
7
 copies/µ l.  Following the final incubation period, the plate 
was washed 5 times in PBST and 3 times in dH2O.  DNA was eluted from the 
plate by heating it to 100¡C for 30 secs; this was immediately amplified by real-
time PCR on the Roche Lightcycler. 
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Figure 4.11  Crossing point values obtained using a dilution series of 
neutravidin labelled DNA in I-PCR. Plates were coated in anti-ovalbumin 
polyclonal capture antibody at the concentrations described in the table and 
blocked in 2 % (w/v) milk powder solution.  Ovalbumin was added to columns 1 
to 12 at the concentrations stated in the graph (ng/µl). 2.5 µg/ml of biotinylated 
anti-ovalbumin antibody was then was added to each well.   Neutravidin 
labelled DNA was added to each well at the concentrations stated.  Following 
the final incubation period, the plate was washed 5 times in PBST and 3 times in 
dH2O.  DNA was eluted from the plate by heating it to 100 ¡C for 30 secs; this 
was immediately amplified by real-time PCR on the Roche Lightcycler. 
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4.4.5 Detection of ovalbumin using directly labelled antibodies  
 
It was thought that the crude methods used to label antibodies with DNA in previous 
experiments may have prevented the I-PCR methods used from fully exploiting the 
sensitivity of PCR detection.  Therefore a more controlled labelling method was 
investigated.  The anti-ovalbumin antibodies used in previous experiments were 
covalently labelled with a 78 bp oligonucleotide amino-modified tag by Alchemy 
(UK).  An oligonucleotide label was used in comparison for these experiments as it 
could be synthesised directly rather than amplified by PCR, as used by Hendrickson 
et al., (1995). The simplicity of the assay is summarised in Figure 4.12.
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Figure 4.12.  Immuno-PCR scheme using DNA labelled antibodies.  Plates were 
coated in anti-ovalbumin polyclonal capture antibody, followed by the addition 
of ovalbumin.  Covalently DNA labelled anti-ovalbumin antibody was then was 
added to each well.   DNA was eluted from the plate by heating it to 100 ¡C for 
30 secs; this was immediately amplified by real-time PCR on the Roche 
Lightcycler. 
 
 
4.4.5.1 Detection using high antibody concentration 
Immuno-PCR using 0.85 mg/ml amino-modified DNA labelled antibodies, with 
ovalbumin concentrations ranging between 1000ng/ml and 0.01 ng/ml, was carried 
out.  The anti-ovalbumin capture antibody was bound to the plate, washed and 
followed by ovalbumin addition.  The plate was re-washed and the DNA labelled 
secondary antibody added.  Following further washes the plate was heated briefly to 
disrupt antibody binding and samples were analysed by PCR.  Initial results showed 
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that the DNA coupling reaction had worked well and that the concentration of DNA 
bound to the antibody was suitable for use in immuno-PCR.  However, the 
background signal was excessive, once again leading to false positive results.  The 
experiment was repeated with an additional three washes of the microtitre plate in 
dH2O.  This resulted in a reduction in background signal, however the Ct value of 
sample 7 was lower than that of the negative control, leading to this sample being 
incorrectly classified as negative (Figure 4.13).   
 
Experiments to lower the background signal were then carried out, using six PBS-T 
washes, followed by numerous washes in dH2O.  An ovalbumin concentration range 
between 1 µg and 0.1 pg/ml was tested in the presence and absence of capture 
antibody, with the aim of quantifying the amount of non-specific antibody binding 
occurring on the plate.  The signal obtained from the row containing capture 
antibody was higher than that of the negative control row, however a high 
background signal was observed.  This indicated that the amount of DNA-labelled 
antibody used in the I-PCR assay was excessive.  Two washes in dH2O were then 
carried out, which significantly reduced the amount of background signal, as did 
three washes.  However, it was not possible to reduce the background signal further 
using this approach (Figure 4.14).  Therefore, further experiments were carried out 
using less DNA labelled antibody. 
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Figure 4.13 Immuno-PCR results obtained using 0.85 mg/ml DNA labelled 
antibody as the detection ligand in an ovalbumin immunoassay.  The 
immunoassay was carried out using a standard ovalbumin ELISA, however 
colorimetric detection was replaced by PCR.  Additionally, three extra washes 
of the microtitre plate were carried out with distilled water in order to remove 
unbound antibody.       
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Figure 4.14.  Immuno-PCR results obtained using 0.85 mg/ml DNA labelled 
antibody as the detection ligand in an ovalbumin immunoassay.  The 
immunoassay was carried out using a standard ovalbumin ELISA, however 
colorimetric detection was replaced by PCR using ord specific primers and 
probe.  Additional washes of the microtitre plate were carried out, as detailed 
above, with distilled water in order to remove unbound antibody.   
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4.4.5.2 Detection of ovalbumin using low covalently labelled antibody 
concentrations. 
Theoretically, it should be possible to use a lower concentration of detection 
antibody in I-PCR compared to conventional ELISA.  Accordingly, as with 
conventional I-PCR, the  concentration of detection antibody used was reduced.  The 
average Ct value obtained using 1µg of ovalbumin with 2.5 µg detection antibody 
and three dH2O washes was 25.  This was increased to 26 using 1.25 µg of antibody, 
however the background signal was excessive.  Results using 0.25 µg of detection 
antibody were promising, with many of these samples being negative following three 
stringency washes in dH2O.  However, these results were not reproducible once the 
plate had been heated to release the antibody-DNA molecules.  Further experiments 
were carried out using 0.125 and 0.025 µg of detection antibody.  However, false 
positive and negative results were obtained using 0.125 µg of antibody.  
Furthermore, the no template controls amplified at cycle 30, an unfortunate 
consequence of performing the same reaction an excessive number of times in one 
laboratory, as previously experienced in this thesis (Section 4.4.3).   
 
A final experiment was performed using 0.025 µg of detection antibody.  Results 
were inconsistent, with no predictable pattern being observed across the dilution 
series of ovalbumin.  Only samples 1, 7 and 6 gave a higher signal than the 
background, with false negative results being observed with all other concentrations.  
Therefore, the concentration of detection antibody used in this experiment was too 
low to allow reliable detection.  These results are summarised in Figure 4.15.  
Further experiments utilising a low concentration of capture antibody were not 
carried out as the approach was unsuccessful with neutravidin labelled antibodies.  
Instead, a different approach was used which also eliminated the DNA labelling step. 
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Figure 4.15.  Immuno-PCR results obtained using varying concentrations of 
covalently labelled antibodies for the detection of ovalbumin.  The immunoassay 
was carried out using a standard ovalbumin ELISA, however colorimetric 
detection was replaced by PCR.  Additionally, three extra washes of the 
microtitre plate were carried out with distilled water in order to remove 
unbound antibody.  The amount of detection antibody used was varied as 
described above. 
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4.5 DETECTION OF BACILLUS CEREUS BY I-φ-PCR 
4.5.1 Introduction to Immuno-phage-PCR 
Immuno-PCR was demonstrated to offer increased sensitivity over ELISA (Section 
4.4.2) when performance was optimal and background signal was sufficiently low.  
However, the results also showed that the way in which DNA was bound to the 
detection antibody affected the sensitivity and reproducibility of the method.  
Therefore, an alternative approach was investigated, using single chain antibodies 
(scFv) in place of poly- or mono-clonal antibodies.  Single chain antibodies are 
produced by cloning and expressing the mRNA of a mouse immunised with an 
antigen of interest. They are expressed in E. coli cells as phage displayed particles, 
enabling the antibody to be presented to an antigen (Krebber et al., 1997).  The 
antibodies are usually purified using recombinant protein purification methods and 
would therefore be expected to carry a small quantity of contaminating DNA.  
However, the scFv used for this study were not purified extensively, simply being 
precipitated from the culture supernatant instead.  The aim of using scFv in immuno-
PCR was to eliminate the need for a separate DNA labelling reaction.  The approach 
is depicted in Figure 4.16. 
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Figure 4.16.  Summary of immuno-phage-PCR.  The Bacillus cereus spores were 
bound directly to the ELISA plate at 4 
o
C overnight.  The phage particles 
displaying B. cereus specific scFv were bound to the spores.  DNA was released 
from the phage particles by heating it to 100 ¡C for 30 secs; this was 
immediately amplified by real-time PCR on the Cepheidª Smartcycler. 
 
As scFv to ovalbumin or bacterial toxins were unavailable, a scFv to Bacillus cereus 
spores, designated CMAN8, was used instead.  CMAN8 was obtained as a cross 
reactant of antibodies developed for the detection of Bacillus anthracis spores.   
CMAN8 had previously been shown to work well in ELISA by colleagues at Dstl 
and was thought therefore suitable for conversion to an I-φ-PCR format.  Detection 
of a positive immunoassay result was obtained using a CMAN8 PCR assay specific 
for the DNA encoding the single chain antibody used in this experiment, as detailed 
in Table 4.2.  
 
 
     
  
Key: 
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4.5.2 PCR detection of spores 
 
A real time TaqMan¨ PCR assay was designed to target the enterotoxin (bceT) gene 
using Primer Express to identify suitable oligonucleotide sequences.  The PCR 
worked using standard PCR conditions (Table 4.2) once optimised with DNA from 
B. cereus NCTC 2566. The bceT gene is carried by only a few B. cereus strains, 
therefore, the specificity of the assay was determined by testing the B. cereus strains 
held at Dstl.  DNA from strains NCTC 11124, FRI 41, FRI 42, FRI 43 and FRI 13 
were all negative for the bce gene as expected, as was the standard Dstl test panel.  
The PCR assay was therefore demonstrated to be specific for enterotoxigenic B. 
cereus.     
 
Bacillus cereus spore samples were treated with 5 % sodium hypochlorite solution 
and then washed three times in distilled water in order to remove vegetative cell 
debris and extracellular DNA.  The detection limit of the PCR assay for the detection 
of the B. cereus enterotoxin gene was 10
6
 purified spores / ml (Figure 4.17).   
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Figure 4.17 - Detection limit of real-time bce PCR assay with Bacillus cereus 
spores.  PCR was carried out on a dilution series of B. cereus spores ranging 
from 10
7
 (positive control) to 10
2
 spores per ml using primers specific for the bce 
enterotoxin gene.   50 cycles of denaturation at 94 
o
C and annealing / elongation 
at 60 
o
C were carried out on the Cepheid SmartCycler¨.   
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4.5.3 Singleplex I-φ-PCR detection of spores 
Single chain antibodies were available in limited supplies as they were donated from 
a colleague in kindness, for proof-of-principle experiments.  They were an unwanted 
bi-product of an antibody generation programme, discovered to cross react with 
Bacillus cereus.  It was not possible to express large volumes of this antibody due to 
financial constraints, so pilot experiments were carried out with a view to carrying 
out further experiments if the method showed potential.  A preparation of phage 
particles was expressed in recombinant E. coli cells and precipitated in sodium 
chloride and PEG 8000.  It was hypothesised that a crude preparation would contain 
sufficient levels of contaminating DNA to facilitate immuno-PCR without the need 
for a DNA labelling step.  Spores were bound to an ELISA plate during an overnight 
incubation.  The plate was then washed, non-specific binding to the plate was 
prevented using 2 % milk powder solution in PBS and the plate was re-washed.  The 
crude single chain antibody preparation was subsequently added to the plate.  
Following incubation for one hour the plate was washed five times and then boiled 
briefly to release phage particles and their associated DNA. 
 
Initial results showed that the Immuno-Phage assay offered increased sensitivity over 
the bce PCR assay, with 10
4
 washed spores per ml being detected reliably using the 
lac gene as the immuno-PCR target (Figure 4.18).  However, the positive results (Ct 
19-23) were difficult to distinguish from negative results (Ct 24) as the lac gene is 
commonly found in M13 based cloning vectors, used routinely in the laboratory in 
which the immuno-PCR work was carried out.  In this case, laboratory 
contamination, together with the use of lac and bce internal control plasmids, 
comprising an M13 backbone, contributed to a high background signal.   
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The results shown in Figure 4.18 also indicate that the phage preparation worked best 
as a detection ligand when used undiluted (10
7
 transforming units per microlitre), as 
samples using diluted phage were indistinguishable from the background signal. 
Owing to the high background signal obtained using the lac PCR assay, the 10
7
 to 
10
0
 spore/ml samples detected using 10
7
 TU/ml of phage were also used in a 
singleplex PCR assay using scFv specific primers.  The melt curve analysis of PCR 
products showed that 10
5
 spores/ml were strongly detected, with 10
3 
spores/ml being 
the limit of detection (Figure 4.19).  Therefore I-φ-PCR was able to lower the limit of 
detection of B. cereus spores from 10
6
 washed spores/ml by PCR to 10
3
 spores/ml.   
 
The results obtained using the scFv assay were far superior to those obtained using 
the lac assay as it was not subject to a background signal.  I-φ-PCR was repeated one 
last time, using TaqMan
¨
 PCR.  The background was high on this occasion with a Ct 
value of 25.2, but was clearly different to the positive samples, demonstrating the 
potential for sensitive detection of spores using this technique.  When Ct values were 
plotted against spore concentration, the regression co-efficient was 0.9884, 
demonstrating a trend between the two variables (Figure 4.20).  Although high, the 
background signal was significantly different to those obtained using low spore 
concentrations, but was high.  The use of a sandwich immunoassay format and 
additional washes in water may reduce the background signal in further work, 
however it was not possible to test this theory within the confines of this study. 
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Figure 4.18 - Detection limit of B. cereus immuno-phage PCR.  Immuno-phage PCR was carried out using a range of B. 
cereus spore concentrations from 10
7
 to 10
0 
/ ml.  Phage concentration ranged from 10
7
 transforming units (TU)/ml to 10
5
 
TU/ml.  Positive amplification was observed using 10
7
 tu/ml only; using diluted phage  resulted in background amplification.  
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Figure 4.19 - Melt curve analysis of scFv PCR products   PCR of I-φ-PCR samples containing 107 to 103 spores/ml 
produced a specific product with a Tm of 90¡C.  Non specific products were also observed, with a Tm of 81 
o
C.   
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Spore concentration/ml 
 
Figure 4.20.  I-φ-PCR detection of B cereus spores.  The I-φ-PCR signal, 
measured as Crossing point value, is proportional to the spore concentration.  
The background signal of the assay is significantly different from the positive 
samples. 
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4.5.4 Quadruplex PCR of Bacillus cereus spores 
 
Quadruplex PCR was carried out for the detection of spores using four channels on 
the Cepheid¨ Smartcycler, as summarised in Table 4.5.    
 
Channel Target Gene 
1 Fam Bce (Bacillus cereus) 
2 Cy3 bce internal control 
3 Texas Red CMAN8 (scFv) 
4 Cy5 CMAN8 internal control 
 
Table 4.5.  Summary of the quadruplex PCR strategy used for detection of 
Bacillus cereus spores.  Channels 1 and 2 were used to detect the toxin gene 
directly and channel 3 and 4 were used simultaneously for immuno-phage-PCR. 
 
As it was not possible to repeat the I-φ-PCR due to the limited supply of phage the 
same samples used to produce the results shown in Figure 4.19 were used in 
quadruplex PCR.  The results in Figure 4.21 would ideally be a replicate of those 
obtained previously; however, the background was very high (Ct value 20.21).  The 
reason for this is thought to be a result of contamination between wells of the 96 well 
plate.  All other Ct values were slightly lower than in the duplex assay as a result of 
competition for reaction components, but the sensitivity of detection was not 
reduced.  This method demonstrates potential for sensitive detection of samples 
where genetic material is limited, such as washed spores or toxins.  In summary, 
Immuno-phage-PCR is considered to be a useful approach to toxin detection. 
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Figure 4.21.  Summary of cycle threshold values obtained from immuno-phage-
PCR detection of Bacillus cereus spores.  Detection of bce and scFv genes, plus 
their respective internal controls, was carried out using real time PCR.     
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4.6 IMMUNO-PCR USING ANTI-OVALBUMIN APTAMERS 
4.6.1 Introduction to SELEX 
Aptamers are short random DNA sequences that have a high affinity for specific 
antigens, developed using a process known as Selective Evolution of Ligands by 
Exponential Enrichment (SELEX).  The method is not widely used in comparison to 
methods using traditional ligands such as antibodies, however, aptamers have the 
advantage of being cheap to produce in vitro.  For that reason, they were chosen for 
investigation as part of this study. 
 
Aptamers can be RNA, double stranded or single stranded DNA.  RNA aptamers 
have the advantage of a higher degree of secondary structure compared to DNA, 
however RNA is inherently unstable and therefore more difficult to work with.  
Therefore, DNA aptamers were developed to ovalbumin using the method described 
by Bruno and Kiel (1999).   
 
4.6.2 SELEX results 
Ovalbumin was bound to Tosyl activated Dynabeads¨ in order to provide a suitable 
platform for washing and removal of unbound aptamer species.  A negative pre-
selection round of SELEX was carried out to eliminate aptamers with an affinity to 
the paramagnetic beads. The unbounds aptamers were amplified using PCR with 
aptamer specific primers (AP F and R; Section 2.9.1). The amplified aptamers were 
then used in the first SELEX experiment using ovalbumin immobilised on Tosyl 
Dynabeads¨.  The aptamer pool was incubated with the ovalbumin beads for an 
hour, unbound species were removed and aptamers with an affinity for ovalbumin 
were immobilised by magnetic separation.  The beads were washed to remove 
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residual species with low affinity for ovalbumin.  Anti-ovalbumin aptamers were 
eluted from the beads by boiling for thirty seconds and then amplified using aptamer 
PCR.    Sybr Green I was added to the aptamer real time PCR reactions in order to 
facilitate monitoring of the progress of the SELEX experiment overall.  The 
amplification cycle threshold value of the ovalbumin-specific round 1 aptamers was 
lower than that of the unbound species. This indicated that, as expected, the majority 
of the aptamer pool initially had poor affinity for ovalbumin.  However, it was 
assumed that the concentration of ovalbumin specific aptamers would increase with 
each round of selection, until finally the majority of the pool contained a majority of 
ovalbumin specific aptamers.  PCR analysis of samples taken during various stages 
of round 1 showed the presence of several species (Figure 4.22).  Bound and 
unbound species had the same melting temperature (87.5 
o
C).  Similar amplification 
products were obtained from each round. 
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Figure 4.2.2 Agarose gel electrophoresis of SELEX products.  Lane 1: Roche 
marker XIV (100 bp ladder), Lane 2: round 17 aptamers, Lane 3: negative 
control.  A 2 % (w/v) agarose gel was prepared with 0.25ng/ml ethidium 
bromide in 1 x TAE buffer.  The gel was electrophoresed for 30 minutes at 90 
volts.
500 bp 
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In total, 17 rounds of selection were performed, however, after 17 rounds the 
majority of the DNA in the pool was not bound to ovalbumin at the point of 
sampling.  At this point, the theory that bound species should be in excess to 
unbound species was re-examined.  It may have been a result of poor affinity to 
ovalbumin as previously thought, but more likely, it was an effect of the binding 
reaction kinetics.  Therefore, the round 17 pool was purified by microconcentration 
and then cloned into a pT7 blue TA cloning vector.  The recombinant plasmid was 
then transformed into competent E.coli JM109 cells, with 115 clones resulting from 
the experiment.  Real time PCR was used to screen clones for inserts using aptamer 
(AP F and R) primers.  In total, 90 positive clones were obtained (78 %) and 
screened.  The amplicons were concentrated and purified by microconcentration and 
then sequenced in both orientations at the Dstl sequencing.   
 
The first 32 sequences were aligned in SeqMan, in order to determine whether any of 
the sequences were duplicated.  Seven of the 32 sequences aligned to one contig, 
including the forward and reverse complement of clone 5.  All other contigs 
contained single sequences, affirming the dominance of clone 5 within the aptamer 
pool.  Clone 5 was therefore used in subsequent experiments.  The secondary 
structure was modelled using Gene Quest software.  Although the software models 
RNA rather than DNA, the degree of secondary structure is demonstrated in Figure 
4.23.   
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Figure 4.23 Predicted secondary structure of the dominant anti-ovalbumin 
aptamer (clone 5), as determined by Gene Quest software (Lasergene, 
DNAstar).  The clone 5 DNA sequence was imported into Gene Quest as RNA 
and folded using Vienna-RNA folding parameters of 37 
o
C, with the Ôspecially 
stable tetra loopsÕ and Ôuse dangling energiesÕ options selected. 
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4.6.3 ELONA 
The purified clone 5 aptamer was used in an ELISA-like assay termed Enzyme 
Linked OligoNucleotide Assay ELONA, (Drolet, 1996). The double stranded clone 5 
DNA was used as a capture ligand with 100 µg of ovabumin and 2.5 µg detection 
antibody.  Streptavidin-HRP was used to report aptamer binding, however, no signal 
was observed (A414=0.05, n = 84) following the addition of the ABTS substrate apart 
from in the control row which used ovalbumin antibodies  as the capture ligand 
(detection limit 0.1 ng/ml; A414= 0.128).  Immuno-PCR was also carried out with 
these samples.  Results were inconsistent, with cycle threshold values between 9 and 
15 being obtained arbitrarily.   
 
The clone 5 aptamer dsDNA pool did not function effectively as a capture ligand in 
the previous experiment, presumably as it had low affinity for ovalbumin in spite of 
17 rounds of evolution being carried out.  As affinity was expected to be higher an 
alternative use of the aptamer was evaluated.  In order for it to function as a detection 
ligand it was biotin labelled to facilitate enzymatic detection.  Labelled aptamers 
were produced by PCR using biotinylated AP F and AP R primers, followed by 
purification by microconcentration.  An Immulon 2 96 well plate was coated with 
ovalbumin ranging in concentration from 1 µg/ml to 0.1pg/ml.  The plate was then 
blocked in 2 % (w/v) skimmed milk powder, followed by the addition of clone 5 
aptamers, labelled either at the 5Õ, 3Õ or both ends.  Signal was generated by the 
addition of a streptavidin horseradish peroxidase enzyme conjugate, followed by the 
addition of ABTS substrate.  The control wells, utilising biotinylated antibodies 
rather than aptamers, gave an A414 signal of between 1.9 and 2.4 with an ovalbumin 
concentration of 1 µg/ml.  One well, the 5Õ and 3Õ labelled aptamer with 1 µg/ml of 
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ovalbumin, gave an A414 reading of 0.443.  However, this result was not reproduced 
when the experiment was repeated, indicating that the colour change was spurious.  
All other aptamer containing wells gave a reading similar to that of the background 
(0.05-0.07).  The false negative results obtained by using aptamers in place of 
antibodies also indicated the aptamers were not able to bind ovalbumin sufficiently.   
 
The same protocol was then followed using an initial ovalbumin concentration of 
100 µg/ml, but again no signal was generated by aptamer binding. 
 
The 96 well plates described in Section 4.6.3 were also subjected to PCR analysis, 
using the aptamer primers to amplify clone 5 DNA bound to the ovalbumin on the 
plate.  The results were non-specific, confirming the ELONA results.  This approach 
was also tried with unlabelled aptamers, in case steric hinderance was caused by the 
late introduction of the biotin molecule to the experiment.  Ovalbumin was added to 
the plate at a concentration ranging between 1 mg/ml and 0.1 fg/ml.  The aptamer 
was added at a concentration of 28 ng per well.  The results using unlabelled dsDNA 
aptamers were also non-specific and subject to a high background, with amplification 
occurring indiscriminately at a cycle threshold value of between 12 and 15 on the 
Corbett Rotorgene. 
 
4.6.4 Anti-ovalbumin aptamers as capture ligands 
A final investigation of the affinity of clone 5 aptamers for ovalbumin was 
undertaken, using them as capture ligands in an ELISA-type assay.  A 96 well 
Immulon 2 plate was coated with 200 ng of aptamer dsDNA in Reacti-Bindª DNA 
Coating Solution (Pierce, UK).  The plate was then blocked with 2 % (w/v) skimmed 
milk powder and ovalbumin was added at a concentration of 100 µg per well.  
Chapter 4 Immuno-PCR               
 207 
Colorimetric detection of antigen binding was carried out with the biotin labelled 
polyclonal antibodies used in I-PCR experiments.  Colour was observed throughout 
the whole plate, with an absorbance reading of 2, indicating that either blocking was 
insufficient or that the aptamer binds non-specifically to a component of the reaction.  
The aptamer concentration was reduced to 20 ng with the aim of reducing the 
background signal.  However, colour was observed throughout the plate again, with a 
reading of 0.2.  Diluting the aptamer concentration further simply reduced the 
absorbance reading proportionally, with 2 and 0.2 ng of aptamer giving readings of 
0.073, the same as the background signal.  These experiments therefore indicated that 
the aptamer had poor specificity for ovalbumin and the colour change was assumed 
to be a cross reaction with one of the immunoassay components.  To determine 
which reaction component the aptamers had affinity for, the assay was repeated with 
several extra controls.  The assay was carried out without the biotin labelled 
detection antibody, which should have given a negative result.  However, an 
aborbance reading of 1.9 was observed.  As streptavidin-HRP is very commonly 
used in immunoassays it was thought that the possibility of non-specific binding to 
ovalbumin or the plastic ELISA plate was unlikely. However, the plate had been 
treated with Reacti-Bindª which may have affected the protein binding properties 
of the plastic.  A second control experiment was carried out, eliminating the use of 
ovalbumin.  The absorbance reading was also 2, again suggesting that the 
streptavidin-HRP was binding to the aptamer or plate.  To discount the possibility of 
the aptamer having affinity for the plate a final set of experiments was carried out 
with varying concentrations of aptamer.  Eliminating the capture aptamer resulted in 
an absorbance reading of 0.3 which, at three times the normal background signal of 
0.07, would be falsely interpreted as positive.  Similarly, the use of a low aptamer 
concentration with varying ovalbumin concentrations resulted in a reading of 0.3.  
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Therefore excess background signal was caused by insufficient blocking.  As the 
absorbance reading was only high when the aptamer concentration was high, 
therefore it can be assumed that streptavidin-HRP was able to bind to the aptamer.  
The aptamer was therefore not considered suitable for ovalbumin detection in an 
assay using biotin and streptavidin and was not investigated further.  These results 
are summarised in Table 4.6.   
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Aptamer 
Concentration 
(ng) 
Ovalbumin 
Concentration 
(µg) 
A414 (mean) 
200 ng 100 2.12 (strong positive) 
20 100 0.236 (weak positive) 
2 100 0.073 (background) 
0.2 100 0.076 (background) 
Neat aptamers 
(200ng), no 
biotinylated 
antibody control 
100 1.91 (strong positive, 
demonstrating poor 
specificity of the aptamer) 
Neat aptamers 
(200ng) , no 
antigen control 
100 2.07 (strong positive, 
demonstrating poor 
specificity) 
No aptamer 
(H2O control) 
100 0.30 (weak positive/high 
background 
20 100 0.2-0.5 (weak positive/high 
background) 
20 10 0.2-0.5 (weak positive/high 
background) 
20 1 0.2-0.5 (weak positive/high 
background) 
20 0.1 0.2-0.5 (weak positive/high 
background) 
20 0 0.2-0.5 (weak positive/high 
background) 
Table 4.6 Summary of data obtained using an anti-ovalbumin aptamer as a 
capture ligand. 
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4.6.5 Immuno-PCR using ssDNA aptamers 
The experiments described previously were performed using double stranded DNA.  
It was unknown whether this would present a problem, since other researchers have 
found that single and double stranded DNA from the SELEX pool bind equally well 
to their targets (Bruno and Kiel 2002).  However, as SELEX experiments were 
performed with ssDNA, an experiment was performed to isolate either the sense or 
antisense strands for further use.  Biotin labelled aptamer-specific forward or reverse 
oligonucleotides were bound to Dynabeads Streptavidin as described in Section 2.7.  
The oligo coated beads were then used to capture their complementary strands from 
the heat denatured SELEX pool.  The removal of dsDNA from the pool was then 
verified using Sybr Green I agarose gel electrophoresis.  The single stranded DNA 
pools were further supplemented using asymmetric PCR. 
 
Immuno-PCR using ss-DNA aptamers was carried out as described in Section 4.6.3.  
Following incubation of the aptamers, the plate was washed three times in PBST, 
then three times in dH2O, soaking the wash for 1 minute each time to reconstitute as 
much free DNA as possible.  However, PCR samples taken at this stage were 
positive, indicating the presence of a large amount of unbound DNA.  A further three 
washes were performed, however PCR results were still indiscriminately positive, 
regardless of whether the sense or antisense aptamer was used.   
 
The SELEX experiments presented here were unsuccessful.  Agarose gel 
electrophoresis was performed on DNA samples taken from experiment rounds 1, 4, 
5, 6, 11 and 17 which showed the presence of smears in each lane.  This indicated 
that the diversity of the pool was high, indicating that the aptamer pool was not the 
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cause of the problem.  The failure of the aptamer to capture ovalbumin when used 
with Reacti-Bind¨ solution may have been caused by steric hinderance.  The 
possible cross reaction with streptavidin is likely to have contributed to the poor 
results observed when the aptamer was used as a detection ligand.  Similarly, the 
addition of biotin to the aptamer may have changed its structure, preventing it from 
binding effectively to ovalbumin.  The use of real time PCR in SELEX was intended 
to provide more information about the experiment, using changes in melting 
temperature and crossing point to indicate changes occurring within the pool.  
However, the use of Sybr Green I may have affected the binding of the aptamer to 
ovalbumin when ds-DNA was used.  With this in mind, a second SELEX experiment 
was carried out, this time using biotin labelled AP primers. 
 
4.6.6 SELEX to develop biotin labelled aptamers 
Tosyl activated beads were used as described in Bruno and Kiel (2002) to produce 
ovalbumin coated magnetic particles.  Briefly, the SELEX library (23 µg) was 
amplified by PCR as described in Section 2.9.1 using biotin labelled AP F and AP R 
primers.  A negative pre-selection round of SELEX was carried out to eliminate 
biotinylated aptamers that bound to Tosyl activated magnetic beads.  The unbound 
species were denatured and added to ovalbumin coated beads for 1 hour at room 
temperature on a rolling platform, and then washed three times in 1 ml of binding 
buffer.  The aptamer bound beads were then added directly to a 100 µl PCR reaction.  
The supernatant containing amplified biotinylated aptamers was recovered by 
magnetic bead separation in a Dynal MPC. The aptamers were then used in 5 rounds 
of SELEX.   
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The biotinylated aptamers produced following five rounds of SELEX were briefly 
tested in several immunoassays for the detection of ovalbumin.  Non-specific binding 
was observed when using the round 5 aptamer pool as a capture or detection ligand 
(data not shown).  It is thought that immobilisation of ovalbumin on paramagnetic 
beads may have influenced the selection process adversely, by reducing the number 
of binding sites available to the aptamers.  This is in contrast to the results reported 
by Bruno and Kiel (2002), who successfully used magnetic bead bound toxin to 
evolve aptamers for the detection of toxins.  Furthermore, they were able to amino-
modify the resulting aptamers without their binding efficacy being adversely 
affected.  However, in their work reported in since then (Fan et al., 2008), they note 
that the speed at which an experiment is carried out may have an effect on the 
specificity of the aptamer. 
4.7 DISCUSSION  
 
A number of immuno-PCR methods were developed for detecting toxin simulants.  
The simplest method involved converting an existing ELISA to I-PCR using biotin 
labelled DNA.  It was discovered that the method by which the biotin labelled DNA 
was bound to streptavidin affected the sensitivity and background signal of the assay 
significantly.  Binding streptavidin to an antibody-antigen sandwich, followed by 
addition of biotinylated DNA lead to high levels of non-specific binding.  It was 
thought that adding streptavidin and biotinylated DNA in succession favoured the 
formation of biotin labelled antibody-streptavidin complexes, leaving limited binding 
capacity for biotin labelled DNA molecules.  When biotinylated DNA and 
streptavidin molecules were pre-incubated together prior to their addition to the 
immunoassay, the results obtained were in line with those discussed in the open 
literature (including but not limited to Sano et al., 1992; McKie et al., 2002; Lind 
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and Kubista 2005; Babu et al., 2011).  Although the I-PCR format seemed inelegant 
compared to others used in this study, the labelled DNA was simple to synthesise and 
could be used in conjunction with any biotin labelled antibody.  This would facilitate 
the conversion of any ELISA to immuno-PCR with relative ease, meaning that the 
technique could be accessed by any laboratory when the extra sensitivity of I-PCR is 
required.  Therefore, I-PCR using biotin labelled DNA would be a useful toxin 
detection method for future experiments. 
 
Another simple I-PCR conversion was tested using neutravidin labelled amplicon.  
This was added directly to the biotin labelled secondary antibody and therefore did 
not increase the assay time compared to ELISA, in contrast to I-PCR using 
biotinylated DNA.  Although results obtained using this method were inconsistent 
compared to those obtained with the biotin labelled I-PCR system, the detection limit 
was comparable once the concentration of amplicon used was optimised at 100 
copies/µl.  It is thought that the optimal concentrations of biotin and neutravidin 
labelled DNA were different as a result of the method used to produce the labelled 
oligonucleotide primers.  Biotin-TEG oligonucleotides are simpler to produce in 
comparison to thiol modified molecules which must then be further treated to bind to 
neutravidin.  Both oligonucleotides were purified by HPLC, however the average 
concentration of neutravidin may have been low compared to the number of biotin 
molecules per oligonucleotide.  Therefore it is conceivable that, although the method 
used to bind the biotin labelled DNA to the antibody was crude, the DNA labelling 
method may have been more efficient.  Further work to reduce the non-specific 
binding could involve increasing the stringency of the wash steps, for example by 
using a higher concentration of Tween-20.  Alternatively, other non-ionic detergents 
such as Triton-X100 or Pluronic¨ could be used in future work. 
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It was thought that covalently linking DNA to antibodies may increase the sensitivity 
of I-PCR further, since the number of DNA molecules bound per antibody would be 
less variable than those exploiting the affinity of biotin for avidin.  The covalent 
conjugation of the amine modified DNA with the NHS ester allowed formation of 
amide bonds.  Furthermore, the number of components that could bind non-
specifically to the Immulon 2 plate was lower than with the other I-PCR methods 
tested.  However, the method used to produce the DNA conjugated antibodies was 
complex.  Furthermore, it was not possible to optimise the antibody labelling 
reaction since only one attempt could be made at Alchemy.  The assumption was 
made that one DNA molecule was bound to each antibody, however this may not 
have been the case.  The results obtained using this method were poor compared to 
the other I-PCR methods tested, with the detection limit on average remaining the 
same as with the ELISA or higher.  This was unexpected and contradicted 
observations made in the open literature at the time of this study (Hendrickson 1995, 
Lind and Kubista 2005, Niemeyer 2007).  It is thought that the high background was 
a consequence of being unable to optimise the reaction to the same degree as with the 
non-covalent methods of labelling.  Furthermore, some researchers are still opting to 
use the ÔcrudeÕ biotin labelled DNA I-PCR method (He et al., 2011).  Therefore, the 
assumption that directly labelling the antibody would be the quickest and most 
sensitive I-PCR method was incorrect.  If future I-PCR work were to be carried out 
as an extension of this study, the simplicity of the ÔcrudeÕ method would be 
exploited.   
 
I-φ-PCR was demonstrated to be successful for the detection of B. cereus, with the 
signal obtained from the negative control samples comparable to that obtained with 
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optimised I-PCR methods using biotin and neutravidin labelled antibodies described 
previously.  However, this method was advantageous since it eliminated the need for 
antibody labelling as single chain antibodies could be detected using a PCR reaction 
specific for the phage they were displayed on.  Since the DNA was packaged within 
phage the assay may have been less prone to non-specific binding of DNA. 
 
The sensitivity of the I-φ-PCR assay was not compared to the conventional 
immunoassay, since it was not a fully characterised antibody, being designed to 
target Bacillus anthracis rather than Bacillus cereus.  Instead the sensitivity of the I-
φ-PCR assay was compared to the spore PCR.  I-φ-PCR was demonstrated to be 
more sensitive than PCR with samples containing low concentrations of DNA.  This 
would make the method particularly suitable for detecting purified toxins.  It is 
possible that the method may be further improved by the use of single chain 
antibodies displayed on the surface of hyperphage, since the number of antibodies 
per hyperphage would be greater.  However it was not possible to test this within this 
study.  Phage display mediated I-PCR was also used successfully by Guo et al., 
(2006).  However, the method is not widely used as it is thought that single chain 
antibodies do not have the affinity for their target molecules that their parent 
monoclonal antibodies have.  Therefore, although the use of single chain antibodies 
is becoming more widespread, their use in I-PCR is unlikely to increase.     
 
The SELEX process used in this study was unable to produce aptamers suitable for 
use in ovalbumin detection assays, although the SELEX process itself had been, and 
continues to be used successfully by numerous research groups.  Most SELEX 
experiments use 5 to 10 cycles of selection.  17 rounds of selection were carried out 
in this study due to assumptions made incorrectly by monitoring the reaction by real 
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time PCR.  However, this is not thought to be the cause of the failed experiment.  
Sequence analysis of the round 17 pool showed that one species, clone 5, was 
represented more commonly, indicating that the SELEX experiment was successful.   
 
Steric hinderance caused by the use of Reacti-Bindª solution may have been a 
problem when using clone 5 as a capture ligand, as the method used to bind the DNA 
to the plate was proprietory.  It may have changed the conformation of the aptamer 
or bound the ovalbumin-binding site to the plate making it non-functional as a 
capture ligand.  Similarly, the ovalbumin immobilised on paramagnetic beads may 
have been presented to the aptamers in a different orientation on a 96 well plate. 
However, this effect has not been observed by other researchers including Bruno and 
Keil (2002), who successfully switched between magnetic bead and polystyrene 
supports. Magnetic beads are commonly used to immobilise antigens as they 
facilitate rapid removal of unbound aptamers and are used by numerous research 
groups.  The automated method developed by Famulok et al., (1996), using magnetic 
bead immobilised antigen and a robotic platform has been used commonly since then 
(Hunsicker et al., 2009).   
 
A lack of secondary structure of the DNA has also been ruled out.  Although RNA 
aptamers are commonly used, the decision to use DNA aptamers was taken due to 
the expense of stabilising the molecule to avoid nuclease degradation.  dsDNA was 
used in the SELEX experiments in this study, which is not common, however Fan et 
al., (2008) proposed that, once bound to their target, dsDNA aptamers are denatured, 
leaving ssDNA bound to the target.  Therefore, a lack of secondary structure is not 
thought to be the cause of the lack of affinity of the clone 5 aptamers for ovalbumin.  
It should be noted that some of the aptamers developed by Fan et al., (2008) 
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exhibited cross reactivity with other toxins.  When their experiment was repeated the 
same cross reaction was observed.  The reason for the failure of some of their 
experiments is unknown, but may be attributed to the speed at which the whole 
process was completed (10 hours).  The method in which SELEX is carried out may 
therefore be crucial to the success of the experiment.  The use of Sybr Green I, a 
DNA intercalater, may have prevented efficient binding to ovalbumin, therefore end-
point PCR should be used in future experiment, with samples being taken for real 
time ÐPCR analysis if required. 
 
The cross-reaction of clone 5 with streptavidin-HRP is interesting.  The control 
experiments summarised in Table 4.3 showed that the aptamer did not bind 
indiscriminately to the ELISA plate or reaction components, with the exception of 
streptavidin-HRP.  Ovalbumin and avidin are both present in hen egg white, so it 
seems possible that the ovalbumin purchased from Sigma (type III; 90 % purity) also 
contained avidin.   It is possible that failure of the SELEX experiment could partly be 
attributed to the evolution of aptamers to egg white rather than ovalbumin 
specifically.  However, immuno-PCR using an anti-ovalbumin capture antibody with 
clone 5 as the detection ligand also resulted in false positive results, despite the lack 
of streptavidin.  This indicates that the aptamers generally had poor specificity for 
ovalbumin and they were not suitable for further use.    
 
Other research groups have recently published papers describing immuno-PCR 
strategies using aptamers which indicates that the method has potential for sensitive 
detection of proteins despite the results presented here (Yoshida et al., 2009; Pinto et 
al., 2009).  Ding et al., (2009) showed that the length of the aptamer is important to 
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the success of the experiment and had the most success with a 93 bp aptamer.  The 
aptamers used in this study were of a similar length, at 96 bp.   
 
Further SELEX experiments should be performed with a different antigen; however 
this was not possible within the funding constraints of this study. Furthermore, the 
new library could be biotin labelled, in order to ensure steric hinderance is not caused 
by the addition of a label once the aptamer has been evolved. The use of a competitor 
protein must also be considered to improve the specificity of aptamers introduced to 
the experiment.  The most vital lesson to be learnt from this study however, is that 
the purity of the antigen is crucial to the success of the experiment.   
  
The data presented here demonstrated that a fully optimised immuno-PCR assay can 
offer a significant increase in sensitivity of detection compared to ELISA, although it 
should be noted that the method used to DNA label antibodies is crucial to the 
success of the assay.  This may not be necessary for routine use in most laboratories, 
particularly as there are increased reagent costs and assay time.  However, immuno-
PCR offers an advantage over ELISA for detection of samples containing low 
concentrations of protein, such as toxin.  Additionally, I-PCR was also able to detect 
samples where PCR failed due to the low concentration of DNA in the sample.  This 
is particularly important in samples that may have been extensively treated, such as 
purified toxins, which evade PCR detection.  In conclusion, I-PCR is considered to 
be a useful approach for detecting biological toxins. 
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5  GENETIC DIFFERENTIATION OF R. COMMUNIS  
5.1   INTRODUCTION 
The results presented in Chapter Three showed that PCR was not a reliable method 
of toxin detection if contaminating DNA was present in low quantities, therefore it is 
not recommended that it be used routinely.  Conversely, if DNA was present in 
sufficient quantity such as in culture, plant material or crude toxin preparation 
samples, PCR could be used to successfully infer the presence of toxin. Therefore 
PCR is considered a useful approach to toxin detection in specific situations.  A 
positive result obtained by PCR could be a starting point for a researcher to perform 
further analyses with the aim of determining the origin of the causative agent. The 
use of PCR as a strain differentiation method is well described for bacterial and plant 
species and has been used routinely for many years.  More relevant to this study, it 
has also been used for typing toxin DNA, for example Macdonald et al., (2008) used 
variable number tandem repeat (VNTR) analysis to differentiate between species of 
Clostridium botulinum A using contaminating DNA in crude toxin preparations.  
However, at the time of starting the research for this thesis, similar methods for the 
differentiation of Ricinus communis strains had been unsuccessful as it is assumed to 
have low genetic diversity, making differentiation problematic (Allan et al., 2008).  
Numerous techniques exist for genetic typing of plants, for example those based on 
hypervariability of satellite DNA within the genome.  Those chosen to complement 
the research carried out by other groups are summarised in Table 5.1. However, the 
main emphasis of this Chapter was to evaluate the potential of rapid pyrosequencing, 
specifically 454ª as a single nucleotide polymorphism (SNP) discovery tool 
(Barbazuk 2007; Sugarbaker  2008; Vera et al., 2008).   
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Table 5.1.  Nucleic acid methods chosen for differentiation of R. communis 
cultivars. 
 
Name Acronym Description 
Roche 454ª Sequencing 454 High-throughput, rapid 
 pyrosequencing with long reads (>400 
bp).  
Random amplified 
polymorphic DNA 
RAPD Amplification of genomic DNA using 
a random sequence 10 bp primer. 
Restriction fragment 
length polymorphism 
RFLP Restriction enzyme digestion of 
genomic DNA which is agarose gel 
electrophoresed to produce a DNA 
fingerprint. 
Amplified fragment length 
polymorphism 
AFLP As RFLP, however digested fragments 
are ligated to specific primers and then 
amplified by PCR. 
Simple sequence repeat SSR Short regions of repeated sequence 
consisting of 2 or more nucleotides.  
Also known as microsatellites, they 
are easily detected and quantified by 
PCR. 
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5.1.1  454 sequencingª 
The genome of R. communis Hale strain was Sanger sequenced by the J. Craig 
Venter Institute (JCVI) in 2008.  Using a whole genome shotgun strategy, Chan et 
al., (2008) achieved a four-fold coverage of the R. communis genome. This was 
assembled and annotated using multiple gene prediction programs and alignments 
derived from 50,000 expressed sequence tags along with cDNA and protein 
sequences. The genome assembly is publicly available (http://castorbean.jcvi.org) as 
are the Expressed Sequence Tags (ESTs) (http://plantta.jcvi.org). These data could be 
useful to help devise PCR primers specific to R. communis for the genetic 
differentiation between cultivars: regions of repeat sequence, for example, can be 
found de novo using repeat search programmes. However, previous attempts to 
differentiate between cultivars have been unsuccessful using such methods (Allen et 
al., 2008), presumably due to the lack of genetic diversity amongst crops.   SNP 
discovery by high-throughput sequencing has been reported for species other than R. 
communis (Barbuzuk 2007).  The method is ideal for rapid genome annotation and 
analysis and is capable of producing mega-, if not giga-bases of sequence per 
experiment. High-throughput sequence analysis of the R. communis genome was 
previously unstudied; therefore the method was investigated as part of this study. 
 
5.1.2 Aims 
The aim of this part of the study was to evaluate the potential of 454 Sequencingª 
for identification of regions of genetic variability within the R. communis genome.  
For simplicity, the software supplied with the 454 Sequencerª was investigated as a 
SNP discovery method, as the Roche De novo Assembler and Reference Mapper 
software provided are reportedly suitable for this application.   The secondary aim 
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was to investigate more traditional genetic approaches for differentiating between 
cultivars for comparison. 
 
5.2 SNP DISCOVERY BY 454 SEQUENCINGª 
5.2.1 R. communis Library Preparation 
In order for the R. communis genome to be sequenced it was necessary to extract 
high quality DNA from plant material.  The MoBio Powerplantª kit was used 
successfully to extract 5 µg of DNA. DNA was quantified using the Nanodrop¨ 
spectrophotometer and the Qubit fluorimeter as the concentration used for library 
preparation had been finely optimised by Roche.   The library was then prepared 
using the method described in detail in Section 2.11.  Briefly, the genomic DNA was 
sheared by nebulisation and then purified on a silica column.  The eluted DNA was 
size separated, ligated to sequencing adapters and then analysed on a high resolution 
gel matrix to confirm that it had been sheared to the optimal fragment size for 
sequencing.  The library was quantified once more to ensure that a titration could be 
carried out to determine the number of copies of DNA per sequencing bead that 
would give optimal enrichment.  A small volume emulsion PCR was then carried out 
using 2, 4, 8 and 16 copies per bead.  The PCR reactions were recovered by 
aspiration and washed in isopropanol and ethanol.  Beads carrying the DNA library 
were annealed to an enrichment primer-bound magnetic particle and then quantified.  
The enrichment results should show a correlation to the number of copies of DNA 
per bead.  This was not the case.  Therefore a second small volume emulsion PCR 
was repeated.  The results of the second experiment were also not as expected, with 
the percentage enrichment for 1 copy per bead, at 14 % (Table 5.2), being excessive 
according to the guidance issued by Roche.  It should be noted, however, that since 
the conclusion of this study, Roche have issued new guidance stating that enrichment 
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values of up to 20 % are likely to give high quality sequence output.   It is very 
important to titrate the number of copies of DNA per bead as too few would lead to 
empty picotitre plate wells and too many would cause mixed sequence reads, 
however, in the absence of useful emPCR titration results, 4 copies per bead were 
chosen for conducting a large volume PCR in consultation with Roche technical 
support.  The results are shown in Table 5.2.   
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Table 5.2.  Library preparation results for R. communis strains Jianxiang and 
Zibo 1 using 454ª Sequencing emulsion PCR.  Jianxiang emPCR results for 
regions 1 and 2 are shown in grey and white respectively. 
 
Copies 
per bead 
 Percentage Enrichment (small or large volume emulsion 
PCR) 
Jianxiang SV Jianxiang LV Zibo 1 LV 
1 5.46 14.76   
2 4.16 7.5   
4 3.5 10.78 4 2.2 3.2 3.8 1.8 1.3  
8 6.29 6.1   
16    2 1.7 
32    7.1 3.3 
Chapter 5 Genetic Differentiation   
 225 
 
5.2.2 De novo assembly and SNP analysis 
In total 179 megabases of sequence were obtained from one Jianxiang LV emPCR.  
The second and third emPCR reactions did not produce sufficient DNA to run on the 
sequencer (data not shown).  It is thought that the DNA extracted from plants grown 
overseas degraded during shipping as a result of nuclease release, as it was also 
unsuitable for production of PCR amplicons over 500 basepairs. Therefore, a second 
shotgun library was prepared using existing Zibo 1 genomic DNA using updated 
Phase C Chemistry released by Roche.  Both the small and large emPCR kits were 
improved to include 4, 8, 16 or 32 copies per bead.  The small volume PCR 
enrichment results did not follow a trend; therefore the data was not used to define 
the DNA concentration required in the large volume experiments.  For that reason, 
the large volume PCR was carried out using different DNA concentrations, resulting 
in 2 % and 7.1 % enrichment for 16 and 32 copies per bead respectively (Table 5.2).  
The DNA from this reaction was loaded onto the sequencer, yielding 146 Mb of Zibo 
1 sequence which was subsequently analysed using the Roche GS De Novo 
Assembler.  Although this level of coverage would not be sufficient to produce 
reliable genome sequence for complete annotation, the amount of data produced was 
suitable for discovery of a number of high confidence differences with 20 times 
coverage using the GS Reference Mapper software.  Accordingly, SNPs with a 
minimum of 20 times coverage of Jianxiang sequence were investigated further.    
However, the contigs containing putative SNPs did not align with 100 % homology, 
due to ambiguous base calling (N).  Therefore, these SNPs were not investigated 
further. 
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In the same way 37 high confidence differences were identified by the GS Reference 
Mapper software using Zibo 1 DNA.  The six most useful SNPs, in terms of depth of 
coverage and homology amongst Zibo 1 contigs, are summarised in Table 5.3.   
BLAST analysis was carried out using the sequence from each contig (Table 5.3).  
Four out of six SNPs had homology to conserved hypothetical proteins encoded by 
mitochondrial DNA.  One SNP was identified within 26S rRNA sequence, another 
SNP-rich target commonly used in genotyping studies.  A further SNP was identified 
in a retrotransposon carried within the R. communis genome.   
 
In order to validate and determine whether the SNPs were present in other R. 
communis cultivars it was necessary to perform further sequence analysis.  The 
sequences flanking the SNPs detailed in Table 5.3 were exported to the Biotage 
Pyrosequencingª Assay Design Software (Qiagen, UK).  This software facilitates 
the design of PCR assays that flank the SNP, plus a sequencing primer located 
upstream of the SNP site.  The output of the assay design software is summarised in 
Table 5.4.   
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Table 5.3 Location of SNPs identified by the Roche GS reference mapper 
software in Zibo cultivars. 
Hale strain 
accession 
number 
Hale SNP  Depth Zibo 1 
Contig  
SNP  Zibo or 
Jianxia
ng SNP 
BLAST  
nucleotide  
results 
53166 1857 84 154654 GTTA
AA 
deletio
n 
1332 Ricinus communis 
conserved hypothetical 
protein, mRNA; accession 
numbers 
gi|255591121|XM_0025353
95.1 and 
gi|255581851|XM_0025316
80.1 (100% identity).  Other 
matches to mitochondrial 
genes. 
38467 1487 70 19819 G>T 1115 Ricinus communis 
conserved hypothetical 
protein, mRNA;  
gi|255560297|XM_0025211
20.1 84% identity.  
Mitochondrial gene. 
30056 948913 84 03509 C>T 588 Ricinus communis 
retrotransposon RC-Tekay, 
complete sequence; 75% 
identity GQ294573.1;  
Ricinus communis 
conserved hypothetical 
protein, mRNA 
XM_002533692.1 85% 
identity 
27949 34984 66 60110 T>G 551 Euphorbia polychroma and 
other species 26S ribosomal 
RNA gene, complete 
sequence is the best hit, no 
R. communis sequences 
were matched.   
29016 32575 60 122881 A>C 2040 Ricinus communis 
conserved hypothetical 
protein, mRNA;  
gi|255582548|XM_0025320
12.1; (12 similar loci 
identified in total, all JCVI 
annotations)   
51309 3404 54 63875 A>C 3061 R. communis conserved 
hypothetical protein (JCVI 
annotation), 
gi|255589077|XM_0025347
79.1 
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Table 5.4 Small amplicon sequencing assays designed using Biotage 
Pyrosequencingª Assay Design Software for six SNPs identified by 454ª 
sequencing. 
Jianxiang 
or Zibo 
contig 
number 
Sequence (5Õ-3Õ) Forward primer 
sequence (5Õ-3Õ) 
Reverse primer 
sequence (5Õ-3Õ; 5Õ 
biotin labelled)  
Sequencing primer 
(5Õ-3Õ); biotin 
labelled 
154654 TAAGGAAGGA
GGGACGAAGA
GGAACGACCA
AAACAAAAGA
GGGATCAGAC
CCCCT 
GGCAAGAACGCC
TTATTACAACT 
TGCCTAAAGGGG
GTCTGATCC 
CTTTCCCTAATA
CATTAAAT 
19819 GGGGATTTGG
ATCAGGCTGC
TGTTGTTGAA
CTAGG 
GTCCGTCAATTCC
GAAAATG 
TGGGAGAGGTAG
CCGAATTAG 
CGTCATGCTGG
AGCG 
03509 GACATTAAGA
ATTGGCGTAA
AGAATCATGG
GAATATAATT
AACAAGCTTG
ACCGG 
TGCACCATTAGGT
TCTACATCATT 
TAAGTCACGCCCT
AATGCTACC 
GCATGAGGACT
CTTGAT 
60110 CTCGTGTGGA
ACAAAAGGGT
AAAAGCTCGT 
TTGATTCTGAT
TTCCAGTACG
AATA 
ACATTGTCAGGTG
GGGAGTT 
CACGCTTTCACGG
TTCGTAT 
CTCAACGAGAA
CAGAAAT 
122881 AGCCTACCAT
AAGACTGACA
ATAAAGTCCC 
AGGCGCACCT
GAAGAGTTCT
AACTA 
GCCCTGTTTTCCA
TACGGAGATC 
CCCTTGCTTTTCG
CCACAT 
TCATGAAAGAT
TGTTGGT 
63875 CTGGTCCATT
CTGGATTTTG
GATGACCGGT
TCTTTGTCGG
AGTTCCCGGT
AGATCTG 
TCGACAGCCAGG
AGACCTC 
CCTACTGAGCTTG
GGCTGGTAA 
GCCTCAGGTGCT
GAA 
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5.2.3 SNP validation by targeted pyrosequencing (PyroMark)  
The six putative SNPs were investigated further using targeted pyrosequencing.  
Briefly, PCR amplicons were produced and purified using a Promega Wizard¨ SV 
PCR clean-up kit.  Biotinylated PCR amplicons were then immobilised onto 
streptavidin-coated magnetic beads and denatured to produce single-stranded DNA 
by using the PSQ 96 sample prep tool supplied with the sequencer.  The sequencing 
primers were hybridised to the single stranded products and then sequencing was 
performed according to the PyroMarkª instructions.  The dispensation order of 
nucleotides was calculated by the instrumentation when the sequence to be analysed 
was entered, thereby allowing identification of the SNP.    Four strains were analysed 
using the method.  Initially all of the sequences were aligned in Megalign (Figure 
5.1), with the aim of verifying that the sequences from each row of the plate aligned 
with each other as expected.  Separate phylogenetic trees were subsequently 
produced for each Hale contig number studied.  The results for Hale references 
53166 (Figure 5.2) and 29016 (Figure 5.4) were as expected, with sequence being 
read immediately downstream from the sequencing primer.   
 
The sequence around the SNP site for contig 53166 showed that the predicted 
deletion was present only in Zibo 1 and downstream sequence varied between all 
four strains, hence the decision to present the complete alignment rather than 
highlight the putative SNP data.  This SNP locus and surrounding sequence may 
prove to be useful for generating data to facilitate differentiation in future.  However, 
other cultivars should be examined in further work.   
 
The SNP identified in contig 29016 was carried by two of the cultivars examined, 
with the other two cultivars having the same sequence as the reference Hale strain.  
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Accordingly, the locus may serve to aid differentiation of cultivars in conjunction 
with other loci. 
 
One sequencing reaction failed to yield a product (30056).  The sequences shown in 
Figure 5.3,  Figure 5.5 and Figure 5.6 should have been from homologues of contigs 
38467, 27949 and 51309 respectively.  However, extensive analysis of the PyroMark 
data using BLASTN at Pubmed and the castor bean genome assembly at JCVI, plus 
alignment of the parent contigs in Seqman and Megalign could not match the data to 
any known sequence. It is noteworthy however that the original 454 data (Table 5.3) 
showed only 85 % identity to the nearest match in the BLASTN database for 38467 
and 30056.  The Zibo 1 sequence with homology to Hale contig 27949 showed no 
identity to known R. communis sequence, with the nearest match being Euphorbia 
26S rRNA.  Contig 30056 showed homology to a retrotransposon found within the R. 
communis genome.  It is a possibility that this sequence is highly unstable and may 
not be found within the strains used in this study, explaining the failure of the primer 
set specific to contig 30056 to produce a sequencing amplicon.  The alignment in 
Figure 5.5 shows that numerous unexpected homopolymer stretches were yielded.  
These may be genuine as the stretches are short, however, is a known error 
associated with pyrosequencing (Oliver et al., 2011).  The relationship between the 
fluorescence and number of bases when called by pyrosequencing is generally only 
linear up to 10 identical nucleotides (Gong et al., 2010).  Although it was not 
possible to validate four of the SNP assays during this study, they should not be 
excluded from further study.   In general, the pyrosequencing reactions generated 
useful data which serve as an interesting starting point from which to base further 
differentiation assays, however extensive further work would be required to validate 
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the data generated by 454 Sequencingª, possibly using a germplasm database.  
Accordingly, more traditional genotyping methods were examined. 
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Figure 5.1.  Phylogenetic tree illustrating the relationship between each SNP 
assay.  Sequences obtained from 6 targeted pyrosequencing assays were aligned 
in Megalign using Clustal W.  Dotted lines represent a distant relationship 
whereas solid lines denote a close relationship between two species. 
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Figure 5.2. Biotage generated sequence alignment and dendrogram aligned to 
Hale reference contig 53166 for four cultivars of R. communis, generated using 
Clustal W (DNAstar, US).  A putative deletion is underlined in red and shown 
above at position 1331 to 1332 (GAACGACCAAAACAAAAGAG).   
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Figure 5.3. Biotage generated sequence data alignment and dendrogram for 
four cultivars of R. communis.  
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Figure 5.4 Biotage generated sequence alignment and dendrogram around the 
SNP (2063 A>C) site in Hale reference contig 29016 (Zibo 1 122885) for four 
cultivars of R. communis.  
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Figure 5.5. Biotage generated sequence alignment and dendrogram for four 
cultivars of R. communis.   
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Figure 5.6. Biotage generated sequence alignment and dendrogram for Hale 
reference contig 27949 for four cultivars of R. communis.   
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5.3 ALTERNATIVE APPROACHES 
The sequence analysis showed that 0.85 X coverage interrogation of a genome was 
not suitable for the discovery of unique SNPs in Ricinus communis, although its 
utility has been demonstrated with other genomes (Vera et al., 2008; Oliver et al., 
2011) with greater coverage.  It would have been desirable to continue preparing 
samples for sequencing using emulsion PCR.  However, this was not possible as the 
sequencing chemistry was only updated and used successfully very close to the end 
of this study (Roche alert number AA0110PAN GS Titanium 12/3/10).  At the time 
of this study 454 Sequencingª was an emerging technology and a new capability to 
Dstl, therefore it was designated as high risk.  Accordingly, a more traditional 
approach was developed for comparison to the 454 SNP data.   
 
A review of the literature confirmed that there was no single genetic locus that would 
enable genotyping of R. communis plants.  However, several research groups had 
initiated genotyping studies.  Allen et al., (2008) assessed the genetic diversity of 41 
castor bean germplasm accessions using AFLP and simple sequence repeats (SSRs).  
Three AFLP primer sets were used which identified 43 polymorphisms overall. 
However, no banding patterns revealed cultivar specific markers.  Similarly, SSR 
was able to identify several polymorphic loci but unable to differentiate between 
cultivars within their germplasm database.  O'Connell et al., (2006) sequenced the 
preproricin genes from 63 cultivars and found 14.4% variability across 1262 bases.  
Hinckley (2006) used 25 primer sets to investigate a number of loci commonly used 
for plant genotyping, including trn, rpo, and psb, however none were able to 
distinguish between cultivars.   With this in mind, several alternative approaches 
were evaluated. 
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5.3.1 Random Amplified Polymorphic DNA (RAPD) 
Six commercially available RAPD primer sequences were obtained from Eurofins 
MWG Operon (Germany) (OPAA1, OPAB5, OPT05, OPAB18, OPAA10 and 
OPAA20; Section 2.10.1).   The primers were demonstrated to work effectively, 
however none of the six primers was able to produce distinctively different 
fingerprints with the R. communis DNA samples tested (Figure 5.7).  Although 
RAPD is well regarded as a tool for producing DNA fingerprints, the limited number 
of RAPD primers evaluated in this study were not suitable for this purpose with R. 
communis DNA, again suggesting its genetic diversity is low. 
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Figure 5.7 RAPD PCR of R. communis cultivars using primer OPC-10 resolved 
on a 2 % agarose E-gel (invitrogen) run for 30 minutes on an E-gel iBaseª 
(Invitrogen). Lanes 2 and 11: 100 bp molecular weight marker; lane 3, Shang 
Dong 108; Lane 4, Jin Castor 2; Lane 5, Black Diamond; Lane 6, Sanguinis; 
Lane 7, Kunming 202; Lane 8, Zanzibar; Lane 9, Zibimas; Lane 10, Zibo 1. 
500 bp 
1000 bp 
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5.3.2 Restriction Fragment Length Polymorphism (RFLP) analysis 
A new rca assay was designed in order to obtain the larger amplicon required for 
RFLP, in comparison to the rca assay used for toxin detection in Chapter 3.  
Amplification was achieved using primers R1 F and R2 R which produced the 
expected 1.6 kb fragment (Section 2.10.2). It is of note that some of the cultivars 
gave rise to a pair of bands around 1.6 kb (data not shown).  This was previously 
reported by OÕConnell et al., (2006) who attributed the doublet to truncated versions 
of the preproricin gene occurring in the genome of some cultivars along with the full 
length gene. The genome of R. communis is either haploid, diploid or tetraploid 
(Timko et al., 1980), therefore multiple bands may be expected.  Although the plants 
were assumed to be diploid, the ploidy of the samples in question is unknown.   
 
Single digests of R. communis DNA were performed with BstNI, HaeIII and TaqI. 
Double digests were carried out with HaeIII and TaqI and also EcoRI and HindIII. 
For all enzymes there were fewer restriction sites in the EST fragment than there 
were in the rca gene fragment. As Figure 5.8 demonstrates, even with just six ricin 
cultivars and using a double digest with two frequent cutter enzymes, only two 
finger-print patterns were produced. This illustrates the lack of differentiation 
achieved by this technique.  Similarly, a double digest with EcoRI and HindIII 
(Figure 5.9) did not adequately differentiate between cultivars. 
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Figure 5.8.  RFLP analysis of a 1.6 kb fragment of the rca gene of R. communis 
cultivars. The DNA was cut with HaeIII and TaqI and resolved on a 2% agarose 
E-gel (Invitrogen), run for 30 minutes on an E-gel iBaseª (Invitrogen). Lane 2, 
Shang Dong 108; Lane 3, Jin Castor 2; Lane 4, Sanguinis; Lane 5, Zanzibar; 
Lane 6, Zibimas; Lane 7, Zibo 1; Lane 8, HaeIII and TaqI digest of molecular 
weight marker XIV (Roche; enzyme control); Lane 9, uncut molecular weight 
marker XIV (Roche); Lane 10, 100 bp marker. 
 
1000  
 
bp 
500 bp 
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Figure 5.9.  RFLP analysis of a 1.6 kb fragment of the preproricin gene of R. 
communis cultivars. The DNA was cut with EcoRI and HindIII and resolved on 
a 2 % agarose E-gel for 30 minutes. Lane 3, Shang Dong 108; Lane 4, Jin Castor 
2; Lane 5, Sanguinis; Lane 6, Zanzibar; Lane 7, Zibimas; Lane 8,  Zibo 1; Lane 
9, Molecular weight marker III (Roche). 
1584 bp 
937 
bp 
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5.3.3 Simple Sequence Repeat (SSR) analysis 
Two previous publications have used SSR primers successfully for genomic analysis 
of ricin (Allan, et al., 2008; Gedil et al., 2009).  Allan et al., (2008) used 9 
microsatellite primer sets, however neither published the amplification conditions 
nor the sequences of the primers used. The six SSR primer pairs used in this work 
(Table 5.4) were obtained by searching the castor bean genome using the publicly 
available FASTA Simple Sequence Repeat finder software 
 http://espressosoftware.com/sputnik/index.html  (Jewell et al., 2006). 
 
The SSRs primers were combined into two sets of three primers in order to make the 
finger-printing process more rapid and cost-effective: Primer set A (SSR26, SSR40 
and SSR47) and Primer set B (SSR52, SSR61 and SSR189).  The thermal cycling 
profiles for the triplex reactions are shown in Table 5.5. 
 
Each reaction was demonstrated to work well with a variety of DNA samples, 
demonstrated by the presence of numerous amplicon bands on an agarose gel (not 
shown).  In order to discriminate between the number of repeats it was necessary to 
finely separate amplicons by size using a PAGE gel.  Amplicon volumes were 
reduced to 10 µl by microconcentration. The gels were electrophoresed in 1x Tris 
Borate EDTA (TBE) buffer, stained in ethidium bromide and de-stained in dH2O 
(Figure 5.10).  
 
Cluster analysis was carried out using the Uviband Map software included with the 
gel documentation apparatus used for this study (UVTec, UK.) with each of the band 
sets normalised. The Jaccard coefficient method was used to identify the presence or 
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absence of bands, creating a binary profile. The Unweighted Pair Group Method with 
Arithmetic Mean (UPGMA) algorithm was used to create a phenetic dendrogram 
(Figure 5.11).  There was sufficient discriminatory power using just one set of 
primers to differentiate between all of the cultivars tested.   
 
All of the Zibo cultivars clustered together using the UPGMA analysis.  
Furthermore, Shang Dong 108 is the closest relative to the Zibo cluster. It would 
seem to be more than a coincidence that Zibo is a city in Shang Dong province, in 
the PeopleÕs Republic of China. Presumably the clustering of these cultivars from 
one Chinese region reflects some genetic commonality, reflected in this analysis. It 
must be recognised, however, that the UPGMA analysis presented here is based on 
phenotypic differences, which cannot be used to determine genetic divergence.  
Nevertheless, Figure 5.7 serves as an example of the data handling that is possible 
from the SSR analysis.  
 
Chapter 5 Genetic Differentiation   
 246 
 
 
Locus Repeat Type Primer sequence (5Õ-3Õ) 
SSR26 GA Forward: TGCTAATTGCAGGAAATAGGAT 
Reverse: GCAGCTTTTTAGCATAACAATCAA 
SSR40 GA Forward: TGCATCATGGTCCACTCACT 
Reverse: CATTCTTTTCGGCATTCCAT 
SSR47 CA Forward: GGAGCACCTTTTGCTGAGTT 
Reverse: TTGGAACAAAGCAGCATCAC 
SSR52 GT Forward: GCCAGCAAGGTTTGCTACAT 
Reverse: AACTGTCAAACCATTCTACTTGC 
SSR61 CA Forward: GGCTGCTTTACCTTCTACTCAGA 
Reverse: CAAGAACGCCAATATGCTGA 
SSR189 TTTTA(2)TTA 
(3)TTTTA 
Forward: GATGACTGGTCTCAAGTGGTGA  
Reverse: AAGAAGAGCTCCTCCTGCAA  
Table 5.4. Genetic location, repeated nucleotides and primer sequences used to 
amplify the SSRs used in this study.  
 
Temperature Duration Number 
of cycles 
94 
o
C 2 min  
94
 o
C 30 seconds  
35 
cycles 
51
 o
C (Primer set A) 
53
 o
C (Primer set B) 
30 seconds 
72 
o
C 30 seconds 
72
 o
C 5 min  
Table 5.5 Thermal cycling conditions for the two triplex reactions used to 
amplify the selected SSR loci. 
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         1           2           3          4          5         6           7          8          9          10  
 
 
Figure 5.10. SSR amplification of R. communis cultivar DNA using primer Set A 
resolved on a 6% polyacrylamide gel.  Lane 1, 100 bp marker; Lane 2, Zanzibar 
Kenya; Lane 3, Zibo 305; Lane 4, Zibo 1; Lane 5, Zibo 101; Lane 6, Zibo 108; 
Lane 7, Zibo 2; Lane 8, Shang Dong 108; Lane 9, 50bp marker; Lane 10, 
Kungming 202.  
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Figure 5.1Error! No text of specified style in document..6  Cluster analysis of SSR 
data by UPGMA, generated using UVIBand Map software (Uvitec, UK) to 
analyse PAGE gel banding patterns produced with SSR primers.  
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5.4 DISCUSSION 
The data resulting from 454ª sequencing reactions were suitable for identification 
of SNPs when compared to the R. communis Hale reference genome assembly.  Six 
SNPs were chosen for further study using targeted sequencing, of which only two 
yielded sequence with homology to the Hale reference.  Un-attributable sequence 
was obtained from three SNP assays, as analysed by BLASTN searches of the 
Pubmed nucleotide and castor bean whole genome assembly.  The additional 
polymorphisms observed when comparison was made to Hale reference contigs 
51366 and 122885 may be genuine and could be confirmed by additional targeted re-
sequencing of the same and alternative cultivar DNA samples.  However, they may 
be a result of sequencing or PCR aberrations.  The SNP results derived from 
reference contigs 51309, 38467 and 27948 were attributed to sequencing error, as 
they had no identity to the reference Hale strain.  Each of the six SNPs investigated 
by targeted pyrosequencing was obtained using a 454 read depth of 20 times, which 
should be ample for identification of genuine SNPs.  This is far greater coverage than 
used by Oliver et al., (2011) and Foster et al., (2010) however their interrogation 
approach was entirely different to that used in this study.  Foster et al., (2010) used 
Nucmer analysis of the castor bean assembly, with a cut-off of 3 times coverage or 
greater, to generate SNP typing assays.  Putative SNPS were subsequently validated 
using a Sequenom iPlex mass array typer to sequence 48 SNPs.  Oliver et al., (2011) 
used 454 Sequencingª of the oat genome with a read depth of greater than four.  
They eliminated 55 % of the predicted SNPs based on conservation between reads of 
a single germplasm, eventually choosing SNPs that varied between 4 oat cultivars.  
Although the SNP calling criteria used in this study differed from the approaches 
used by other researchers, 20 X coverage with 100 % identity between contigs 
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should have been stringent enough to eliminate pseudo-SNPs.  The high level of 
polymorphism surrounding the putative SNP sites and the lack of identity to the 
reference strain may indicate that sequencing errors caused spurious results.  SNP 
discovery if commonly performed using 454 Sequencingª but there are other 
platforms, such as the Illumina Solexa or MiSeq which may be better suited for the 
task as, although the read lengths are shorter, they offer increased depth of coverage.  
The data obtained by Foster et al., (2010) using Sanger sequencing were more robust 
than the data generated for this study.  In spite of this, it was unsuitable for 
differentiation of R. communis, which confirms the theory that the R. communis 
populations have low genetic diversity (Allan et al., 2008; Foster et al., 2010; Chan 
et al., 2010).  Therefore targeted sequencing experiments could be repeated to enable 
conclusions to be formed.  However, this work was beyond the scope of this study 
since it was apparent that using six SNPs would not be sufficient to differentiate 
between cultivars of R. communis.   
 
More traditional approaches of population differentiation were investigated as an 
alternative to 454 Sequencingª, namely AFLP, RAPD, RFLP and SSR.  Low 
genetic diversity was observed with the cultivars tested with each method, with the 
exception of SSR analysis.  These results are in concordance with those reported by 
Allan et al., (2008).  The SSR assays designed for this study were able to 
differentiate between 13 cultivars, with a unique profile being generated for each 
one.  The dendrogram generated using the electrophoresis data was interesting as the 
Zibo cultivars clustered together, indicating that the technique is suitable for 
geographical differentiation of cultivars to a degree, however the sample size used in 
this study is much smaller than that used by other researchers.  In spite of this, the 
genomes assumed to originate in South America, Africa and China clustered closely 
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to each other.  This is in contrast to the data reported by Allen et al. (2008) who used 
UPGMA analysis to represent the SSR data that they produced from 41 cultivar 
accessions from around the world. They found a lack of geographical structure in 
their phylogenetic tree: accessions even from the same continent did not cluster 
together.  It is to be expected that different SSR assays would give different results 
and, accordingly, the SSR data obtained for this study was suitable for differentiation 
between each cultivar studied. However the number of samples examined was 
extremely small compared to the populations used by other researchers.  It is not 
anticipated that the SSR assays developed here would be more suitable for use than 
those developed by Allan et al., (2008), rather they may serve as a useful addition to 
their array.   It is also of note that a germplasm collection was not used, rather 
samples obtained from a commercial seed grower.  The utility of the six SSR assays 
developed for this study for differentiating between samples obtained from a 
germplasm database remains untested and was not appropriate for inclusion in this 
study.  However it would serve as an interesting starting point for further 
investigation of the technique.   
 
5.5 CONCLUSIONS 
Evidently, the subject of differentiating between strains of an organism with low 
genetic diversity, such as R. communis, is complex and is not going to be easily 
solved using one technique.  Microsatellite data were the most useful in terms of 
discriminatory power, however further investigation is required to determine whether 
the assays have the potential to differentiate between large numbers of strains.  
Additionally, it is more difficult to automate microsatellite analysis than SNP 
analysis which can be carried out on a larger scale using array technology or high 
resolution melt curve analysis.  Therefore, it is felt that a combination of classical 
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genetics and next generation sequencing will provide the information required for 
differentiation of R. communis strains in the near future. 
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6  GENERAL DISCUSSION 
    
6.1 OVERVIEW 
Almost all biological toxins are present on the Centers For Disease Control and 
Prevention (CDC) category A, B and C threat lists.  In the event of a biological 
attack it would be necessary to identify the causative agent.  An investigation of an 
unusual outbreak of disease may be undertaken using clinical or environmental 
samples using a variety of methods.  Microbiological culture is the gold standard for 
detection of human pathogens; however it is not suitable for detecting non-viable 
organisms or extracted toxins.  Culture may not therefore be suitable for detecting 
biological weapons as the organisms may not survive for prolonged periods in 
samples such as dust, soil or water.  Additionally, not all biological toxins are of 
bacterial or fungal origin and, as such, the use of a culture-based method would 
preclude the identification of plant or animal toxins.  Antibody methods are routinely 
used for toxin detection as they do not rely on the survival of the causative agent for 
positive identification.  Antibody assays such as ELISA are sensitive, specific and 
simple to use once developed.  However it can be difficult to obtain good quality 
antibodies to toxins, since they kill their host before eliciting an effective immune 
response, requiring toxoids to be used in immunisation schedules instead.  
Ultrasensitive detection would be desirable in a BTWC scenario, in order to avoid 
false negative results. Additionally, it would be important to use a variety of 
techniques for analysis of biological weapons, since both identification and 
confirmatory analysis using an orthologous method may be required.   For these 
reasons three nucleic acids based approaches were investigated, namely PCR, 
immuno-PCR and genotyping using a variety of techniques. 
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6.1.1 PCR detection of toxins 
One of the initial areas of investigation was based on the premise that residual DNA 
could be detected in purified toxin and that this could be detected by PCR.  The way 
in which a toxin was purified was demonstrated to affect the quantity of DNA 
present in the sample, directly determining whether or not PCR was suitable as a 
detection method.  Acid and ammonium precipitation, the simplest form of toxin 
purification investigated and reportedly deployed during the Gulf war for the 
preparation of C. botulinum neurotoxin (Zilinskas, 1998), did not remove DNA, 
allowing PCR detection of the toxins.  This is a significant finding as PCR is known 
to be capable of amplifying trace amounts of DNA.  It is conceivable that trace 
analysis of toxin gene DNA would be extremely useful following a biological attack 
as it would facilitate detection in environmental samples such as soil or water 
(Romanowski et al., 1992; Paget et al., 1998), in turn informing forensics, attribution 
and disease surveillance.  However, not all of the toxins investigated contained 
sufficient DNA to allowed detection of the gene using PCR.  Ricin extracted in PET 
ether and purified using sepharose affinity chromatography did not contain any 
detectable DNA.  Similarly, SEB and alpha toxins produced commercially were not 
detectable using PCR.  With this in mind the decision to use PCR as a toxin detection 
method would have to be very carefully considered.  The origin of the sample could 
be used determine whether a suspect sample could have been purified by an expert 
capable of using technology that would be regarded as highly complex to non 
scientists, such as HPLC.  This in itself makes PCR analysis of toxins less suitable 
for routine use than the initial results obtained with C. botulinum neurotoxins would 
suggest.  In spite of this, the utility of PCR for analysis of toxin gene DNA should 
not be underestimated.  For example, it may be possible to take swab samples from 
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laboratory equipment or surroundings and obtain a positive PCR signal from residual 
toxin gene DNA.  Therefore PCR is considered to be a useful toxin detection method 
in specific scenarios.  With the aim of providing unequivocal and ultrasensitive 
detection of the toxin however, immuno-PCR was investigated.   
 
6.2 IMMUNO-PCR 
 
Six variants of immuno-PCR were developed and tested as part of this study, each 
using a different method to label a detection antibody with DNA.  This demonstrated 
that the specific method used to label the antibody with DNA was crucial to the 
success of the method.  The simplest method of I-PCR evaluated was originally 
reported by Sano et al., (1992).  Other more elegant I-PCR approaches were 
evaluated with less success.  The covalent linkage of a DNA tag to the antibody 
offered less sensitivity than the initial approach.  This phenomenon has also been 
observed by other researchers (He et al., 2007).  The addition of a biotin labelled 
DNA tag to a streptavidin containing immunoassay ÔsandwichÕ already containing 
biotin was crude and may be difficult to reproduce, however it offered a nine-fold 
increase in sensitivity.  The use of scFv antibodies in a more novel approach termed 
immuno-phage-PCR was also shown to offer increases of sensitivity of three orders 
of magnitude over the conventional ELISA.  This could be significant when studying 
samples that contain toxins at low concentrations, as may be found in suspect BW 
agent samples.  However, the generation of single chain antibodies for the specific 
purpose of developing an immuno-phage-PCR assay would be labour intensive and 
require the use of animal work that would be difficult to justify if existing 
monoclonal or polyclonal antibodies were available.  Therefore, although the 
techique showed promise it would only be suitable for converting existing 
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immunoassay utilising scFvs.  It may be that researchers would favour emerging 
technologies, such as those using gold nanoparticles or SERS (Graham and Faulds, 
2010) for example, over immuno-phage-PCR unless they have a particular 
requirement to generate single chain antibodies. Nevertheless, immuno-phage-PCR 
was demonstrated to offer a significant increase in sensitivity and, as such, should be 
considered for future BW sample analysis. 
 
In contrast to the practical and ethical difficulties faced by researchers when 
generating antibodies, there would be few objections to a research team generating 
aptamers to a target molecule.  Aptamers are theoretically simple and rapid to 
generate without the use of animals or expensive cell line maintenance.  Therefore 
they have many advantages over antibodies.  As such, they were investigated as part 
of this thesis with the aim of testing aptamers for detection of ovalbumin in ELISA 
and immuno-PCR formats.  One clone dominated the aptamer pool after 17 rounds of 
selection, indicating that the process had been successful.  However, all experiments 
carried out utilising the clone 5 aptamer resulted in a high non-specific background, 
including immuno-aptamer-PCR.  Generally, aptamers are reported to be generated 
with ease although the success of an experiment can vary depending on aptamer 
length (Fan et al. 2008) and the number of cycles carried out (Bruno and Keil 2002).  
The failure of the experiment could have been attributed to a number of things 
including steric hinderance caused by a change in solid support or the addition of 
biotin.  It is thought that the aptamer may have had an affinity for streptavidin, an 
avidin derivative also from egg white.  It may also be possible that the Sybr Green I 
used to report aptamer amplification may have remained bound to the double 
stranded aptamers, limiting secondary structure formation.  Single stranded, Sybr 
Green I-free aptamers were also demonstrated to have poor affinity for ovalbumin, 
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however they were derived from the double stranded clone 5 aptamers.  As such, 
they would not represent single stranded aptamers developed using a ss-DNA 
SELEX experiment.  A second experiment was carried out using end-point PCR to 
amplify a biotin labelled aptamer pool, however it was not possible to evaluate the 
resulting aptamers fully during this study. 
 
The failure of the experiment means that the question of whether aptamers have a 
useful role in immuno-PCR experiments remains unanswered.  Although immuno-
aptamer-PCR had not been reported at the start of this study, it has subsequently been 
used very successfully by Yoshida et al., (2009) and Pinto et al., (2009).  Yoshida et 
al. (2009) used a trace amount of unmodified RNA aptamers from round 18 to detect 
16 attomoles of vascular endothelial growth factor, thereby proving the utility of the 
technique.  Likewise, Pinto et al., (2009) used 50 nM of aptamer to detect 450 
femtomoles of thrombin.  Although it was not possible to evaluate immuno-aptamer-
PCR for this thesis, it would be interesting to generate aptamers to a different toxin 
with the aim of re-evaluating the method, this time including near neighbour and 
competitor proteins in the screening process. Immuno-aptamer PCR may not gain 
wide acceptance as a detection method for toxins where antibodies already exist.  
However, they have numerous advantages over antibodies which should make them 
attractive to researchers.  They can be generated within a week if efforts are focused, 
in contrast to the lengthy immunisation schedule required for antibody production.  A 
Home Office license is not required for SELEX experiments.  Aptamers can be 
generated to highly toxic materials, therefore they may be useful for trace analysis of 
toxins, chemicals or haptens that are not detectable by other means.  SELEX can be 
carried out in the presence of competitor and near neighbour molecules, potentially 
increasing the specificity of the aptamers generated.  Similarly, aptamers could be 
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designed to function in non-physiological conditions by simply changing the pH or 
solvent used as the binding buffer.  Therefore, although the experiments presented 
here were unable to demonstrate the utility of aptamers, their use in immuno-
aptamer-PCR for BW agent analysis scenarios is recommended.   
 
6.3 GENETIC DIFFERENTIATION OF R. COMMUNIS 
As discussed previously PCR may not always be suitable for toxin detection.  
However, on the occasions it enables the positive identification of a toxin, further 
genetic analysis would be useful.  Genetic differentiation of bacterial species is well 
established and numerous methods exist for genotyping bacteria including the BW 
agents Bacillus anthracis (Rasko et al., 2011), Yersinia pestis (Vogler et al. 2011) 
and C. botulinum (Macdonald et al., 2008).  However there have been difficulties in 
developing similar methods for Ricinus communis as it has low genetic diversity 
(Allan et al., 2008; Foster et al. 2010; Chan et al., 2010).  The use of 454ª 
Sequencing as a SNP discovery tool has been reported for plant species other than R. 
communis (Foster et al., 2010; Oliver et al., 2011).  On this occasion, the 454ª 
Sequencing generated 179 megabases of data from R. communis Hale strain.  
Although this is a vast amount of sequence that would have taken years to generate a 
decade ago, it represents coverage of only 85 % of the genome.  It would have been 
preferable to work with between two and five times coverage, to ensure that the data 
were high quality.   
 
 Six SNPs identified using the Roche reference mapper software were investigated 
further, each occurring in twenty contigs or more with 100 percent homology.  
However, further investigation of the SNPs using targeted DNA sequencing 
eliminated four of the SNP sites, with two yielding sequence with homology to the 
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Hale strain.    The sequence data generated using the two genuine SNP sites was 
suitable for phylogenetic analysis, however two SNPs are not sufficient to 
differentiate between cultivars of a species with such low diversity.  Similar results 
were obtained using the more traditional genotyping methods AFLP, RAPD and 
RFLP.  SSR (or microsatellite) analysis was the only method suitable of 
discriminating between the limited number of strains.  Therefore, it would be 
interesting to carry out the same SSR analysis on a larger R. communis sample set in 
future, such as a germplasm database.  It would also be ideal to repeat the 454ª 
Sequencing analysis of R. communis Zibo 1 to obtained more coverage of the 
genome, if only to conclude that the complete genome does not contain sufficient 
SNPS to enable strain differentiation.  It would also be worthwhile repeating the 
454ª Sequencing with a different strain for comparison.   In summary, the R. 
communis genotyping experiments presented in this study were insufficient to allow 
discrimination on their own. Nevertheless, ricin remains high on the CDC threat list 
and it is expected that efforts to continue this work will be made by a number of 
research groups.   
6.4 CONCLUDING REMARKS 
 
PCR is widely acknowledged as suitable for inferring the presence of a toxin from 
the amplification of its coding gene in clinical or food samples.  However, this thesis 
has demonstrated that it is not suitable for detecting biological weapon samples that 
have been purified using molecular biology techniques such as HPLC or affinity 
chromatography.  As biological weapons may be used in which ever form an 
aggressor chooses, PCR can not be used as a primary method of toxin detection as 
there is the chance that the technique would produce false negative results.  
Therefore, PCR is not considered to be a useful primary method for toxin detection.  
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However, the sensitivity of PCR and the stability of DNA in the environment suggest 
that PCR would be appropriate for forensic analysis, either with or without the 
trigger of a positive result using a method such as ELISA.  Furthermore, a positive 
PCR result may serve as the starting point of a full genotyping investigation; 
therefore PCR is thought to be a useful approach to toxin detection.  Genetic 
differentiation of biological weapon samples may be useful for attribution of an 
attack to individuals or nations so it was also studied as part of this thesis.  Although 
the volume of data generated here was insufficient for complete discrimination of R. 
communis cultivars, it may prove to be crucial as this area of science continues to 
develop.  Immuno-PCR is considered to be a useful method for toxin detection in 
samples of low concentration.  Although time consuming, the additional sensitivity 
of detection obtained using I-PCR may be useful in certain scenarios.  For example, 
I-PCR may not be suited to routine use in laboratories in which adequate detection 
limits are achieved using a well optimised sample extraction method.  However, it 
may be the only method available to detect a sample of low concentration.  Therefore 
it is particularly applicable to BW agent detection where a false negative would have 
far reaching implications.  Additionally, I-PCR lends itself well to automation and it 
is conceivable that many antigens would be detectable simultaneously once the 
instrumentation necessary for multiplex PCR is developed further.  In summary, both 
the PCR and immuno-PCR assays developed here may prove useful in future 
biological weapons investigations.  The 454ª sequence and SSR data may be useful 
for differentiating between R. communis cultivars when used with other techniques.  
Therefore, nucleic acids are considered to be useful for toxin detection.   
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7  APPENDICES 
Table 7.1 General Bacterial DNA test panel used in this study. 
 
Strain Origin (if known) 
Bacillus anthracis Ames 
Coxiella burnettii 9 mile 
Yersinia pseudotuberculosis NCTC 10275 
Yersinia enterocolitica NCTC 10461 
Pseudomonas aeruginosa NCTC 606 
Pseudomonas maltophila NCTC 10257 
Pseudomonas mendocina NCIMB 10541 
Pseudomonas pickettii NCTC 11149 
Pseudomonas testoni NCTC 10698 
Burkholderia mallei NCTC 10229 
Burkholderia pseudomallei NCTC 4845 
Burkholderia cepacia NCTC 10743 
Staphylococcus aureus FRI 361 
Staphylococcus typhimurium SL1344 
Shigella sonnei 9744 
Shigella boydii 9327 
Shigella dysemberiae 9952 
Shigella flexneri 8517 
Vibrio cholera 01 E105239 
Vibrio cholera 01EL E87019 
Escherichia. coli 0109 E8017 
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Erwinia herbicola 490291A 
Francisella novicida  
Bacillus globigii  
Bacillus subtilis 10073 
Bacillus subtilis 3610 
Bacillus cereus 10320 
Bacillus cereus 11143 
Bacillus cereus 11145 
Bacillus cereus  
Bacillus cereus 9945 
Bacillus cereus 9939 
Bacillus cereus 7464 
Bacillus cereus 2599 
Bacillus thurengiensis  
Clostridium botulinum B  
Clostridium botulinum E  
Clostridium botulinum F  
Clostridium bifermentans  
Clostridium sordeii  
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Clostridium histolyticum  
Clostridium chauvoi  
Clostridium perfringens  
Clostridium perfringens  
Clostridium perfringens  
Clostridium perfringens  
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